Document:

EX-10.22

 Exhibit 10.22 
 API DEVELOPMENT AGREEMENT 
 This API DEVELOPMENT AGREEMENT (this
“Agreement”) is entered into as of July 12, 2012 (the “Effective Date”) by and between Aratana Therapeutics Inc., a Delaware corporation (“Aratana”) and RaQualia Pharma Inc., a Japanese
corporation (“RaQualia”). Aratana and RaQualia are referred to herein individually as a “Party” and collectively as the “Parties”. 

RECITALS 

WHEREAS, the Parties have entered into that certain Exclusive IP License Agreement for RQ-00000007 dated December 27,
2010, as amended on July 12, 2012 (the “License Agreement”), pursuant to which RaQualia granted Aratana an exclusive, worldwide license to RQ-00000007 Technology for animal use only (as that term is defined in the License
Agreement); 
 WHEREAS, Aratana desires to develop the API (as defined below) and obtain the API Information (as defined
below) for animal use as licensed by RaQualia under the License Agreement. 
 WHEREAS, RaQualia desires to have Aratana
develop the API and obtain the API Information for human use for RaQualia and a third party designated by RaQualia; and 

WHEREAS, the Parties now agree that Aratana will develop the API and obtain the API Information not only for animal use to be
exploited by Aratana but also for human use to be exploited by RaQualia or a third party designated by RaQualia pursuant to the terms and conditions of this Agreement. 
 NOW, THEREFORE, in consideration of the foregoing recitals, the terms and provisions set forth herein and other valuable and sufficient consideration, the receipt and sufficiency of which is
hereby acknowledged, and intending to be legally bound hereby, the Parties agree as follows: 
 AGREEMENT 

Article 1 

Definitions 
  

	1.1.	“Act” means the Federal Food and Drug Cosmetic Act of the United States of America, United States Code Title 21, Chapter I, as
amended, and the regulations and guidelines promulgated thereunder from time to time, or any applicable European Union counterpart thereof. 

  

	1.2.	“Affiliate” of a Party means any Person, which controls, is controlled by, or is under common control with such Party, where “control”
means ownership of fifty percent (50%) or more of the outstanding voting securities. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

1 

	1.3.	“Applicable Laws” means the applicable, federal, state and local laws, and regulations applicable to this Agreement, including, without
limitation, the Act. 

  

	1.4.	“API” means the active pharmaceutical ingredient of the RQ-00000007 Technology, also known as AT-001. 

 

	1.5.	“API Information” means all data, quality control information, manufacturing processes, drug manufacturing file (“DMF”),
chemistry, manufacturing and controls (“CMC”) packages, and all other material and information reasonably needed by a third party manufacturer to manufacture commercially suitable API. 

 

	1.6.	“cGMPs” means current Good Manufacturing Practices as established by the FDA Standards as promulgated under and in accordance with the Act,
Title 21 of the U.S. Code of Federal Regulations, Parts 210, 211, as each may be amended from time to time, or any successors thereto, or any applicable European Union counterpart thereof. 

 

	1.7.	“CMC Technical Section” means a phrased review component of the Investigational New Animal Drug Application (NADA) which includes CMC of an API
and a drug product based on the API reviewed by the Center for Veterinary Medicine’s Division of Manufacturing. Approval of CMC Technical Section is required to gain NADA approval. 

 

	1.8.	“Confidential Information” means, with respect to any party (the “Disclosing Party”), any information relating to the
Disclosing Party or the Disclosing Party’s business (including, but not limited to, technical information, research, personnel, financial, marketing, strategic or other information, and, in the case of Aratana, the API Information, API, and
Samples) that is disclosed in writing to the other party (“Receiving Party”) in the course of the Parties’ negotiation of or performance under this Agreement (it being understood that if any information is disclosed verbally,
in order for that information to be considered Confidential Information, the Disclosing Party must notify the Receiving Party in writing that the information is Confidential Information within [***] days after disclosure or must be disclosed under
circumstances such that the Receiving Party knows or reasonably should know such information is to be considered Confidential Information), but shall not include information that the Receiving Party can prove: (a) the Receiving Party knew,
owned or controlled prior to receipt from the Disclosing Party as shown by written records; (b) is or becomes public through no fault of the Receiving Party or any Affiliate thereof; (c) is developed by the Receiving Party independent of
any disclosure from the Disclosing Party; or (d) the Receiving Party obtains from a third party not under a confidentiality obligation to the Disclosing Party. 

 

	1.9.	“FDA” means the United States Food & Drug Administration, or any successor thereto. 

 

	1.10.	“Governmental Authority” means any federal, state, local or foreign governmental authority, agency or other body having jurisdiction over a
Party. 

  

	1.11.	“Intellectual Property Rights” means patent rights, copyrights, database rights, trademark rights, trade secret rights, and any and all other
intellectual property rights available under any applicable laws 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

2 

	1.12.	“Person” means any natural person, corporation, partnership, limited liability company, joint venture, trust, proprietorship, or other entity or
organization. 

  

	1.13.	“Samples” means samples of the API obtained during the development of the API. 

 

	1.14.	“Specifications” is defined in Section 2.1. 

 Article 2 
 Development, Ownership, and Licensing of API 

 

	2.1.	Specification. The specifications for the API to be developed and manufactured by Aratana pursuant to this Agreement are provided in Exhibit A
hereto. (the “Specifications”). 

  

	2.2.	API Development. Aratana will use commercially reasonable efforts to develop and establish a manufacturing process for the API that is cGMP compliant and
fully characterized and substantially conforms to the Specifications. The target date for completion is no later than [***], provided that Aratana could be delayed due to causes beyond Aratana’s reasonable control. In case that Aratana finds
the causes of delay, Aratana should promptly notify RaQualia the causes and the Parties will negotiate and set the next target date. Aratana anticipates all development of the API will take place at Cambridge Major Laboratories
(“CML”) and will be performed as generally described in [***] attached hereto as Exhibit B. 

  

	2.3.	Ownership of API. Aratana will exclusively own all right, title, and interest in and to the API and to all Samples and API Information created, conceived,
developed, made, or otherwise obtained in the course of development of the API, including all Intellectual Property Rights therein. 

  

	2.4.	API License. Subject to the terms and conditions of this Agreement, including payment to Aratana of the amount set forth in Section 5.1 hereof, upon
completion of the development of the API as set forth in Section 2.2 hereof, Aratana will grant RaQualia a limited, non-exclusive right and license to use any Samples and API Information provided by Aratana to RaQualia solely for:
(a) conducting research and development; (b) filing applications for regulatory approval; and (c) manufacturing and commercializing drugs incorporating the API for human use only. RaQualia may sublicense the rights granted herein
solely in conjunction with licensing RQ-0000007 Technology to a third party for human use only and may transfer the rights granted herein solely in conjunction with transferring RQ-0000007 Technology to a third party for human use only. RaQualia
covenants and agrees that this license will not permit the Samples, API Information, or API to be used for the manufacture or commercialization of drugs for use in the animal field. 

Article 3 

Supply of API 
  

	3.1.	Sample API. Upon completion of the development of the API (the “Completion Date”), Aratana will supply RaQualia up to [***] of API [***].

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

3 

	3.2.	Supply of API after the Completion Date. With respect to the API which will be manufactured after the Completion Date, the Parties agree to negotiate in
good faith an API Supply Agreement based on the form attached hereto as Exhibit C (the “Supply Agreement”), provided that Aratana has no obligation to supply to RaQualia the API manufactured after the Completion Date
unless and until the Parties have entered into the Supply Agreement. In addition, the Parties agree that all of the provisions in Exhibit C are negotiable and modifiable under such negotiation provided hereof. 

 

	3.3.	Other Suppliers. RaQualia and its licensees may use any third party manufacturer, other than Aratana’s contracted supplier (i.e., CML) to manufacture
the API on behalf of RaQualia and/or its licensees, and upon RaQualia’s request, Aratana shall provide RaQualia and RaQualia’s other licensees in the field of human health (“Other Licensees”) with copies of all API
Information and applicable Samples necessary for the manufacture of the API. Notwithstanding the foregoing, RaQualia and its licensees may use Aratana’s contracted supplier in the event RaQualia terminates this Agreement under Section 8.3
or 8.4 or the Supply Agreement under Section 7.3 or 7.4. 

 Article 4 

Quality Control 
  

	4.1.	Compliance. Aratana represents and warrants that the Sample API supplied to RaQualia pursuant to Section 3.1 hereof shall be manufactured, stored and
supplied by Aratana in accordance with applicable cGMPs and shall substantially meet the Specifications. In the event Aratana is in breach of a representation or warranty set forth in this Section 4.1, then, as RaQualia’s sole and
exclusive remedy, Aratana will, replace, free of charge, the API subject to the breach. 

  

	4.2.	Changes to Specifications. Any change to Specifications shall require each Party’s mutual agreement, to be negotiated in good faith between the
Parties. The Parties will report any change as required by the FDA and/or any applicable Governmental Authority. Aratana shall have at least [***] months from date of the Parties’ agreement to implement such changes to the Specifications. If
any such change will result in an increase or decrease in the manufacturing costs, timing, or requirements of the API, the Parties shall negotiate in good faith and agree upon corresponding adjustments in this Agreement. 

 

	4.3.	Disclaimer of Warranties. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 4.1, ARATANA GIVES NO WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE SAMPLES, THE
API INFORMATION, THE API, OR THE MANUFACTURE THEREOF. EXCEPT AS PROVIDED IN SECTION 4.1, THE SAMPLES, THE API INFORMATION, AND THE API ARE PROVIDED “AS IS.” ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION,
WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT OF THIRD PARTY RIGHTS, ARE EXPRESSLY DISCLAIMED. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

4 

	4.4.	LIMITATION OF LIABILITY. EXCEPT FOR BREACH OF ARTICLE 6 OR ARISING OUT OF A PARTY’S INDEMNIFICATION OBLIGATIONS, IN NO EVENT WILL EITHER PARTY BE
LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INDIRECT, PUNITIVE, EXEMPLARY, SPECIAL OR INCIDENTAL DAMAGES, INCLUDING ANY LOST DATA AND LOST PROFITS, ARISING FROM OR RELATING TO THIS AGREEMENT, THE API, THE SAMPLES, OR THE API
INFORMATION. ARATANA’S TOTAL CUMULATIVE LIABILITY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE API, THE SAMPLES, AND API INFORMATION, WHETHER IN CONTRACT OR TORT OR OTHERWISE, WILL NOT EXCEED THE TOTAL AMOUNT OF FEES PAID BY RAQUALIA UNDER
THIS AGREEMENT. 

 Article 5 
 Purchase Price/Payment 
  

	5.1.	API Development Cost. To offset some of the costs incurred by and to be incurred by Aratana to develop a cGMP compliant and fully characterized API that
is sufficient for use in FDA monitored studies to prove safety and efficacy in Aratana’s target specifies, RaQualia will pay Aratana (USD) $1.6 million as follows: 

 

	 	a)	(USD) $800,000 due upon the execution of this Agreement; and 

  

	 	b)	(USD) $800,000 due upon the delivery of [***] of the API that (i) is cGMP compliant, (ii) substantially meets the Specifications, and (iii) conforms
to International Conference on Harmonisation (ICH) guidelines for new drug substances. The API will be suitable for use in human clinical trials, but not necessarily for commercialization. Within [***] business days after receiving the
API, RaQualia must send to Aratana a written notice of acceptance or rejection of the API, and if RaQualia is rejecting the API, RaQualia must describe in writing in detail the basis for the rejection. Failure to provide such notice within such
period or any use of the API other than for purposes of determining acceptance or rejection will be deemed acceptance of the API by RaQualia. Upon receiving a written notice of acceptance from RaQualia, Aratana will send an invoice to RaQualia.

 RaQualia will make all payments due under Section 5.1 within [***] days of the receipt of the invoice. 

Article 6 

Confidentiality 
 During
the terms of this Agreement and for a period of [***] years following the termination or expiration of this Agreement, each Party shall hold in confidence and use only in furtherance of its rights and obligations under this Agreement all
Confidential Information that it acquires from the other Party pursuant to this Agreement, unless (a) the Disclosing Party consents to the Receiving Party’s disclosure or use, or (b) disclosure of the Disclosing Party’s
Confidential 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

5 

 
Information by the Receiving Party is required by order of any Governmental Authority, in which event the Receiving Party will notify the Disclosing Party of that order as soon as practicable,
shall use reasonable efforts (at the Disclosing Party’s expense) to obtain a protective order covering the Confidential Information and shall disclose only such Confidential Information that its legal counsel determines is legally required.
Each Party shall make Confidential Information that it acquires from the other Party pursuant to this Agreement available only to those of its Affiliates, directors, officers, employees, consultants, advisors or representatives who need to have
access thereto for the purposes of this Agreement and who are bound by an obligation of confidentiality consistent with the provisions herein. 
 Article 7 
 Indemnification 

 

	7.1.	By Aratana. Aratana will defend, indemnify, and hold RaQualia, its Affiliates, and their directors, officers, employees, and agents harmless from and
against any and all claims, losses, liabilities, damages, costs, and expenses (including attorneys’ fees, expert witness fees, and court costs) directly or indirectly arising from or relating to any negligence, willful misconduct, or violation
of Applicable Laws by Aratana or its directors, officers, employees, or agents in the performance of this Agreement or in connection with the development of the API. 

 

	7.2.	By RaQualia. RaQualia will defend, indemnify, and hold Aratana, Aratana’s Affiliates, and their directors, officers, employees, and agents harmless
from and against any and all claims, losses, liabilities, damages, costs, and expenses (including attorneys’ fees, expert witness fees, and court costs) directly or indirectly arising from or relating to (i) any claims based on the use of
any API, API Information, or products incorporating the API Information by RaQualia, its licensees, its manufacturers, its distributors, or any of their customers, or (ii) any negligence, willful misconduct, or violation of Applicable Laws by
RaQualia or its directors, officers, employees, or agents in the performance of this Agreement or in connection with the use of the API, API Information, or products incorporating the API. 

 

	7.3.	Indemnity Conditions. A Party’s obligation to indemnify as provided in this Agreement is conditioned upon the indemnified Party promptly notifying
the indemnifying Party in writing within a reasonable period of time of any and all claims for which the indemnified Party is entitled to indemnification, giving the indemnifying Party sole control of the defense thereof and any related settlement
negotiations, and indemnified Party cooperating and, at indemnifying Party’s request and expense, assisting in such defense. The indemnified Party may participate in the defense of the claim at its own expense with counsel of its own choosing.
The indemnifying Party may not settle any such claim without the indemnified Party’s prior written consent. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

6 

 Article 8 
 Effective Date, Term and Termination 
  

	8.1.	Term. This Agreement shall commence on the Effective Date and, unless terminated earlier as provided below, shall continue in full force and effect until
Aratana has obtained FDA approval of a CMC Technical Section. 

  

	8.2.	Termination by Aratana for Material Breach. Aratana may terminate this Agreement for a material breach by RaQualia if RaQualia fails to cure any such
breach within [***] days (or within [***] days in the event of failure to pay any amounts owed by RaQualia hereunder) after receipt of written notice from Aratana or any of its Affiliates, specifying such breach. 

 

	8.3.	Termination by RaQualia for Material Breach. RaQualia may terminate this Agreement for a material breach of this Agreement by Aratana if Aratana fails to
cure any such breach within [***] days after receipt of written notice from RaQualia specifying such breach. 

  

	8.4.	Termination for Cause. This Agreement may further be terminated for cause at any time prior to its expiration for the following reasons: (a) by
either Party, if a petition in bankruptcy with respect to the other Party is filed or if such other Party is liquidated or if a trustee is appointed, provided that in an involuntary bankruptcy proceeding, such right of termination shall only become
effective if the proceeding is not dismissed within [***] days of the filing; or (b) by either Party, upon a termination or expiration of the License Agreement. 

 

	8.5.	Termination for FDA Governmental Action. If any FDA governmental action occurs which prevents Aratana from developing and supplying the API as required
under this Agreement (“FDA Governmental Action”), then Aratana and RaQualia will work together to establish a plan of action for handling the particular FDA Governmental Action. If the Parties are unable to agree on such a plan of
action, then either Party may terminate this Agreement upon reasonable written notice to the other Party, not less than [***] days. 

  

	8.6.	 Effect of Termination. In the event this Agreement is terminated for cause by Aratana pursuant to Sections 8.2 or 8.4(a), then all
licenses granted by Aratana to RaQualia under this Agreement will be revoked and RaQualia will cease all further use of the API Information. Otherwise, in the event this Agreement expires or is terminated pursuant to Section 8.4(b) or 8.5 or
terminated by RaQualia pursuant to Section 8.3 or 8.4(a), RaQualia’s license as set forth in Section 2.4 shall survive termination or expiration of this Agreement, provided that the license set forth in Section 2.4 shall
immediately terminate in the event RaQualia is in breach of Section 2.4 or any other term or condition of this Agreement that survives termination or expiration and fails to cure such breach within [***] days of receiving written notice
thereof. For avoidance of doubt, after termination or expiration of this Agreement, RaQualia may use any Samples and API Information provided by Aratana for (a) conducting research and development; (b) filing applications for regulatory
approval; and (c) manufacturing and commercializing drugs 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

7 

	 	
incorporating the API for human use, if the license granted under Section 2.4 is to survive as stated in this Section 8.6. In addition, the Parties agree that if this Agreement is
terminated prior to the Completion Date, the Supply Agreement will automatically terminate. 

  

	8.7.	Transfer of Ownership. In the event Aratana ceases the development of the API or RQ-00000007 Technology for any reason either directly or through an
assignee, successor, or licensee, and if requested by RaQualia, Aratana will negotiate with RaQualia in good faith the terms (including payment of applicable fees) under which Aratana would transfer to RaQualia all ownership in the API as provided
for in Section 2.4, any remaining Samples and the API, provided that under no circumstance does Aratana have any obligation to transfer such ownership to RaQualia. 

 

	8.8.	Survival. Upon termination or expiration of this Agreement, Sections 2.3, 2.4 (solely as stated in Section 8.6), 4.1, 4.3, 4.4, 5.1, and 8.6 and
Articles 1, 3, 6, 7, and 9 will survive. 

 Article 9 

General 
  

	9.1.	Notice. Any notice, approval, authorization, consent, or other communication required or permitted to be delivered to either Party under this Agreement
must be in writing and will be deemed properly delivered, given, and received (i) when delivered by hand, or (ii) three (3) business days after delivery by international courier or express delivery service (return receipt requested).
All notices shall be sent to address set forth below (or to such other address as may be designated by a Party by giving written notice to the other party pursuant to this Section 9.1): 

 

							
		 	 If to RaQualia to:
  

RaQualia Pharma, Inc.
 5-2 Taketoyo, Aichi
470-2341
 Japan
 Attention:
President
 Phone No.: 89 904 790 3811
	  	 If to Aratana, to:
  

Aratana Therapeutics Inc.
 1901 Olathe
Boulevard
 Kansas City, KS 66103

USA
 Attention: President & COO

Phone No.: 913-951-2132
	  	

  

	9.2.	 Governing Law; Arbitration. This Agreement will be construed in accordance with and governed in all respects by the laws of the State of
New York, USA. Any dispute, controversy or claim arising out of or in connection with this Agreement, or breach, termination or invalidity thereof, shall be settled by arbitration in accordance with the commercial arbitration rules of the
International Chamber of Commerce (“ICC”). The arbitral tribunal shall be composed of three arbitrators, one to be appointed by Aratana and one to be appointed by RaQualia and the chairman to be appointed by the two arbitrators. If
the two aforementioned Parties have not appointed their arbitrators within [***] weeks from the request of the other Party, or the two arbitrators have not agreed on the chairman within three weeks after their appointment, the ICC shall appoint the
arbitrator or the chairman, as the case may be. In the event arbitration is requested by 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

8 

	 	
RaQualia, the place of arbitration shall be [***]; in the event arbitration is requested by Aratana, the place of arbitration shall be [***]. The arbitration proceedings will be conducted in
English. The results of the arbitration procedure will be considered Confidential Information of the Parties. Any arbitration decision rendered will be final and binding, and judgment thereon may be entered in any court of competent jurisdiction.
Notwithstanding this Section, neither Party will be required to arbitrate any dispute or controversy relating to any actual or threatened unauthorized use or disclosure of its intellectual property or confidential information.

  

	9.3.	Assignment. Neither Party may assign or transfer this Agreement or any of its rights hereunder without the prior written consent of the other Party.
Notwithstanding the foregoing, either Party may assign this entire Agreement or any of its rights hereunder, upon notice to the other Party but without such other Party’s consent, (i) to any of the assigning Party’s Affiliates; and
(ii) to a third party in connection with a merger, change in control, or sale of all or substantially all of the assets or business of the assigning Party pertaining to this Agreement. This Agreement will be binding upon and shall inure to the
benefit of the Parties hereto and their respective successors and assigns. 

  

	9.4.	Waiver. All waivers must be in writing and signed by an authorized representative of the Party to be charged. Any waiver or failure to enforce any
provision of this Agreement on one occasion will not be deemed a waiver of any other provision or of such provision on any other occasion. 

  

	9.5.	Severability. If any provision of this Agreement is unenforceable, such provision will be changed and interpreted to accomplish the objectives of such
provision to the greatest extent possible under applicable law and the remaining provisions will continue in full force and effect. 

  

	9.6.	Independent Contractors. This Agreement is not intended to establish any partnership, joint venture, employment, or other relationship between the Parties
except that of independent contractors. 

  

	9.7.	Construction. The section headings in this Agreement are for convenience of reference only, will not be deemed to be a part of this Agreement, and will
not be referred to in connection with the construction or interpretation of this Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting Party will not be applied in the construction or
interpretation of this Agreement. As used in this Agreement, the words “include” and “including,” and variations thereof, will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words
“without limitation.” All references in this Agreement to “Sections” are intended to refer to Sections of this Agreement. 

  

	9.8.	Counterparts. This Agreement may be executed in several counterparts, each of which will constitute an original and all of which, when taken together,
will constitute one agreement. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

9 

	9.9.	English Language. This Agreement has been prepared in the English language and the English language shall control its interpretation. In addition, all
notices required or permitted to be given hereunder, an all written, electronic, or other communications between the parties regarding this Agreement shall be in the English language 

 

	9.10.	Entire Agreement. This Agreement sets forth the entire understanding of the Parties relating to the subject matter hereof and supersedes all prior
agreements and understandings between the Parties relating to the subject matter hereof. This Agreement may not be amended, modified, altered, or supplemented other than by means of a written instrument duly executed and delivered on behalf of both
Parties. 

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above
written. 
  

									
	RaQualia Pharma, Inc.	 		 	Aratana Therapeutics, Inc.
					
	By:	 	 /s/ Atsushi Nagahisa
	 		 	By:	 	 /s/ David K. Rosen

	Name:	 	Atsushi Nagahisa	 		 	Name:	 	David K. Rosen
	Title:	 	President & CEO	 		 	Title:	 	President & COO
	Date:	 	July 23, 2012	 		 	Date:	 	12 July 12

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

10 

 EXHIBIT A – SPECIFICATION OF RQ-00000007 

 

							
	 TEST
DESCRIPTION
	  	METHOD	 	COMPONENTS	 	ACCEPTANCE
CRITERIA
	 [***]
	  		 		 	
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  		 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  		 		 	
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]
	 [***]
	  	[***]	 	[***]	 	[***]

 Note 1: [***] 
 Note 2: [***] 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

11 

 EXHIBIT B - CML PROPOSAL 

[***] 
 [A total
of 13 pages have been redacted from this Exhibit B.] 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

12 

 EXHIBIT C - API SUPPLY AGREEMENT 

This API SUPPLY AGREEMENT (this “Agreement”) is entered into as of
            (the “Effective Date”) by and between Aratana Therapeutics Inc., a Delaware corporation (“Aratana”) and RaQualia Pharma Inc., a Japanese
corporation (“RaQualia”). Aratana and RaQualia are referred to herein individually as a “Party” and collectively as the “Parties”. 

RECITALS 

WHEREAS, the Parties have entered into that certain API Development Agreement dated July 12, 2012 (the “Development
Agreement”), pursuant to which Aratana carried out development of the API (as defined in the Development Agreement); and 
 WHEREAS, the Parties now desire for Aratana to supply the API to RaQualia pursuant to the terms and conditions of this Agreement. 

NOW, THEREFORE, in consideration of the foregoing recitals, the terms and provisions set forth herein and other valuable and
sufficient consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound hereby, the Parties agree as follows: 
 AGREEMENT 
 Article 1 

Definitions 
  

	1.1	“Act” means the Federal Food and Drug Cosmetic Act of the United States of America, United States Code Title 21, Chapter I, as
amended, and the regulations and guidelines promulgated thereunder from time to time, or any applicable European Union counterpart thereof. 

  

	1.2	“Affiliate” of a Party means any Person, which controls, is controlled by, or is under common control with such Party, where “control”
means ownership of fifty percent (50%) or more of the outstanding voting securities. 

  

	1.3	“Applicable Laws” means the applicable, federal, state and local laws, and regulations applicable to this Agreement, including, without
limitation, the Act. 

  

	1.4	“API” means the active pharmaceutical ingredient of the RQ-00000007 Technology, also known as AT-001. 

 

	1.5	“API Information” means all data, quality control information, manufacturing processes, drug manufacturing file (“DMF”),
chemistry, manufacturing and controls (“CMC”) packages, and all other material and information reasonably needed by a third party manufacturer to manufacture commercially suitable API. 

 

	1.6	“cGMPs” means current Good Manufacturing Practices as established by the FDA Standards as promulgated under and in accordance with the Act,
Title 21 of the U.S. Code of Federal Regulations, Parts 210, 211, as each may be amended from time to time, or any successors thereto, or any applicable European Union counterpart thereof. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

13 

	1.7	“Confidential Information” means, with respect to any party (the “Disclosing Party”), any information relating to the.
Disclosing Party or the Disclosing Party’s business (including, but not limited to, technical information, research, personnel, financial, marketing, strategic or other information, and, in the case of Aratana, the API Information, API, and
Samples) that is disclosed in writing to the other party (“Receiving Party”) in the course of the parties’ negotiation of or performance under this Agreement (it being understood that if any information is disclosed verbally,
in order for that information to be considered Confidential Information, the Disclosing Party must notify the Receiving Party in writing that the information is Confidential Information within [***] days after disclosure or must be disclosed
under circumstances such that the Receiving Party knows or reasonably should know such information is to be considered Confidential Information), but shall not include information that the Receiving Party can prove: (a) the Receiving Party
knew, owned or controlled prior to receipt from the Disclosing Party; (b) is or becomes public through no fault of the Receiving Party or any Affiliate thereof; (c) is developed by the Receiving Party independent of any disclosure from the
Disclosing Party; or (d) the Receiving Party obtains from a third party not under a confidentiality obligation to the Disclosing Party. 

  

	1.8	“FDA” means the United States Food & Drug Administration, or any successor thereto. 

 

	1.9	“Governmental Authority” means any federal, state, local or foreign governmental authority, agency or other body having jurisdiction over a
Party. 

  

	1.10	“Intellectual Property Rights” means patent rights, copyrights, database rights, trademark rights, trade secret rights, and any and all other
intellectual property rights available under any applicable laws 

  

	1.11	“Person” means any natural person, corporation, partnership, limited liability company, joint venture, trust, proprietorship, or other entity or
organization. 

  

	1.12	“Specifications” means specifications mutually agreed to by the Parties for the API and the manufacture thereof for use in human drug
development and commercial application. 

 Article 2 

Commercial Supply of API 
  

	2.1	Minimum Supply of API. Aratana agrees to sell RaQualia the API pursuant to the terms and conditions of this Agreement. During the term of this Agreement,
RaQualia shall purchase at least [X] [***] of API per contract year at a price of $[X] per [***]. In the event RaQualia fails to submit purchase orders (POs) for such amount during any contract year, Aratana shall charge RaQualia an amount
equal to the difference between (a) the amount RaQualia would have paid Aratana during the prior calendar year had the minimum amount of API been purchased, and (b) the amount of API actually purchased during the prior calendar year
multiplied by the cost of such API. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

14 

 Article 3 
 Quality Control 
  

	3.1	Compliance. Aratana represents and warrants that the API supplied to RaQualia pursuant to Section 2.1 hereof shall be manufactured, stored and
supplied by Aratana in accordance with applicable cGMPs and shall meet Specifications. In the event Aratana is in breach of a representation or warranty set forth in this Section 3.1, then, as RaQualia’s sole and exclusive remedy, Aratana
will, at its option, either: (a) replace, free of charge, the API subject to the breach, or (b) provide a refund to RaQualia for the non-conforming API. 

 

	3.2	Changes to Specifications. Any change to Specifications shall require each Party’s mutual agreement, to be negotiated in good faith between the
Parties. The Parties will report any change as required by the FDA and/or any applicable Governmental Authority. Aratana shall have at least [***] months from date of the Parties’ agreement to implement such changes to the Specifications.
If any such change will result in an increase or decrease in the manufacturing costs, timing, or requirements of the API, the Parties shall negotiate in good faith and agree upon corresponding adjustments this Agreement. 

 

	3.3	Disclaimer of Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE 3, ARATANA GIVES NO WARRANTIES, EXPRESS OR IMPLIED, REGARDING THE API OR THE
MANUFACTURE THEREOF. ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT OF THIRD PARTY RIGHTS, ARE EXPRESSLY DISCLAIMED.

  

	3.4	Limitation of Liability. Except for breach of Article 5 or arising out of a Party’s indemnification obligations, in no event will either Party
be liable to the other Party or any third party for any consequential, indirect, punitive, exemplary, special or incidental damages, including any lost data and lost profits, arising from or relating to this Agreement or the API. Aratana’s
total cumulative liability arising out of or relating to this Agreement and the API whether in contract or tort or otherwise, will not exceed the total amount of fees paid by RaQualia under this Agreement during the [***] months preceding the
event giving rise to the claim. 

 Article 4 

Purchase Price/Payment 
  

	4.1	Purchase Price and Payment. The purchase price per kilogram of the API as set forth in Section 2.1 does not include sales, use, consumption, or
excise tax of any taxing authority. The amount of such taxes, if any, will be added to the price in effect at the time of purchase and shall be reflected in the invoices submitted to RaQualia pursuant to this Agreement. All amounts are in U.S.
dollars. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

15 

	4.2	Forecast. On a             basis, RaQualia will provide to Aratana a non-binding
            months forecast of expected purchase of the API. The forecast will be used by Aratana for planning purposes only. 

 

	4.3	Purchase Order. In the event RaQualia desires to purchase the API, RaQualia shall issue a binding PO to Aratana at least [X] days prior to the
requested delivery date of the API. The PO shall specify, at a minimum, the quantity of API, the price for the API (as set forth in Section 2.1), the requested delivery date, and the destination of delivery. Aratana shall inform RaQualia about
its acceptance or rejection of any PO in writing within [***] business days of receipt of the PO. Cancellation of an accepted PO by RaQualia more than [X] days prior to delivery will be subject to a cancellation fee of [X]%.
Accepted POs may not be cancelled by RaQualia less than [X] days prior to delivery. 

  

	4.4	Shipment, Title, and Delivery. Aratana will use commercially reasonable efforts to meet the requested delivery dates that are no earlier than the lead
times. All sales of the API are made F.O.B. (as defined in U.C.C. § 2-319) the place of manufacture, notwithstanding any prepayment of freight by RaQualia. RaQualia will be responsible for and reimburse Aratana for all shipping costs
incurred by Aratana. At the time the API is delivered to RaQualia or an agent of RaQualia, including common carrier, title and risk of loss of the API shall pass to RaQualia, and Aratana and its contracted supplier (e.g., CML) will not be
responsible for any subsequent delay in transportation or non-delivery of the API. RaQualia shall provide whatever insurance against loss or damage it considers necessary once the API leaves the place of manufacture. All API shall be deemed to be
irrevocably accepted unless rejected in writing by RaQualia within [***] days of delivery. 

  

	4.5	Payment Terms. Upon delivery of the API, Aratana shall provide RaQualia with an invoice for payment of the API. All amounts set forth in the invoice shall
be paid by RaQualia net [***] days after receipt. In the event RaQualia fails to make any payments when due under this Agreement, RaQualia may be charged a late fee on any amount that is not paid when due at a rate of [***] percent
[***] per month or the maximum rate allowed by applicable law, whichever is lower, from the due date until paid. In the event of any late payment by RaQualia, Aratana may decline to make further sales of the API until all amounts due and late
fees are paid in full without in any way affecting its rights under this Agreement. 

 Article 5 

Confidentiality 
 During
the terms of this Agreement and for a period of [***] years following the termination or expiration of this Agreement, each Party shall hold in confidence and use only in furtherance of its rights and obligations under this Agreement all
Confidential Information that it acquires from the other Party pursuant to this Agreement, unless (a) the Disclosing Party consents to the Receiving Party’s disclosure or use, or (b) disclosure of the Disclosing Party’s
Confidential Information by the Receiving Party is required by order of any Governmental Authority, in which event the Receiving Party will notify the Disclosing Party of that order as soon as practicable, shall use reasonable efforts (at the
Disclosing Party’s expense) to obtain a protective 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

16 

 
order covering the Confidential Information and shall disclose only such Confidential Information that its legal counsel determines is legally required. Each Party shall make Confidential
Information that it acquires from the other Party pursuant to this Agreement available only to those of its affiliates, directors, officers, employees, consultants, advisors or representatives who need to have access thereto for the purposes of this
Agreement and who are bound by an obligation of confidentiality consistent with the provisions herein. 
 Article 6

 Indemnification 
  

	6.1	By Aratana. Aratana will defend, indemnify, and hold RaQualia, its Affiliates, and their directors, officers, employees, and agents harmless from and
against any and all claims, losses, liabilities, damages, costs, and expenses (including attorneys’ fees, expert witness fees, and court costs) directly or indirectly arising from or relating to: (i) any product liability claims based
solely on the manufacture of the API; or (ii) any negligence, willful misconduct, or violation of Applicable Laws by Aratana or its directors, officers, employees, or agents in the performance of this Agreement or in connection with manufacture
of the API. 

  

	6.2	By RaQualia. RaQualia will defend, indemnify, and hold Aratana, Aratana’s Affiliates, and their directors, officers, employees, and agents harmless
from and against any and all claims, losses, liabilities, damages, costs, and expenses (including attorneys’ fees, expert witness fees, and court costs) directly or indirectly arising from or relating to: (i) any claims based on the
marketing, promotion, sale, distribution, or use of any API, or products incorporating the API, by RaQualia or its distributors, or licensees; or (ii) any negligence, willful misconduct, or violation of Applicable Laws by RaQualia or its
directors, officers, employees, or agents in the performance of this Agreement. 

  

	6.3	Indemnity Conditions. A Party’s obligation to indemnify as provided in this Agreement is conditioned upon the indemnified Party promptly notifying
the indemnifying Party in writing within a reasonable period of time of any and all claims for which the indemnified Party is entitled to indemnification, giving the indemnifying Party sole control of the defense thereof and any related settlement
negotiations, and indemnified Party cooperating and, at indemnifying Party’s request and expense, assisting in such defense. The indemnified Party may participate in the defense of the claim at its own expense with counsel of its own choosing.
The indemnifying Party may not settle any such claim without the indemnified Party’s prior written consent. 

Article 7 

Effective Date, Term and Termination 
  

	7.1	Term. This Agreement shall commence on the Effective Date and shall continue in full force and effect for an initial term of [[***]] years. Thereafter,
this Agreement will automatically renew for additional [***] year terms unless the Agreement is terminated in writing by either Party within [***] months of the end of the then current term. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

17 

	7.2	Termination by Aratana for Material Breach. Aratana may terminate this Agreement for a material breach by RaQualia if RaQualia fails to cure any such
breach within [***] days (or within [***] days in the event of failure to pay any amounts owed by RaQualia hereunder) after receipt of written notice from Aratana or any of its Affiliates, specifying such breach. 

 

	7.3	Termination by RaQualia for Material Breach. RaQualia may terminate this Agreement for a material breach of this Agreement by Aratana if Aratana fails to
cure any such breach within [***] days after receipt of written notice from RaQualia specifying such breach. 

  

	7.4	Termination for Cause. This Agreement may further be terminated for cause at any time prior to its expiration for the following reasons: (a) by
either Party, if a petition in bankruptcy with respect to the other Party is filed or if such other Party is liquidated or if a trustee is appointed, provided that in an involuntary bankruptcy proceeding, such right of termination shall only become
effective if the proceeding is not dismissed within [***] days of the filing; or (b) by either Party, upon a termination or expiration of the License Agreement. 

 

	7.5	Termination for FDA Governmental Action. If any FDA governmental action occurs which prevents RaQualia from importing, purchasing or selling the API or
that has the effect of making Aratana’s manufacture and RaQualia sale of products incorporating the API unlawful (“FDA Governmental Action”), then Aratana and RaQualia will work together to establish a plan of action for
handling the particular FDA Governmental Action. If the Parties are unable to agree on such a plan of action, then either Party may terminate this Agreement upon reasonable written notice to the other Party, not less than [***] days.

  

	7.6	Termination due to Change in Control. Either Party may terminate this Agreement with [***] months prior written notice to the other Party, if a
controlling interest in Aratana or all or substantially all of the business or assets of Aratana is acquired by any third party, whether through merger, sale of assets, sale of stock or otherwise, or the RQ-0000007 Technology is sublicensed to a
third party. 

  

	7.7	Survival. Upon termination or expiration of this Agreement, Sections 3.3, 3.4, Articles 1, 5, 6, 7, and 8 will survive. For avoidance of doubt,
the Parties agree that the termination of this Agreement will not have any effect on the effectiveness of the Development Agreement, unless otherwise provided in the Development Agreement and/or this Agreement. 

Article 8 

General 
  

	8.1	 Notice. Any notice, approval, authorization, consent, or other communication required or permitted to be delivered to either Party under
this Agreement must be in writing and will be deemed properly delivered, given, and received (i) when delivered by hand, or (ii) three (3) business days after delivery by international courier or express delivery

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

18 

	 	
service (return receipt requested). All notices shall be sent to address set forth below (or to such other address as may be designated by a Party by giving written notice to the other party
pursuant to this Section 8.1): 

  

					
		 	 If to RaQualia to:
  

RaQualia Pharma, Inc.
 5-2 Taketoyo, Aichi
470-2341
 Japan
 Attention:
President
 Phone No.: 89 904 790 3811
	 	 If to Aratana, to:
  

Aratana Therapeutics Inc.
 1901 Olathe
Boulevard
 Kansas City, KS 66103

USA
 Attention: President & COO

Phone No.: 913-951-2132

  

	8.2	Governing Law; Arbitration. This Agreement will be construed in accordance with and governed in all respects by the laws of the State of New York, USA.
Any dispute, controversy or claim arising out of or in connection with this Agreement, or breach, termination or invalidity thereof, shall be settled by arbitration in accordance with the commercial arbitration rules of the International Chamber of
Commerce (“ICC”). The arbitral tribunal shall be composed of three arbitrators, one to be appointed by Aratana and one to be appointed by RaQualia and the chairman to be appointed by the two arbitrators. If the two aforementioned
Parties have not appointed their arbitrators within [***] weeks from the request of the other Party, or the [***] have not agreed on the chairman within three weeks after their appointment, the ICC shall appoint the arbitrator or the chairman, as
the case may be. In the event arbitration is requested by RaQualia, the place of arbitration shall be [***]; in the event arbitration is requested by Aratana, the place of arbitration shall be [***]. The arbitration proceedings will be conducted in
English. The results of the arbitration procedure will be considered Confidential Information of the Parties. Any arbitration decision rendered will be final and binding, and judgment thereon may be entered in any court of competent jurisdiction.
Notwithstanding this Section, neither Party will be required to arbitrate any dispute or controversy relating to any actual or threatened unauthorized use or disclosure of its intellectual property or confidential information.

  

	8.3	Assignment. Neither Party may assign or transfer this Agreement or any of its rights hereunder without the prior written consent of the other Party.
Notwithstanding the foregoing, either Party may assign this entire Agreement or any of its rights hereunder, upon notice to the other Party but without such other Party’s consent, (i) to any of the assigning Party’s Affiliates; and
(ii) to a third party in connection with a merger, change in control, or sale of all or substantially all of the assets or business of the assigning Party pertaining to this Agreement. This Agreement will be binding upon and shall inure to the
benefit of the Parties hereto and their respective successors and assigns. 

  

	8.4	Waiver. All waivers must be in writing and signed by an authorized representative of the Party to be charged. Any waiver or failure to enforce any
provision of this Agreement on one occasion will not be deemed a waiver of any other provision or of such provision on any other occasion. 

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

19 

	8.5	Severability. If any provision of this Agreement is unenforceable, such provision will be changed and interpreted to accomplish the objectives of such
provision to the greatest extent possible under applicable law and the remaining provisions will continue in full force and effect. 

  

	8.6	Independent Contractors. This Agreement is not intended to establish any partnership, joint venture, employment, or other relationship between the Parties
except that of independent contractors. 

  

	8.7	Construction. The section headings in this Agreement are for convenience of reference only, will not be deemed to be a part of this Agreement, and will
not be referred to in connection with the construction or interpretation of this Agreement. Any rule of construction to the effect that ambiguities are to be resolved against the drafting Party will not be applied in the construction or
interpretation of this Agreement. As used in this Agreement, the words “include” and “including,” and variations thereof, will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words
“without limitation.” All references in this Agreement to “Sections” are intended to refer to Sections of this Agreement. 

  

	8.8	Counterparts. This Agreement may be executed in several counterparts, each of which will constitute an original and all of which, when taken together,
will constitute one agreement. 

  

	8.9	English Language. This Agreement has been prepared in the English language and the English language shall control its interpretation. In addition, all
notices required or permitted to be given hereunder, an all written, electronic, or other communications between the parties regarding this Agreement shall be in the English language 

 

	8.10	Entire Agreement. This Agreement sets forth the entire understanding of the Parties relating to the subject matter hereof and supersedes all prior
agreements and understandings between the Parties relating to the subject matter hereof. This Agreement may not be amended, modified, altered, or supplemented other than by means of a written instrument duly executed and delivered on behalf of both
Parties. 

  

									
	RaQualia Pharma, Inc.	 		 	Aratana Therapeutics, Inc.
					
	By:	 	  
	 		 	By:	 	  

	Name:	 	  
	 		 	Name:	 	  

	Title:	 	  
	 		 	Title:	 	  

	Date:	 	  
	 		 	Date:	 	  

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.

  

	[***]	Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to the omitted portions. 

  

20Secured Loan Agreement

 Exhibit 10.1 
 SECURED LOAN AGREEMENT 
 for a loan in the aggregate amount of 

$30,000,000.00 

MADE BY AND AMONG 

CHP BATESVILLE HEALTHCARE OWNER, LLC, 
 CHP BROADWAY HEALTHCARE OWNER, LLC, 
 CHP JONESBORO HEALTHCARE OWNER, LLC,

 CHP MAGNOLIA HEALTHCARE OWNER, LLC, 
 CHP MINE CREEK HEALTHCARE OWNER, LLC, 
 and 

CHP SEARCY HEALTHCARE OWNER, LLC, 
 as Borrowers, 
 KEYBANK NATIONAL ASSOCIATION, 

as Agent, 

and 

The lending institutions a party hereto from time to time. 
 Dated as of May 31, 2013 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	ARTICLE 1 INCORPORATION OF RECITALS AND EXHIBITS	  	 	2	  
	 1.1
	  	Incorporation of Recitals	  	 	2	  
	 1.2
	  	Incorporation of Schedule Exhibits	  	 	2	  
		
	ARTICLE 2 DEFINITIONS	  	 	2	  
	 2.1
	  	Defined Terms	  	 	2	  
	 2.2
	  	Other Definitional Provisions	  	 	11	  
		
	ARTICLE 3 BORROWERS’ REPRESENTATIONS AND WARRANTIES	  	 	11	  
	 3.1
	  	Representations and Warranties	  	 	11	  
	 3.2
	  	Survival of Representations and Warranties	  	 	17	  
		
	ARTICLE 4 LOAN AND LOAN DOCUMENTS	  	 	17	  
	 4.1
	  	Agreement to Borrow and Lend; Lenders’ Obligation to Disburse	  	 	17	  
	 4.2
	  	Loan Documents	  	 	18	  
	 4.3
	  	Term of the Loan	  	 	19	  
	 4.4
	  	Prepayments	  	 	19	  
	 4.5
	  	Required Principal Payments	  	 	19	  
	 4.6
	  	Late Charge	  	 	20	  
		
	ARTICLE 5 INTEREST	  	 	20	  
	 5.1
	  	Interest Rate	  	 	20	  
	 5.2
	  	Interest Rate Agreement	  			
		
	ARTICLE 6 COSTS OF MAINTAINING LOAN	  	 	21	  
	 6.1
	  	Increased Costs and Capital Adequacy	  	 	21	  
	 6.2
	  	Borrower Withholding	  	 	21	  
		
	ARTICLE 7 LOAN EXPENSE AND ADVANCES	  	 	22	  
	 7.1
	  	Loan and Administration Expenses	  	 	22	  
	 7.2
	  	Lender’s Attorneys’ Fees and Disbursements	  	 	22	  
	 7.3
	  	Time of Payment of Fees and Expenses	  	 	22	  
	 7.4
	  	Expenses and Advances Secured by Loan Documents	  	 	22	  
	 7.5
	  	Right of Lender to Make Advances to Cure Borrowers’ Defaults	  	 	23	  
		
	 ARTICLE 8 REQUIREMENTS PRECEDENT TO THE OPENING OF THE LOAN AND ANY SUBSEQUENT DISBURSEMENT
	  	 	23	  
	 8.1
	  	Conditions Precedent to Closing and Opening of the Loan	  	 	23	  
		
	ARTICLE 9 RESERVED	  	 	25	  
		
	ARTICLE 10 BORROWERS’ AGREEMENTS	  	 	25	  
	 10.1
	  	Borrowers further covenant and agree as follows:	  	 	25	  

  
 -i-

 Table of Contents 

(continued) 
  

							
	 	  	 	  	Page	 
	 ARTICLE 11 CASUALTIES AND CONDEMNATION
	  	 	31	  
	 11.1
	  	 Agent’s Election to Apply Proceeds on Indebtedness
	  	 	31	  
	 11.2
	  	 Borrowers’ Obligation to Rebuild and Use of Proceeds Therefor
	  	 	31	  
		
	 ARTICLE 12 ASSIGNMENTS BY BORROWERS
	  	 	32	  
	 12.1
	  	 Prohibition of Assignments and Transfers by Borrowers
	  	 	32	  
	 12.2
	  	 Prohibition of Transfers in Violation of ERISA
	  	 	33	  
	 12.3
	  	 Successors and Assigns
	  	 	33	  
		
	 ARTICLE 13 TIME OF THE ESSENCE
	  	 	33	  
	 13.1
	  	 Time is of the Essence
	  	 	33	  
		
	 ARTICLE 14 EVENTS OF DEFAULT
	  	 	33	  
	 14.1
	  	 Events of Default
	  	 	33	  
		
	 ARTICLE 15 LENDERS’ REMEDIES IN EVENT OF DEFAULT
	  	 	35	  
	 15.1
	  	 Remedies Conferred Upon Lenders
	  	 	35	  
		
	 ARTICLE 16 GENERAL PROVISIONS
	  	 	36	  
	 16.1
	  	 Captions
	  	 	36	  
	 16.2
	  	 Modification; Waiver
	  	 	36	  
	 16.3
	  	 GOVERNING LAW
	  	 	36	  
	 16.4
	  	 Acquiescence Not to Constitute Waiver of Lenders’ Requirements
	  	 	36	  
	 16.5
	  	 Disclaimer by Lenders
	  	 	36	  
	 16.6
	  	 Partial Invalidity; Severability
	  	 	36	  
	 16.7
	  	 Definitions Include Amendments
	  	 	36	  
	 16.8
	  	 Execution in Counterparts
	  	 	37	  
	 16.9
	  	 Entire Agreement
	  	 	37	  
	 16.10
	  	 Waiver of Damages
	  	 	37	  
	 16.11
	  	 Claims Against Lenders
	  	 	37	  
	 16.12
	  	 Jurisdiction
	  	 	37	  
	 16.13
	  	 Set-Offs
	  	 	38	  
	 16.14
	  	 Authorized Representative
	  	 	38	  
		
	 ARTICLE 17 NOTICES
	  	 	38	  
		
	 ARTICLE 18
	  	 	39	  
		
	 ARTICLE 19 ASSIGNMENTS AND PARTICIPATIONS
	  	 	39	  
	 19.1
	  	 Assignments and Participations
	  	 	39	  
	 19.2
	  	 Several Liability
	  	 	42	  
		
	 ARTICLE 20 AGENT
	  	 	42	  
	 20.1
	  	 Appointment
	  	 	42	  

  
 -ii-

 Table of Contents 

(continued) 
  

							
	 	  	 	  	Page	 
	 20.2
	  	 Reliance on Agent
	  	 	42	  
	 20.3
	  	 Powers
	  	 	42	  
	 20.4
	  	 Disbursements
	  	 	43	  
	 20.5
	  	 Distribution and Apportionment of Payments
	  	 	43	  
	 20.6
	  	 Consents and Approvals
	  	 	44	  
	 20.7
	  	 Agency Provisions Relating to Collateral
	  	 	46	  
	 20.8
	  	 Lender Actions Against Borrower or the Collateral
	  	 	47	  
	 20.9
	  	 Assignment and Participation
	  	 	47	  
	 20.10
	  	 Ratable Sharing
	  	 	47	  
	 20.11
	  	 General Immunity
	  	 	47	  
	 20.12
	  	 No Responsibility for Loan, Recitals, etc.
	  	 	47	  
	 20.13
	  	 Action on Instructions of Lenders
	  	 	48	  
	 20.14
	  	 Employment of Agents and Counsel
	  	 	48	  
	 20.15
	  	 Reliance on Documents; Counsel
	  	 	48	  
	 20.16
	  	 Agent’s Reimbursement and Indemnification
	  	 	48	  
	 20.17
	  	 Rights as a Lender
	  	 	48	  
	 20.18
	  	 Lenders’ Credit Decisions
	  	 	49	  
	 20.19
	  	 Notice of Events of Default
	  	 	49	  
	 20.20
	  	 Successor Agent
	  	 	49	  
		
	 ARTICLE 21 WAIVER OF JURY TRIAL
	  	 	49	  

  
 -iii-

 LIST OF EXHIBITS TO LOAN AGREEMENT 

 

			
	 Exhibit A-1
	  	 Legal Description of Batesville Land

	 Exhibit A-2
	  	 Legal Description of Broadway Land

	 Exhibit A-3
	  	 Legal Description of Jonesboro Land

	 Exhibit A-4
	  	 Legal Description of Magnolia Land

	 Exhibit A-5
	  	 Legal Description of Mine Creek Land

	 Exhibit A-6
	  	 Legal Description of Searcy Land

	 Exhibit B-1
	  	 Batesville Permitted Exceptions

	 Exhibit B-2
	  	 Broadway Permitted Exceptions

	 Exhibit B-3
	  	 Jonesboro Permitted Exceptions

	 Exhibit B-4
	  	 Magnolia Permitted Exceptions

	 Exhibit B-5
	  	 Mine Creek Permitted Exceptions

	 Exhibit B-6
	  	 Searcy Permitted Exceptions

	 Exhibit C
	  	 Title Requirements

	 Exhibit D
	  	 Survey Requirements

	 Exhibit E
	  	 Insurance Requirements

	 Exhibit F
	  	 Reserved

	 Exhibit G
	  	 Form of Covenant Compliance Certificate

	 Exhibit H
	  	 Form of Assignment and Assumption Agreement

		
	 Schedule I
	  	 Environmental Documents

	 Schedule II
	  	 Minimum Quarterly Rent Coverage Requirements

	 Schedule III
	  	 Immediate Repairs

  
 -iv-

 SECURED LOAN AGREEMENT 

THIS SECURED LOAN AGREEMENT (“Agreement”) is made as of May 31, 2013, by and among
Borrowers, KEYBANK NATIONAL ASSOCIATION, a national banking association, its successors and/or assigns, as administrative agent (referred to in such capacity as “Agent” in this Agreement), and the lending institutions a party
hereto from time to time (Agent, as a lender, and each such other lending institution, and their respective successors and assigns, referred to individually a “Lender” and collectively, as the “Lenders”).

 RECITALS 
 A. Batesville Borrower intends to acquire fee simple title to a tract of land in the City of Batesville, State of Arkansas, which land is legally described in Exhibit A-1 (the
“Batesville Land”). In addition, Batesville Borrower proposes to acquire a 150-bed health care facility (the “Batesville Improvements”) located on the Batesville Land commonly known as “Batesville Health Care
Center” (the Batesville Land and the Batesville Improvements collectively referred to herein as the “Batesville Project”). 
 B. Broadway Borrower intends to acquire fee simple title to a tract of land in the City of West Memphis, State of Arkansas, which land is legally described in Exhibit A-2 (the
“Broadway Land”). In addition, Broadway Borrower proposes to acquire a 119-bed health care facility (the “Broadway Improvements”) located on the Broadway Land commonly known as “Broadway Health Care
Center” (the Broadway Land and the Broadway Improvements collectively referred to herein as the “Broadway Project”). 
 C. Jonesboro Borrower intends to acquire fee simple title to a tract of land in the City of Jonesboro, State of Arkansas, which land is legally described in Exhibit A-3 (the “Jonesboro
Land”). In addition, Jonesboro Borrower proposes to acquire a 136-bed health care facility (the “Jonesboro Improvements”) located on the Jonesboro Land commonly known as “Jonesboro Health Care Center” (the
Jonesboro Land and the Jonesboro Improvements collectively referred to herein as the “Jonesboro Project”). 
 D. Magnolia Borrower intends to acquire fee simple title to a tract of land in the City of Magnolia, State of Arkansas, which land is legally described in Exhibit A-4 (the “Magnolia
Land”). In addition, Magnolia Borrower proposes to acquire a 140-bed health care facility (the “Magnolia Improvements”) located on the Magnolia Land commonly known as “Magnolia Health Care Center” (the Magnolia
Land and the Magnolia Improvements collectively referred to herein as the “Magnolia Project”). 

E. Mine Creek Borrower intends to acquire fee simple title to a tract of land in the City of Nashville, State of
Arkansas, which land is legally described in Exhibit A-5 (the “Mine Creek Land”). In addition, Mine Creek Borrower proposes to acquire a 78-bed health care facility (the “Mine Creek Improvements”)
located on the Mine Creek Land commonly known as “Mine Creek Health Care Center” (the Mine Creek Land and the Mine Creek Improvements collectively referred to herein as the “Mine Creek Project”). 

F. Searcy Borrower intends to acquire fee simple title to a tract of land in the City of Searcy, State of Arkansas, which
land is legally described in Exhibit A-6 (the “Searcy Land”). In addition, Searcy Borrower proposes to acquire a 245-bed health care facility (the “Searcy Improvements”) located on the Searcy Land
commonly known as “Searcy Health Care Center” (the Searcy Land and the Searcy Improvements collectively referred to herein as the “Searcy Project”). 

G. Borrowers have requested and applied to the Lenders for a loan in the amount of up to THIRTY MILLION AND NO/100
DOLLARS ($30,000,000.00) (the “Loan”) to reimburse Borrowers for a portion of the costs for the acquisition of the Projects and the closing costs and expenses of Borrowers in connection with the acquisition of the Projects
and the closing of the Loan, and the Lenders are willing to make the Loan on the terms and conditions hereinafter set forth. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained, the parties hereto agree as follows: 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 1

 ARTICLE 1 
 INCORPORATION OF RECITALS AND EXHIBITS 
 1.1
Incorporation of Recitals. 
 The foregoing preambles and all other recitals set forth herein are made
a part hereof by this reference. 
 1.2 Incorporation of Schedule Exhibits. 

Schedules I through III and Exhibits A through H, inclusive, attached hereto are incorporated
herein and expressly made a part hereof by this reference. 
 ARTICLE 2 

DEFINITIONS 
 2.1 Defined Terms. 
 The following terms as used
herein shall have the following meanings: 
 Adjusted Base Rate: An interest rate per annum equal to the
sum of (a) the Base Rate, plus (b) the Applicable Margin. Any change in the Adjusted Base Rate shall be effective immediately from and after a change in the Adjusted Base Rate (or the Federal Funds Effective Rate, as applicable).

 Adjusted LIBOR Rate: For any LIBOR Rate Interest Period, an interest rate per annum equal to the sum
of (i) the rate obtained by dividing (1) the LIBOR Rate for such LIBOR Rate Interest Period by (2) a percentage equal to one hundred percent (100%) minus the Reserve Percentage for such LIBOR Rate Interest Period, and
(ii) the Applicable Margin. 
 Affiliate: With respect to a specified person or entity, any
individual, partnership, corporation, limited liability company, trust, unincorporated organization, association or other entity which, directly or indirectly, through one or more intermediaries, controls or is controlled by or is under common
control with such person or entity, including, without limitation, any general or limited partnership in which such person or entity is a partner. 
 Agreement: This Secured Loan Agreement. 
 Applicable
Margin: Four and one-quarter percent (4.25%). 
 Applicable Rate: As such term is defined in
Section 5.1(a). 
 Appraisal: A MAI certified appraisal of the Projects performed in
accordance with FIRREA and Agent’s appraisal requirements by an appraiser selected and retained by Agent. 

Assignments of Rents: One or more assignments of leases and rents made by the Borrowers in favor of Agent for the
benefit of the Lenders assigning all of Borrowers’ respective interest in and to its Operating Lease, all Leases, subleases and other agreements relating to the use and occupancy of all or any portion of the Projects, and all present and future
Leases, rents, issues and profits therefrom, as the same may be hereafter amended, restated, supplemented or otherwise modified pursuant to the terms thereof. 
 Authorized Representative: As such term is defined in Section 16.14. 
 Available Beds: 780. For purposes of the calculations set forth herein, this number shall not be changed without Agent’s prior written consent. 

Bankruptcy Code: As such term is defined in Section 14.1(d). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 2

 Base Rate: For any day, a fluctuating interest rate per annum as
shall be in effect from time to time which rate per annum shall at all times be equal to the greatest of: 
  

	 	(i)	 the rate of interest established by Agent, from time to time, as its “prime rate,” whether or not publicly announced, which interest rate
may or may not be the lowest rate charged by it for commercial loans or other extensions of credit; 

  

	 	(ii)	 the Federal Funds Effective Rate in effect from time to time, determined one Business Day in arrears, plus 1/2 of 1% per annum; and

  

	 	(iii)	 the Daily LIBOR Rate. 

 Batesville Borrower: CHP Batesville Healthcare Owner, LLC, a Delaware limited liability company. 
 Batesville Mortgage: As such term is defined in Section 4.2(b). 
 Batesville Operating Lease: That certain Lease Agreement of even date herewith between Batesville Borrower and Batesville Operator. 

Batesville Operator: Batesville Health and Rehab, LLC, an Arkansas limited liability company. 

Batesville Permitted Exceptions: Shall mean (i) as of the date hereof, those matters listed on
Exhibit B-1 hereto to which title to the Batesville Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the Batesville Mortgage or other Loan
Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet delinquent at the time in question or are being contested in accordance with the requirements of the Loan Documents; (b) rights of
tenants under Leases or residency agreements; (c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens being contested in accordance with the
requirements of the Loan Documents, and (e) such other title exceptions as Agent may reasonably approve in writing. 
 Borrowers: Batesville Borrower, Broadway Borrower, Jonesboro Borrower, Magnolia Borrower, Mine Creek Borrower, and Searcy Borrower, jointly and severally, as applicable. 

Breakage Costs: Collectively, (a) the cost to Lenders of re-employing funds bearing interest at an Adjusted
LIBOR Rate, incurred (or expected to be incurred) in connection with (i) any payment of any portion of a Loan bearing interest at an Adjusted LIBOR Rate prior to the termination of any applicable LIBOR Rate Interest Period, or (ii) the
conversion of an Adjusted LIBOR Rate to any other applicable interest rate on a date other than the last day of the relevant interest period, and (b) any amounts payable by a Borrower under any Interest Rate Agreement in connection with
termination of such Agreement. 
 Broadway Borrower: CHP Broadway Healthcare Owner, LLC, a Delaware
limited liability company. 
 Broadway Operating Lease: That certain Lease Agreement of even date
herewith between Broadway Borrower and Broadway Operator. 
 Broadway Operator: Broadway Health and
Rehab, LLC, an Arkansas limited liability company. 
 Broadway Mortgage: As such term is defined in
Section 4.2(c). 
 Broadway Permitted Exceptions: Shall mean (i) as of the date hereof,
those matters listed on Exhibit B-2 hereto to which title to the Broadway Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the Broadway
Mortgage or other Loan Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 3

 
delinquent at the time in question or are being contested in accordance with the requirements of the Loan Documents; (b) rights of tenants under Leases or residency agreements;
(c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens being contested in accordance with the requirements of the Loan Documents, and
(e) such other title exceptions as Agent may reasonably approve in writing. 
 Business Day: A day
of the year on which banks are not required or authorized to close in Brooklyn, Ohio. 
 Buyback
Project(s): Shall refer, individually, or collectively, as applicable, to the Batesville Project, the Mine Creek Project and the Searcy Project. 
 Change of Control: Shall mean an event or series of events by which: 
  

	 	(i)	 Guarantor fails to own 100% of the indirect ownership of Borrowers; 

 

	 	(ii)	 any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but
excluding any employee benefit plan of such person or its subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan) becomes the “beneficial owner” (as defined in
Rule 13d-3 and 13d-5 under the Securities Exchange Act of 1934, except that a person or group shall be deemed to have “beneficial ownership” of all equity interests that such person or group has the right to acquire, whether such right is
exercisable immediately or only after the passage of time (such right, an “option right”)), directly or indirectly, of 30% or more of the equity interests of Guarantor entitled to vote for members of the board of directors or
equivalent governing body of Guarantor on a fully-diluted basis (and taking into account all such securities that such person or group has the right to acquire pursuant to any option right); provided that, notwithstanding the above,
unexercised warrants with respect to equity interests of Guarantor shall not be deemed to be ownership of equity interests of Guarantor unless and until such warrants are exercised; or 

 

	 	(iii)	 during any period of 12 consecutive months, a majority of the members of the board of directors or other equivalent governing body of Guarantor
cease to be composed of individuals (a) who were members of that board or equivalent governing body on the first day of such period, (b) whose election or nomination to that board or equivalent governing body was approved by individuals
referred to in clause (a) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (c) whose election or nomination to that board or other equivalent governing body was
approved by individuals referred to in clauses (a) and (b) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body (excluding, in the case of both clause (b) and
clause (c), any individual whose initial nomination for, or assumption of office as, a member of that board or equivalent governing body occurs as a result of an actual or threatened solicitation of proxies or consents for the election or removal of
one or more directors by any person or group other than a solicitation for the election of one or more directors by or on behalf of the board of directors); 

 

	 	(iv)	 after giving effect to the applicable event or events, (a) the total equity, direct or indirect, in any Borrower or Guarantor held by a
particular person exceeds twenty-four percent (24%) of the total equity, direct or indirect, in Guarantor or such Borrower, as the case may be, and (b) such person did not hold in excess of twenty-four percent (24%) of the total
equity, direct or indirect, in Guarantor or any Borrower as of the date hereof; or 

  

	 	(v)	 CNL and its affiliates no longer serve as manager, advisor, or sponsor of the Borrowers or Guarantor. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 4

 CHP Holding: CHP Senior Living Net Lease Holding, LLC, a Delaware
limited liability company. 
 CNL: CNL Financial Group, Inc., a Delaware corporation. 

Commitment: The maximum amount each Lender has agreed to lend to Borrowers as part of the Loan (which amounts are
set forth below the signature line of each Lender), subject to modification by each Assignment and Assumption. 

Control: As such term is used with respect to any person or entity, including the correlative meanings of the
terms “controlled by” and “under common control with”, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of such person or entity, whether through the
ownership of voting securities, by contract or otherwise. 
 Daily LIBOR Rate: The rate of interest
calculated by Agent on a daily basis equal to the one month rate of interest (rounded upward to the next highest 1/16th of 1%) of the one month London interbank offered rate for deposits in U.S. Dollars at approximately 11:00 a.m. (London time) on
the second preceding LIBOR Business Day; as determined and adjusted from time to time in Agent’s sole discretion. 
 Debt Service Coverage: The ratio of (a) the Lease Income for the applicable period, to (b) the Pro Forma Debt Service. 

Default or default: Any event, circumstance or condition which, if it were to continue uncured, would, with notice
or lapse of time or both, constitute an Event of Default hereunder. 
 Default Rate: A rate per annum
equal to 5% (500 basis points) over the Adjusted Base Rate. 
 Eligible Assignee: (i) Any Lender;
(ii) any commercial bank, savings bank, savings and loan association or similar financial institution which (a) has total assets of Five Billion Dollars ($5,000,000,000) or more, (b) is “well capitalized” within the meaning
of such term under the regulations promulgated under the auspices of the Federal Deposit Insurance Corporation Improvement Act of 1991, (c) in the sole judgment of the Agent, is engaged in the business of lending money and extending credit, and
buying loans or participations in loans under credit facilities substantially similar to those extended under this Agreement, and (d) in the sole judgment of the Agent, is operationally and procedurally able to meet the obligations of a Lender
hereunder to the same degree as a commercial bank; (iii) any insurance company in the business of writing insurance which (a) has total assets of Five Billion Dollars ($5,000,000,000) or more (b) is “best capitalized” within
the meaning of such term under the applicable regulations of the National Association of Insurance Commissioners, and (c) meets the requirements set forth in subclauses (c) and (d) of clause (ii) above; and (iv) any other
financial institution having total assets of Five Billion Dollars ($5,000,000,000) (including a mutual fund or other fund under management of any investment manager having under its management total assets of Five Billion Dollars ($5,000,000,000) or
more) which meets the requirement set forth in subclauses (c) and (d) of clause (ii) above; provided that each Eligible Assignee must (w) be organized under the Laws of the United States of America, any state thereof or the
District of Columbia, or, if a commercial bank, be organized under the Laws of the United States of America, any state thereof or the District of Columbia, the Cayman Islands or any country which is a member of the Organization for Economic
Cooperation and Development, or a political subdivision of such a country, (x) act under the Loan Documents through a branch, agency or funding office located in the United States of America, (y) be exempt from withholding of tax on
interest and deliver the documents related thereto pursuant to the Internal Revenue Code as in effect from time to time and (z) not be a Borrower or an Affiliate of a Borrower. 

Environmental Documents: Collectively, the documents listed on Schedule I attached hereto. 

Environmental Proceedings: As such term is defined in Section 3.1(g). 

Environmental Report: As such term is defined in Section 8.1(o). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 5

 ERISA: The Employee Retirement Income Security Act of 1974, as
amended, and the regulations promulgated thereunder from time to time. 
 Event of Default: As such term
is defined in Article 14. 
 Federal Funds Effective Rate: Shall mean, for any day, the rate
per annum (rounded upward to the nearest one one-hundredth of one percent (1/100 of 1%)) announced by the Federal Reserve Bank of Cleveland on such day as being the weighted average of the rates on overnight federal funds transactions arranged by
federal funds brokers on the previous trading day, as computed and announced by such Federal Reserve Bank in substantially the same manner as such Federal Reserve Bank computes and announces the weighted average it refers to as the “Federal
Funds Effective Rate.” 
 Final Maturity Date: The date on which the Note matures, whether by
acceleration, lapse of time or otherwise; provided, that such date shall be the Original Maturity Date, unless earlier accelerated as permitted herein or in any other Loan Document. 

FIRREA: The Financial Institutions Reform, Recovery And Enforcement Act of 1989, as amended from time to time.

 GAAP: Generally Accepted Accounting Principles. 

Governmental Approvals: As such term is defined in Section 3.1(n). 

Governmental Authority: Any federal, state, county or municipal government, or political subdivision thereof, any
governmental or quasi-governmental agency, authority, board, bureau, commission, department, instrumentality, or public body, or any court, administrative tribunal, or public utility. 

Gross Revenues: For any period, all revenues of Operator determined on a GAAP basis derived from the operation,
use, leasing and occupancy of the Projects during such period; provided, however, that in no event shall Gross Revenues include (i) any loan proceeds, (ii) proceeds or payments under insurance policies (except proceeds of
business interruption insurance); (iii) condemnation proceeds; (iv) any security deposits received from tenants in the Projects, unless and until the same are applied to rent or other obligations in accordance with the tenant’s lease;
or (v) any other extraordinary items, in Agent’s reasonable discretion. 
 Guarantor: CNL
Healthcare Properties, Inc., a Maryland corporation. 
 Guaranty: As such term is defined in
Section 4.2(h). 
 Hazardous Material: Means and includes gasoline, petroleum, asbestos
containing materials, explosives, radioactive materials or any hazardous or toxic material, substance or waste which is defined by those or similar terms or is regulated as such under any Law of any Governmental Authority having jurisdiction over
the Project or any portion thereof or its use, including: (i) any “hazardous substance” defined as such in (or for purposes of) the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C.A.
§ 9601(14) as may be amended from time to time, or any so-called “superfund” or “superlien” Law, including the judicial interpretation thereof; (ii) any “pollutant or contaminant” as defined in
42 U.S.C.A. § 9601(33); (iii) any material now defined as “hazardous waste” pursuant to 40 C.F.R. Part 260; (iv) any petroleum, including crude oil or any fraction thereof; (v) natural gas, natural gas
liquids, liquefied natural gas, or synthetic gas usable for fuel; (vi) any “hazardous chemical” as defined pursuant to 29 C.F.R. Part 1910; and (vii) any other toxic substance or contaminant that is subject to any other Law
or other past or present requirement of any Governmental Authority, as any such acts and laws may be amended, modified or supplemented from time to time. 
 Immediate Repairs: Shall mean those repairs to the Broadway Project and the Mine Creek Project as detailed in the property condition reports delivered to Agent and as set forth on Schedule III
attached hereto in connection with the closing of the Loan in an aggregate amount of approximately $109,300.00. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 6

 Improvements: The collective reference to the Batesville
Improvements, the Broadway Improvements, the Jonesboro Improvements, the Magnolia Improvements, the Mine Creek Improvements, and the Searcy Improvements. 
 Including or including: Including but not limited to. 

Indemnity: As such term is defined in Section 4.2(i). 

Jonesboro Borrower: CHP Jonesboro Healthcare Owner, LLC, a Delaware limited liability company. 

Jonesboro Operating Lease: That certain Lease Agreement of even date herewith between Jonesboro Borrower and
Jonesboro Operator. 
 Jonesboro Operator: Jonesboro Health and Rehab, LLC, an Arkansas limited liability
company. 
 Jonesboro Mortgage: As such term is defined in Section 4.2(d). 

Jonesboro Permitted Exceptions: Shall mean (i) as of the date hereof, those matters listed on
Exhibit B-3 hereto to which title to the Jonesboro Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the Jonesboro Mortgage or other Loan
Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet delinquent at the time in question or are being contested in accordance with the requirements of the Loan Documents; (b) rights of
tenants under Leases or residency agreements; (c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens being contested in accordance with the
requirements of the Loan Documents, and (e) such other title exceptions as Agent may reasonably approve in writing. 
 Land: The collective reference to the Batesville Land, the Broadway Land, the Jonesboro Land, the Magnolia Land, the Mine Creek Land, and the Searcy Land. 

Late Charge: As such term is defined in Section 4.6. 

Laws: Collectively, all federal, state and local laws, statutes, codes, ordinances, orders, rules and regulations,
including judicial opinions or precedential authority in the applicable jurisdiction. 
 Lease Income:
Shall mean all rentals or other income paid to Borrowers under the Operating Leases between any Borrower and any Operator in connection with the Projects for any applicable period, but specifically excluding any reserves, escrows, security deposits
or other deposits, taxes, or reimbursements for amounts paid by Borrowers on Operator’s behalf. 

Leases: The collective reference to all Operating Leases and all other leases, subleases and occupancy agreements
affecting a Project or any part thereof now existing or hereafter executed and all amendments, modifications or supplements thereto. 
 LIBOR Adjustment Date: The tenth (10th) day of each calendar month. 
 LIBOR Business Day: A Business Day on which dealings in U.S. dollars are carried on in the London Interbank Market. 

LIBOR Rate: For any LIBOR Rate Interest Period, the average rate (rounded upwards to the nearest 1/16th) as shown
by Reuters at which deposits in U.S. dollars are offered by first class banks in the London Interbank Market at approximately 11:00 a.m. (London time) on the day that is two (2) LIBOR Business Days prior to the first day of such LIBOR Rate
Interest Period with a maturity approximately equal to such LIBOR Rate Interest Period and in an amount approximately equal to the amount to which such LIBOR Rate Interest Period relates, adjusted for reserves and taxes if required by future
regulations. If Reuters no longer reports such rate or Agent determines in good faith that the rate so reported no longer accurately reflects the rate available to Lenders in the London Interbank Market, Agent may select a replacement index.

  

			
	 SECURED LOAN AGREEMENT
	  	Page 7

 LIBOR Rate Interest Period: With respect to each amount bearing
interest at a LIBOR based rate, a period of one month, to the extent deposits with such maturity is available to the Lenders, commencing on a LIBOR Business Day provided, however, that each LIBOR Rate Interest Period shall end on the last LIBOR
Adjustment Date occurring prior to the scheduled end of such LIBOR Rate Interest Period. 
 Loan: As such
term is defined in Recital F on page 1 of this Agreement. 
 Loan Amount: The maximum amount of
the Loan as set forth in Section 4.1(a) as reduced by principal payments, if any, made from time to time. 
 Loan Documents: The collective reference to this Agreement, the documents and instruments listed in Section 4.2, and all the other documents and instruments entered into from time to
time, evidencing or securing the Loans or any obligation of payment thereof or performance of Borrowers’ obligations in connection with the transaction contemplated hereunder and any Interest Rate Agreements, each as amended from time to time.

 Loan Opening Date: The date of this Agreement. 

Magnolia Borrower: CHP Magnolia Healthcare Owner, LLC, a Delaware limited liability company. 

Magnolia Operator: Magnolia Health and Rehab, LLC, an Arkansas limited liability company. 

Magnolia Operating Lease: That certain Lease Agreement of even date herewith between Magnolia Borrower and
Magnolia Operator. 
 Magnolia Mortgage: As such term is defined in Section 4.2(e).

 Magnolia Permitted Exceptions: Shall mean (i) as of the date hereof, those matters listed on
Exhibit B-4 hereto to which title to the Magnolia Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the Jonesboro Mortgage or other Loan
Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet delinquent at the time in question or are being contested in accordance with the requirements of the Loan Documents; (b) rights of
tenants under Leases or residency agreements; (c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens being contested in accordance with the
requirements of the Loan Documents, and (e) such other title exceptions as Agent may reasonably approve in writing. 
 Material Adverse Change or material adverse change: The business prospects, operations or financial condition of a person, entity or property has changed in a manner which could impair the value of
Lenders’ security for the Loan, prevent timely repayment of the Loan or otherwise prevent the applicable person or entity from timely performing any of its material obligations under the Loan Documents. 

Medicaid: That certain program of medical assistance, funded jointly by the federal government and the States, for
impoverished individuals who are aged, blind and/or disabled, and/or members of families with dependent children, which program is more fully described in Title XIX of the Social Security Act (42 U.S.C. §§ 1396 et seq.) and the
regulations promulgated thereunder. 
 Medicare: That certain federal program providing health
insurance for eligible elderly and other individuals, under which physicians, hospitals, skilled nursing homes, home health care and other providers are reimbursed for certain covered services they provide to the beneficiaries of such program, which
program is more fully described in Title XVIII of the Social Security Act (42 U.S.C. §§ 1395 et seq.) and the regulations promulgated thereunder. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 8

 Mine Creek Borrower: CHP Mine Creek Healthcare Owner, LLC, a Delaware
limited liability company. 
 Mine Creek Operator: Mine Creek Health and Rehab, LLC, an Arkansas limited
liability company. 
 Mine Creek Operating Lease: That certain Lease Agreement of even date herewith
between Mine Creek Borrower and Mine Creek Operator. 
 Mine Creek Mortgage: As such term is defined in
Section 4.2(f). 
 Mine Creek Permitted Exceptions: Shall mean (i) as of the date
hereof, those matters listed on Exhibit B-5 hereto to which title to the Mine Creek Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the
Mine Creek Mortgage or other Loan Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet delinquent at the time in question or are being contested in accordance with the requirements of the
Loan Documents; (b) rights of tenants under Leases or residency agreements; (c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens
being contested in accordance with the requirements of the Loan Documents, and (e) such other title exceptions as Agent may reasonably approve in writing. 
 Monthly Excess Cash Flow: The amount by which the monthly Lease Income from the Projects exceeds all amounts due and payable under the Loan Documents for such month. 

Mortgages: The collective reference to the Batesville Mortgage, the Broadway Mortgage, the Jonesboro Mortgage, the
Magnolia Mortgage, the Mine Creek Mortgage, and the Searcy Mortgage. 
 Net Operating Income or
NOI: The difference between (i) the Gross Revenues for the applicable period, less (ii) the Operating Expenses for such period. 
 Notes: As such term is defined in Section 4.2(a). 
 Number of Available Bed Days: Shall mean the product of the Available Beds multiplied by the number of days in the applicable calculation period. 

Number of Resident Days: Shall mean the number of days Available Beds were occupied during the applicable
calculation period. 
 Occupancy: Shall mean the ratio of average Number of Resident Days to average
Number of Available Bed Days. 
 Opening of the Loan or Loan Opening: The first disbursement of Loan
proceeds. 
 Operating Expenses: For any period, the actual costs and expenses of owning, operating,
managing and maintaining the Projects during such period incurred by Operator, determined on a GAAP basis, including, (i) the greater of (a) a $500 per Available Bed annual replacement reserve, and (b) the actual capital expenditures
for the Projects during such period, and (ii) a management fee in an amount equal to five percent (5%), excepting, however, (w) interest expense, (x) taxes, (y) depreciation and amortization, and (z) Rent Expense for such
period. 
 Operating Leases: Collectively, the Batesville Operating Lease, the Broadway Operating Lease,
the Jonesboro Operating Lease, the Magnolia Operating Lease, the Mine Creek Operating Lease, and the Searcy Operating Lease. 
 Operating Statement: As such term is defined in Section 10.1(m). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 9

 Operator(s): Shall mean, individually, or collectively, as
applicable, the Batesville Operator, the Broadway Operator, the Jonesboro Operator, the Magnolia Operator, the Mine Creek Operator and/or the Searcy Operator. 
 Original Maturity Date: May 31, 2016. 
 Permitted
Exceptions: The collective reference to the Batesville Permitted Exceptions, the Broadway Permitted Exceptions, the Jonesboro Permitted Exceptions, the Magnolia Permitted Exceptions, the Mine Creek Permitted Exceptions, and the Searcy Permitted
Exceptions. 
 Pro Forma Debt Service: The total annual installments of principal and interest that would
be required for the Loan calculated based upon a twenty-five (25) year amortization schedule and a per annum interest rate equal to the greater of (i) Applicable Rate, (ii) six percent (6.00%), and (iii) the yield per annum as of
the date of such calculation on U.S. Treasury securities selected in good faith by Lender, maturing approximately seven (7) years after the date of calculation, plus two and one-half percent (2.50%). 

Project(s): Shall mean, individually or collectively as applicable, any of the Batesville Project, the Broadway
Project, the Jonesboro Project, the Magnolia Project, the Mine Creek Project, and/or the Searcy Project. 

Project Operating Account(s): As such term is defined in Section 4.1(d). 

Reimbursement Contracts: means all third-party reimbursement contracts relating to any Project which are now or
hereafter in effect with respect to residents or patients qualifying for coverage under the same, including Medicare and Medicaid, Managed Care Plans and private insurance agreements, and any successor program or other similar reimbursement program
and/or private insurance agreements, now or hereafter existing. 
 Release Price: For any Buyback
Project, an amount equal to sixty percent (60%) of the “fee simple” value of the applicable Buyback Project as shown in the Appraisal delivered to Agent in connection with the closing of the Loan. 

Rent Coverage: With respect to any applicable period ending on the applicable date of determination, the ratio of
(a) the Net Operating Income for such period, to (b) the Rent Expense. 
 Rent Expense: With
respect to any applicable period ending on the applicable date of determination, the total rent paid by Operators to Borrowers under the Leases during such period. 

Required Lenders: Those Lenders holding at least sixty-six and 67/100th percent (66.67%) of the total
outstanding principal balance of the Loans. 
 Reserve Percentage: For any LIBOR Rate Interest Period,
that percentage which is specified three (3) Business Days before the first day of such LIBOR Rate Interest Period by the Board of Governors of the Federal Reserve System (or any successor) or any other governmental or quasi-governmental
authority with jurisdiction over the Lenders for determining the maximum reserve requirement (including, but not limited to, any marginal reserve requirement) for the Lenders with respect to liabilities constituting of or including (among other
liabilities) Eurocurrency liabilities in an amount equal to that portion of the Loan affected by such LIBOR Rate Interest Period and with a maturity equal to such LIBOR Rate Interest Period. 

Searcy Borrower: CHP Searcy Healthcare Owner, LLC, a Delaware limited liability company. 

Searcy Operator: Searcy Health and Rehab, LLC, an Arkansas limited liability company. 

Searcy Operating Lease: That certain Lease Agreement of even date herewith between Searcy Borrower and Searcy
Operator. 
 Searcy Mortgage: As such term is defined in Section 4.2(g). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 10

 Searcy Permitted Exceptions: Shall mean (i) as of the date
hereof, those matters listed on Exhibit B-5 hereto to which title to the Searcy Project may be subject at the Loan Opening, and (ii) at all times thereafter, (a) along with the liens and security interests created by the Searcy
Mortgage or other Loan Documents. statutory liens for ad valorem taxes, standby fees and other governmental charges which are not yet delinquent at the time in question or are being contested in accordance with the requirements of the Loan
Documents; (b) rights of tenants under Approved Leases; (c) other liens and security interests (if any) in favor of Agent for the benefit of the Lenders or otherwise approved by Agent; (d) mechanics’ liens being contested in
accordance with the requirements of the Loan Documents, and (e) such other title exceptions as Agent may reasonably approve in writing. 
 State: The State of Ohio. 
 Synovus: Synovus Bank, a
Georgia banking corporation. 
 Tenant Deposit Account: As such term is defined in
Section 4.1(e). 
 Title Insurer: Fidelity National Title Insurance Company, or such other
title insurance company licensed in the State as may be approved in writing by Agent. 
 Title Policies:
As such term is defined in Section 8.1(a). 
 Transfer: As such term is defined in
Section 12.1. 
 2.2 Other Definitional Provisions. 

All terms defined in this Agreement shall have the same meanings when used in the Note, Mortgages, any other Loan
Documents, or any certificate or other document made or delivered pursuant hereto. The words “hereof”, “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement.

 ARTICLE 3 
 BORROWERS’ REPRESENTATIONS AND WARRANTIES 
 3.1
Representations and Warranties. 
 To induce each of the Lenders to execute this Agreement and perform
its respective obligations hereunder, Borrowers hereby represent and warrant to the Lenders as follows: 
 (a)
Batesville Borrower has good and marketable fee simple title in the Batesville Project, subject only to the Batesville Permitted Exceptions. 
 (b) Broadway Borrower has good and marketable fee simple title in the Broadway Project, subject only to the Broadway Permitted Exceptions. 

(c) Jonesboro Borrower has good and marketable fee simple title in the Jonesboro Project, subject only to the Jonesboro
Permitted Exceptions. 
 (d) Magnolia Borrower has good and marketable fee simple title in the Magnolia Project,
subject only to the Magnolia Permitted Exceptions. 
 (e) Mine Creek Borrower has good and marketable fee simple
title in the Mine Creek Project, subject only to the Mine Creek Permitted Exceptions. 
 (f) Searcy Borrower has
good and marketable fee simple title in the Searcy Project, subject only to the Searcy Permitted Exceptions. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 11

 (g) No litigation or proceedings are pending, or to the best of
Borrowers’ knowledge threatened, against any Borrower or Guarantor, which could, if adversely determined, cause a Material Adverse Change with respect to any Borrower, Guarantor or any Project. To the best of Borrowers’ knowledge, there
are no pending environmental proceedings, whether civil (including actions by private parties), criminal, or administrative proceedings, relating to any Project (collectively, “Environmental Proceedings”), and Borrowers have no
knowledge of any threatened Environmental Proceedings or any facts or circumstances which may give rise to any future Environmental Proceedings. 
 (h) Each Borrower is a duly organized and validly existing Delaware limited liability company and has full power and authority to execute, deliver and perform all Loan Documents to which such Borrower is
a party, and such execution, delivery and performance have been duly authorized by all requisite action on the part of such Borrower. 
 (i) Guarantor is a duly organized and validly existing Maryland corporation and has full power and authority to execute, deliver and perform all Loan Documents to which such person is a party, and such
execution, delivery and performance have been duly authorized by all requisite action on the part of such person. 
 (j) No consent, approval or authorization of or declaration, registration or filing with any Governmental Authority or nongovernmental person or entity, including any creditor, partner or member of any
Borrower or Guarantor, is required in connection with the execution, delivery and performance of this Agreement or any of the Loan Documents other than the recordation of the Mortgages, the Assignments of Rents and UCC-1 Financing Statements, except
for such consents, approvals or authorizations of or declarations or filings with any Governmental Authority or non-governmental person or entity where the failure to so obtain would not have an adverse effect on any Borrower or Guarantor or which
have been obtained as of any date on which this representation is made or remade. 
 (k) The execution, delivery
and performance of this Agreement, the execution and payment of the Notes and the granting of the Mortgages and other security interests under the other Loan Documents have not constituted and will not constitute, upon the giving of notice or lapse
of time or both, a breach or default under any other agreement to which any Borrower or Guarantor is a party or may be bound or affected, or a violation of any law or court order which may affect any Project, any part thereof, any interest therein,
or the use thereof. 
 (l) There is no default under this Agreement or the other Loan Documents, nor any
condition which, after notice or the passage of time or both, would constitute a default or an Event of Default under said documents. 
 (m) (i) No condemnation of any portion of any Project, (ii) no condemnation or relocation of any roadways abutting any Project, and (iii) no proceeding to deny access to any Project from
any point or planned point of access to such Project, has commenced or, to the best of Borrowers’ knowledge, is contemplated by any Governmental Authority. 

(n) To the best of Borrowers’ knowledge, the use of each Project does not violate (i) any Laws (including
subdivision, zoning, building, environmental protection and wetland protection Laws), or (ii) any building permits, restrictions of record, or agreements affecting such Project or any part thereof. To the best knowledge of Borrowers, no Project
violates (i) any Laws (including subdivision, zoning, building, environmental protection and wetland protection Laws), or (ii) any building permits, restrictions of record, or agreements affecting such Project or any part thereof. To the
best of Borrowers’ knowledge, neither the zoning authorizations, approvals or variances nor any other right to own or to use any Project is to any extent dependent upon or related to any real estate other than the Land applicable to such
Project. All consents, licenses and permits and all other authorizations or approvals (collectively, “Governmental Approvals”) required for the ownership and use of each Project have been obtained and remain in full force and
effect. 
 (o) To the best of Borrowers’ knowledge, each Project has adequate water, gas and electrical
supply, storm and sanitary sewerage facilities, other required public utilities, fire and police protection, and means of access between such Project and public highways; to the best of Borrowers’ knowledge, none of the foregoing will be
foreseeably delayed or impeded by virtue of any requirements under any applicable Laws. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 12

 (p) No brokerage fees or commissions are payable by or to any person in
connection with this Agreement or the Loan to be disbursed hereunder. 
 (q) All financial statements and other
information previously furnished by any Borrower or Guarantor to Lender in connection with the Loan are true, complete and correct and fairly present the financial conditions of the subjects thereof as of the respective dates thereof and do not fail
to state any material fact necessary to make such statements or information not misleading, and no Material Adverse Change with respect to any Borrower or Guarantor has occurred since the respective dates of such statements and information. None of
any Borrower, nor Guarantor has any material liability, contingent or otherwise, not disclosed in such financial statements. 
 (r) As of the date hereof and except as disclosed in the Environmental Report, (i) each Project is in a clean, safe and healthful condition, and, except for materials used in the ordinary course of
construction, maintenance and operation of such Project, is free of all Hazardous Material and is in compliance with all applicable Laws; (ii) none of the Borrowers nor, to the best knowledge of Borrowers, any other person or entity, has ever
caused or permitted any Hazardous Material to be placed, held, located or disposed of on, under, at or in a manner to affect any Project in violation of any applicable Laws, or any part thereof, and no Project has ever been used (whether by any
Borrower or, to the best knowledge of Borrowers, by any other person or entity) for any activities involving, directly or indirectly, the use, generation, treatment, storage, transportation, or disposal of any Hazardous Material in violation of any
applicable Laws; (iii) no Project, nor any Borrower is subject to any existing, pending, or, to the best of Borrowers’ knowledge, threatened investigation or inquiry by any Governmental Authority, and no Project is subject to any remedial
obligations under any applicable Laws pertaining to health or the environment; and (iv) to the best of Borrowers’ knowledge, there are no underground tanks, vessels, or similar facilities for the storage, containment or accumulation of
Hazardous Materials of any sort on, under or affecting any Project. 
 (s) Each Project is taxed separately
without regard to any other property and for all purposes the Project may be mortgaged, conveyed and otherwise dealt with as an independent parcel. 
 (t) None of the Borrowers nor their respective agents have entered into any Leases, subleases or other arrangements for occupancy of space within each Project other than the Operating Leases. 

(u) Except as set forth on the applicable survey delivered to Agent for each Project, no portion of the Improvements
encroaches upon any property line, building line, setback line, side yard line or any recorded or visible easement (or other easement of which any Borrower is aware or has reason to believe may exist) with respect to such Project. 

(v) The Loan is not being made for the purpose of purchasing or carrying “margin stock” within the meaning of
Regulation T, U or X issued by the Board of Governors of the Federal Reserve System, and each Borrower agrees to execute all instruments necessary to comply with all the requirements of Regulation U of the Federal Reserve System.

 (w) No Borrower is a party in interest to any plan defined or regulated under ERISA, and none of the assets
of the Borrowers are “plan assets” of any employee benefit plan covered by ERISA or Section 4975 of the Internal Revenue Code. 
 (x) No Borrower is a “foreign person” within the meaning of Section 1445 or 7701 of the Internal Revenue Code. 

(y) No Borrower uses any trade name other than its actual name set forth herein. The principal place of business of
Borrower is as stated in Article 17. 
 (z) Each Borrower’s place of organization is the State of Delaware.

 (aa) All statements set forth in the Recitals are true and correct. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 13

 (bb) No Borrower, nor Guarantor, and, to the best of Borrower knowledge, no
Operator is (or will be) a person with whom any Lender is restricted from doing business under OFAC (including, those Persons named on OFAC’s Specially Designated and Blocked Persons list) or under any statute, executive order (including, the
September 23, 2001 Executive Order Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism), or other governmental action and is not and shall not engage in any dealings or transactions
or otherwise be associated with such persons. In addition, each Borrower hereby agrees to provide Agent with any additional information that any Lender deems necessary from time to time in order to ensure compliance with all applicable Laws
concerning money laundering and similar activities. 
 (cc) Each Operating Lease is in full force and effect. To
Borrower’s knowledge, there are no defaults (either monetarily or non-monetarily) by any Operator or any Borrower under its Operating Lease. 
 (dd) No Borrower has entered into this Agreement or any of the other Loan Documents with the actual intent to hinder, delay, or defraud any creditor, and each Borrower has received reasonably equivalent
value in exchange for its obligations under the Loan Documents. Giving effect to the transactions contemplated by the Loan Documents, the fair saleable value of each Borrower’s assets exceeds and will, immediately following the execution and
delivery of the Loan Documents, be greater than such Borrower’s probable liabilities, including the maximum amount of its contingent liabilities or its debts as such debts become absolute and mature. Each Borrower’s assets do not and,
immediately following the execution and delivery of the Loan Documents will not, constitute unreasonably small capital to carry out its business as conducted or as proposed to be conducted. No Borrower intends to, and does not believe that it will,
incur debts and liabilities (including, without limitation, contingent liabilities and other commitments) beyond its ability to pay such debts as they mature (taking into account the timing and amounts to be payable on or in respect of obligations
of each Borrower). 
 (ee) After consultation with counsel concerning the federal anti-kickback law (42 U.S.C.A.
SEC. 1320a-7b(b)), neither any Borrower nor its agent have offered or given any remuneration or thing of value to any person to encourage referral to the Projects nor has any Borrower or its agent solicited or received any remuneration or thing of
value in exchange for any Borrower’s agreement to make referrals or to purchase goods or services for the Projects. 
 (ff) Except for indirect ownership interests in any Borrower as a result of ownership of publicly traded shares of stock in Guarantor, no physician or other healthcare practitioner has an ownership
interest in, or financial relationship with, any Borrower, any Project or, to the best of Borrowers’ knowledge, any Operator. 
 (gg) The Batesville Project is duly licensed as a 150-bed skilled nursing facility under the applicable laws of the State of Arkansas and is currently operated as a 116 bed skilled nursing facility.
Batesville Operator is, or will be, the lawful owner of all required permits for the operation of the Batesville Project, including, without limitation, the Certificate of Need, if applicable, which (a) are in full force and effect,
(b) constitute all of the permits, licenses and certificates required for the use, operation and occupancy thereof, (c) have not been pledged as collateral for any other loan or indebtedness, (d) are held free from any restriction or
any encumbrance which would materially adversely affect the use or operation of the Batesville Project and (e) are not provisional, probationary or restricted in any way. No waivers of any laws, rules, regulations, or requirements (including,
but not limited to, minimum foot requirements per bed are required for the Batesville Project to operate at the foregoing licensed bed capacity. All Reimbursement Contracts are in full force and effect with respect to the Batesville Project. The
Batesville Borrower and the Batesville Operator are in good standing with all the respective agencies governing such Project’s licenses, program certification and Reimbursement Contracts. Batesville Borrower is current in the payment of all
so-called provider specific taxes or other assessments with respect to such Reimbursement Contracts. Batesville Borrower will maintain the Certificate of Need, if applicable, and/or any required permits in full force and effect. In the event Lender
acquires the Batesville Project through foreclosure or otherwise, neither Lender nor a subsequent manager, a subsequent lessee or any subsequent purchaser (through foreclosure or otherwise) must obtain a Certificate of Need prior to applying for and
receiving a license to operate the Batesville Project and certification to receive Medicare and Medicaid payments (and its successor programs) for patients having coverage thereunder provided that no service or bed complement is changed. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 14

 (hh) The Broadway Project is duly licensed as a 119-bed skilled nursing
facility under the applicable laws of the State of Arkansas and is currently operated as a 119 bed skilled nursing facility. Broadway Operator is, or will be, the lawful owner of all required permits for the operation of the Broadway Project,
including, without limitation, the Certificate of Need, if applicable, which (a) are in full force and effect, (b) constitute all of the permits, licenses and certificates required for the use, operation and occupancy thereof,
(c) have not been pledged as collateral for any other loan or indebtedness, (d) are held free from any restriction or any encumbrance which would materially adversely affect the use or operation of the Broadway Project and (e) are not
provisional, probationary or restricted in any way. No waivers of any laws, rules, regulations, or requirements (including, but not limited to, minimum foot requirements per bed are required for the Broadway Project to operate at the foregoing
licensed bed capacity. All Reimbursement Contracts are in full force and effect with respect to the Broadway Project. The Broadway Borrower and the Broadway Operator are in good standing with all the respective agencies governing such Project’s
licenses, program certification and Reimbursement Contracts. Broadway Borrower is current in the payment of all so-called provider specific taxes or other assessments with respect to such Reimbursement Contracts. Broadway Borrower will maintain the
Certificate of Need, if applicable, and/or any required permits in full force and effect. In the event Lender acquires the Broadway Project through foreclosure or otherwise, neither Lender nor a subsequent manager, a subsequent lessee or any
subsequent purchaser (through foreclosure or otherwise) must obtain a Certificate of Need prior to applying for and receiving a license to operate the Broadway Project and certification to receive Medicare and Medicaid payments (and its successor
programs) for patients having coverage thereunder provided that no service or bed complement is changed. 
 (ii)
The Jonesboro Project is duly licensed as a 136-bed skilled nursing facility under the applicable laws of the State of Arkansas and is currently operated as a 136 bed skilled nursing facility. Jonesboro Operator is, or will be, the lawful owner of
all required permits for the operation of the Jonesboro Project, including, without limitation, the Certificate of Need, if applicable, which (a) are in full force and effect, (b) constitute all of the permits, licenses and certificates
required for the use, operation and occupancy thereof, (c) have not been pledged as collateral for any other loan or indebtedness, (d) are held free from any restriction or any encumbrance which would materially adversely affect the use or
operation of the Jonesboro Project and (e) are not provisional, probationary or restricted in any way. No waivers of any laws, rules, regulations, or requirements (including, but not limited to, minimum foot requirements per bed are required
for the Jonesboro Project to operate at the foregoing licensed bed capacity. All Reimbursement Contracts are in full force and effect with respect to the Jonesboro Project. The Jonesboro Borrower and the Jonesboro Operator are in good standing with
all the respective agencies governing such Project’s licenses, program certification and Reimbursement Contracts. Jonesboro Borrower is current in the payment of all so-called provider specific taxes or other assessments with respect to such
Reimbursement Contracts. Jonesboro Borrower will maintain the Certificate of Need, if applicable, and/or any required permits in full force and effect. In the event Lender acquires the Jonesboro Project through foreclosure or otherwise, neither
Lender nor a subsequent manager, a subsequent lessee or any subsequent purchaser (through foreclosure or otherwise) must obtain a Certificate of Need prior to applying for and receiving a license to operate the Jonesboro Project and certification to
receive Medicare and Medicaid payments (and its successor programs) for patients having coverage thereunder provided that no service or bed complement is changed. 

(jj) The Magnolia Project is duly licensed as a 140-bed skilled nursing facility under the applicable laws of the State
of Arkansas and is currently operated as a 140 bed skilled nursing facility. Magnolia Operator is, or will be, the lawful owner of all required permits for the operation of the Magnolia Project, including, without limitation, the Certificate of
Need, if applicable, which (a) are in full force and effect, (b) constitute all of the permits, licenses and certificates required for the use, operation and occupancy thereof, (c) have not been pledged as collateral for any other
loan or indebtedness, (d) are held free from any restriction or any encumbrance which would materially adversely affect the use or operation of the Magnolia Project and (e) are not provisional, probationary or restricted in any way. No
waivers of any laws, rules, regulations, or requirements (including, but not limited to, minimum foot requirements per bed are required for the Magnolia Project to operate at the foregoing licensed bed capacity. All Reimbursement Contracts are in
full force and effect with respect to the Magnolia Project. The Magnolia Borrower and the Magnolia Operator are in good standing with all the respective agencies governing such Project’s licenses, program certification and Reimbursement
Contracts. Magnolia Borrower is current in the payment of all so-called provider specific taxes or other assessments with respect to such Reimbursement Contracts. Magnolia Borrower will maintain the Certificate of Need, if applicable, and/or any
required permits in full force and effect. In the event Lender acquires the Magnolia Project through foreclosure or otherwise, neither Lender nor a subsequent manager, a subsequent lessee or any subsequent purchaser (through foreclosure or
otherwise) must obtain a Certificate of Need prior to applying for and receiving a license to operate the Magnolia Project and certification to receive Medicare and Medicaid payments (and its successor programs) for patients having coverage
thereunder provided that no service or bed complement is changed. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 15

 (kk) The Mine Creek Project is duly licensed as a 78-bed skilled nursing
facility under the applicable laws of the State of Arkansas and is currently operated as a 78 bed skilled nursing facility. Mine Creek Operator is, or will be, the lawful owner of all required permits for the operation of the Mine Creek Project,
including, without limitation, the Certificate of Need, if applicable, which (a) are in full force and effect, (b) constitute all of the permits, licenses and certificates required for the use, operation and occupancy thereof,
(c) have not been pledged as collateral for any other loan or indebtedness, (d) are held free from any restriction or any encumbrance which would materially adversely affect the use or operation of the Mine Creek Project and (e) are
not provisional, probationary or restricted in any way. No waivers of any laws, rules, regulations, or requirements (including, but not limited to, minimum foot requirements per bed are required for the Mine Creek Project to operate at the foregoing
licensed bed capacity. All Reimbursement Contracts are in full force and effect with respect to the Mine Creek Project. The Mine Creek Borrower and the Mine Creek Operator are in good standing with all the respective agencies governing such
Project’s licenses, program certification and Reimbursement Contracts. Mine Creek Borrower is current in the payment of all so-called provider specific taxes or other assessments with respect to such Reimbursement Contracts. Mine Creek Borrower
will maintain the Certificate of Need, if applicable, and/or any required permits in full force and effect. In the event Lender acquires the Mine Creek Project through foreclosure or otherwise, neither Lender nor a subsequent manager, a subsequent
lessee or any subsequent purchaser (through foreclosure or otherwise) must obtain a Certificate of Need prior to applying for and receiving a license to operate the Mine Creek Project and certification to receive Medicare and Medicaid payments (and
its successor programs) for patients having coverage thereunder provided that no service or bed complement is changed. 
 (ll) The Searcy Project is duly licensed as a 245-bed skilled nursing facility under the applicable laws of the State of Arkansas and is currently operated as a 191 bed skilled nursing facility. Searcy
Operator is, or will be, the lawful owner of all required permits for the operation of the Searcy Project, including, without limitation, the Certificate of Need, if applicable, which (a) are in full force and effect, (b) constitute all of
the permits, licenses and certificates required for the use, operation and occupancy thereof, (c) have not been pledged as collateral for any other loan or indebtedness, (d) are held free from any restriction or any encumbrance which would
materially adversely affect the use or operation of the Searcy Project and (e) are not provisional, probationary or restricted in any way. No waivers of any laws, rules, regulations, or requirements (including, but not limited to, minimum foot
requirements per bed are required for the Searcy Project to operate at the foregoing licensed bed capacity. All Reimbursement Contracts are in full force and effect with respect to the Searcy Project. The Searcy Borrower and the Searcy Operator are
in good standing with all the respective agencies governing such Project’s licenses, program certification and Reimbursement Contracts. Searcy Borrower is current in the payment of all so-called provider specific taxes or other assessments with
respect to such Reimbursement Contracts. Searcy Borrower will maintain the Certificate of Need, if applicable, and/or any required permits in full force and effect. In the event Lender acquires the Searcy Project through foreclosure or otherwise,
neither Lender nor a subsequent manager, a subsequent lessee or any subsequent purchaser (through foreclosure or otherwise) must obtain a Certificate of Need prior to applying for and receiving a license to operate the Searcy Project and
certification to receive Medicare and Medicaid payments (and its successor programs) for patients having coverage thereunder provided that no service or bed complement is changed. 

(mm) No Borrower nor its Operator has granted to any third party the right to reduce the number of licensed beds in any
Project or to apply for approval to transfer the right to any or all of the licensed beds to any other location. 
 (nn) Each Project is in compliance with all requirements for participation in Medicare and Medicaid, including without limitation, the Medicare and Medicaid Patient Protection Act of 1987. Each Project is
in conformance in all material respects with all insurance, reimbursement and cost reporting requirements and has a current provider agreement which is in full force and effect under Medicare and Medicaid. 

(oo) There is no threatened or pending revocation, suspension, termination, probation, restriction, limitation, or
nonrenewal affecting any Borrower, any Project or any participation or provider agreement with any third-party payor, including Medicare, Medicaid, Blue Cross and/or Blue Shield, and any other private commercial insurance managed care and employee
assistance program (such programs, the “Third-Party Payors’ 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 16

 
Programs”) to which Borrowers or the Projects presently is subject. All Medicare (if any), Medicaid (if any) and private insurance cost reports and financial reports submitted by Borrower or
Operator are and will be materially accurate and complete and have not been and will not be misleading in any material respects. No cost reports for any Project remain “open” or unsettled except as otherwise disclosed. 

(pp) No Borrower nor Guarantor nor, to the best of Borrower’s knowledge, any Operator or any Project is currently
the subject of any proceeding by any governmental agency, and no notice of any violation has been received by any Borrower or Guarantor from any federal, state or local government or quasi-governmental body or agency or any administrative or
investigative body that would, directly or indirectly, or with the passage of time: 
 (i) have a
material adverse impact on a Borrower’s or an Operator’s ability to accept and/or retain residents or result in the imposition of a fine, a sanction, a lower rate certification or a lower reimbursement rate for services rendered to
eligible residents; 
 (ii) modify, limit or annul or result in the transfer, suspension,
revocation or imposition of probationary use of any of the permits; or 
 (iii) affect a
Borrower’s continued participation in the Medicare or Medicaid programs or any other Third-Party Payors’ Programs, or any successor programs thereto, at current rate certifications. 

3.2 Survival of Representations and Warranties. 

Each Borrower agrees that all of the representations and warranties set forth in Section 3.1 and elsewhere in
this Agreement are true as of the date hereof, will be true at the Loan Opening and, except for matters which have been disclosed by Borrowers and approved by Agent in writing, at all times thereafter. It shall be a condition precedent to the Loan
Opening that each of said representations and warranties is true and correct as of the date thereof. 
 ARTICLE 4

 LOAN AND LOAN DOCUMENTS 
 4.1 Agreement to Borrow and Lend; Lenders’ Obligation to Disburse. 
 Subject to the terms, provisions and conditions of this Agreement and the other Loan Documents, Borrowers agree to borrow from the Lenders and each Lender agrees to lend to Borrowers the Loan, for the
purposes and subject to all of the terms, provisions and conditions contained in this Agreement. If more than one Lender is a party hereto, the obligations of each such Lender with respect to the amount it has agreed to loan to Borrowers shall be
several (and not joint and several) and shall be limited to its proportionate share of the Loan and of each advance. 
 (a) The maximum aggregate amount of the Loan shall not exceed the lesser of (i) Thirty Million and No/100 Dollars ($30,000,000.00), and (ii) sixty percent (60%) of the “leased
fee” value of the Projects as determined in the Appraisal, and (iii) sixty percent (60%) of the “fee simple” value of the Projects as determined in the Appraisal. The Loan will be funded in a single lump sum advance on the
Loan Opening Date. The Loan is non-revolving, and amounts repaid hereunder shall not be available for further borrowing hereunder. 
 (b) Lenders agree, upon Borrowers’ compliance with and satisfaction of all conditions precedent to the Loan Opening and provided no Material Adverse Change has occurred with respect to any Borrower,
Guarantor or the Projects and no default or Event of Default has occurred and is continuing hereunder, to open the Loan. 
 (c) To the extent that the Lenders may have acquiesced in noncompliance with any requirements precedent to the Opening of the Loan or precedent to the subsequent disbursement of the proceeds of the Loan,
such acquiescence shall not constitute a waiver by Lenders, and Lenders may at any time after such acquiescence require Borrowers to comply with all such requirements. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 17

 (d) Borrowers shall open one deposit account for each Project with Agent
(each such account, a “Project Operating Account” and collectively, the “Project Operating Accounts”). All cash flow from each Project received by Borrowers, including, without limitation, the Lease Income, but
excluding tenant security deposits referenced in (e) below, shall be deposited in the applicable Project Operating Account; provided, however, that any Lender may maintain a separate account in the name of one or more Borrowers for tenant
security deposits from the Projects as agreed to between Agent and such Lender. During the existence of an Event of Default, all such cash flow shall be available for payment of debt service on the Loan, and Agent, for the pro rata benefit of the
Lenders, is authorized to pay principal or interest due upon the Notes during the existence of an Event of Default as well as real estate taxes if the same are not paid by Borrower or Operator prior to delinquency by debiting funds on deposit in the
Project Operating Accounts. Unless an Event of Default shall exist, Borrowers shall have access to and may use any or all Monthly Excess Cash Flow then held in the Project Operating Accounts for any lawful purpose which shall include, without
limitation, payment of the operating expenses for the Projects, dividends, distributions or any other costs or expenses of Borrowers or Guarantors. 
 (e) Borrowers shall open one deposit account for all Projects maintained by Synovus for the benefit of the Lenders (“Tenant Deposit Account”). All tenant security deposits under the
Leases received by Borrowers shall be deposited in the tenant Deposit Account, including, without limitation, $458,431.00 on the date hereof and $76,406.00 per month for the twelve months commencing on the date hereof. For the avoidance of doubt,
the rights of the Lenders in the security deposits referenced herein are subject to the rights of Operators under the Leases. Borrowers hereby pledge the Tenant Deposit Account and all amounts held in therein to Agent for the benefit of the Lenders.
The Tenant Deposit Account shall be a blocked account held by Synovus subject to a control agreement with Borrowers on Synovus’ form. 
 4.2 Loan Documents. 
 Each Borrower agrees that it
will, on or before the Loan Opening Date, execute and deliver or cause to be executed and delivered to Agent the following documents in form and substance acceptable to Agent: 

(a) One or more promissory notes (the “Notes”), in the maximum amount of the Loan, executed by Borrowers
and payable to the order of each Lender in the amount of such Lender’s Commitment. 
 (b) An Arkansas
Mortgage, Absolute Assignment of Rents, Security Agreement and Fixture Filing (the “Batesville Mortgage”), executed by Batesville Borrower in favor of Agent for the benefit of the Lenders securing this Agreement, the Notes, and all
obligations of Borrowers in connection with the Loan, granting a first priority lien on Batesville Borrower’s fee simple interest in the Batesville Project, subject only to the Batesville Permitted Exceptions. 

(c) An Arkansas Mortgage, Absolute Assignment of Rents, Security Agreement and Fixture Filing (the “Broadway
Mortgage”), executed by Broadway Borrower in favor of Agent for the benefit of the Lenders securing this Agreement, the Notes, and all obligations of Borrowers in connection with the Loan, granting a first priority lien on Broadway
Borrower’s fee simple interest in the Broadway Project, subject only to the Broadway Permitted Exceptions. 

(d) An Arkansas Mortgage, Absolute Assignment of Rents, Security Agreement and Fixture Filing (the “Jonesboro
Mortgage”), executed by Jonesboro Borrower in favor of Agent for the benefit of the Lenders securing this Agreement, the Notes, and all obligations of Borrowers in connection with the Loan, granting a first priority lien on Jonesboro
Borrower’s fee simple interest in the Jonesboro Project, subject only to the Jonesboro Permitted Exceptions. 
 (e) An Arkansas Mortgage, Absolute Assignment of Rents, Security Agreement and Fixture Filing (the “Magnolia Mortgage”), executed by Magnolia Borrower in favor of Agent for the benefit of
the Lenders securing this Agreement, the Notes, and all obligations of Borrowers in connection with the Loan, granting a first priority lien on Magnolia Borrower’s fee simple interest in the Magnolia Project, subject only to the Magnolia
Permitted Exceptions. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 18

 (f) An Arkansas Mortgage, Absolute Assignment of Rents, Security Agreement
and Fixture Filing (the “Mine Creek Mortgage”), executed by Mine Creek Borrower in favor of Agent for the benefit of the Lenders securing this Agreement, the Notes, and all obligations of Borrowers in connection with the Loan,
granting a first priority lien on Mine Creek Borrower’s fee simple interest in the Mine Creek Project, subject only to the Mine Creek Permitted Exceptions. 

(g) An Arkansas Mortgage, Absolute Assignment of Rents, Security Agreement and Fixture Filing (the “Searcy
Mortgage”), executed by Searcy Borrower in favor of Agent for the benefit of the Lenders securing this Agreement, the Notes, and all obligations of Borrowers in connection with the Loan, granting a first priority lien on Searcy
Borrower’s fee simple interest in the Searcy Project, subject only to the Searcy Permitted Exceptions. 

(h) A guaranty ( the “Guaranty”) executed by Guarantor and pursuant to which the Guarantor guarantees
the “Guaranteed Indebtedness” as such term is therein defined. 
 (i) An environmental indemnity
(“Indemnity”) from Borrowers and Guarantor indemnifying Agent and the Lenders with regard to all matters related to Hazardous Materials and other environmental matters. 

(j) The Assignments of Rents. 
 (k) Such UCC financing statements as Agent’s counsel determines are advisable or necessary to perfect or notify third parties of the security interests intended to be created by the Loan Documents.

 (l) Such other documents, instruments or certificates as Agent and its counsel may reasonably require,
including such documents as Agent in its sole discretion deems necessary or appropriate to effectuate the terms and conditions of this Agreement and the Loan Documents, and to comply with the laws of the State. 

4.3 Term of the Loan. 

Unless the Loan is otherwise earlier accelerated as permitted herein or under any other Loan Document, all principal,
interest and other sums due under the Loan Documents shall be due and payable in full on the Original Maturity Date. The terms and provisions of this Section 4.3 shall not constitute a waiver of the requirement that any modification of
the Notes or any of the Loan Documents shall require the express written approval of Agent, no such approval (either expressed or implied) having been given as of the date hereof (other than as expressly set forth herein). 

4.4 Prepayments. 
 Borrowers shall have the right to make prepayments of the Loan, in whole or in part, without prepayment penalty other than any Breakage Costs which may be due, upon not less than seven (7) days’
prior written notice to Agent. No prepayment of all or part of the Loan shall be permitted unless same is made together with the payment of all interest accrued on the Loan through the date of prepayment and an amount equal to all Breakage Costs and
attorneys’ fees and disbursements incurred by each Lender as a result of the prepayment. 
 4.5
Required Principal Payments. 
 In addition to, and not in lieu of, each monthly
interest payment required under Section 5.1 hereof, commencing May 10, 2015, and continuing on the tenth
(10th) day of each successive month thereafter until
the Final Maturity Date, principal shall be due and payable in monthly installments. Each such installment shall be in an amount that would be sufficient to fully amortize the Loan on a twenty-five (25) year amortization schedule at a per annum
rate of six percent (6%). Notwithstanding anything to the contrary, the aggregate outstanding balance of the Loan plus all accrued but unpaid interest shall be due and payable on the Final Maturity Date. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 19

 4.6 Late Charge. 

Any and all amounts due hereunder or under the other Loan Documents which remain unpaid more than ten (10) days after
the date said amount was due and payable shall incur a fee (the “Late Charge”) of four percent (4%) of said amount, which payment shall be in addition to all of Lenders’ other rights and remedies under the Loan Documents,
provided that no Late Charge shall apply to the final payment of principal on the Final Maturity Date. 
 ARTICLE 5

 INTEREST 
 5.1 Interest Rate. 
 (a) The
Loan will bear interest at the Applicable Rate, unless the Default Rate is applicable. Except as expressly provided herein, the Adjusted LIBOR Rate shall be the “Applicable Rate”. Borrower shall pay interest in arrears on the tenth
(10th) day of every calendar month in the amount of
all interest accrued and unpaid. All payments (whether of principal or of interest) shall be deemed credited to Borrower’s account only if received by 12:00 noon Brooklyn, Ohio, time on a Business Day; otherwise, such payment shall be deemed
received on the next Business Day. 
 (b) If Agent determines in its reasonable discretion (i) that Dollar
deposits in an amount approximately equal to the Loan for the designated LIBOR Rate Interest Period are not generally available at such time in the London interbank market for deposits in Dollars, (ii) that the rate at which such deposits are
being offered will not adequately and fairly reflect the cost to Lenders of maintaining a LIBOR Rate on such portion of the Loan or of funding the same for such LIBOR Rate Interest Period due to circumstances affecting the London interbank market
generally, (iii) that reasonable means do not exist for ascertaining a LIBOR Rate, or (iv) that an Adjusted LIBOR Rate would be in excess of the maximum interest rate which Borrower may by law pay, then, in any such event, Agent shall so
notify Borrower and all portions of the Loan bearing interest at an Adjusted LIBOR Rate that are so affected shall, as of the date of such notification with respect to an event described in clause (ii) or (iv) above, or as of the
expiration of the applicable LIBOR Rate Interest Period with respect to an event described in clause (i) or (iii) above, bear interest at the Adjusted Base Rate (or such lower rate as required by applicable law) until such time as the
situations described above are no longer in effect or can be avoided, at which time the Loan shall again accrue interest at the Adjusted LIBOR Rate. 
 (c) Interest at the Applicable Rate (or Default Rate) shall be calculated for the actual number of days elapsed on the basis of a 360-day year, including the first date of the applicable period to, but
not including, the date of repayment. 
 (d) Borrower shall pay all Breakage Costs incurred from time to time by
Lenders upon demand. 
 (e) If the introduction of or any change in any Law, regulation or treaty, or in the
interpretation thereof by any Governmental Authority charged with the administration or interpretation thereof, shall make it unlawful for Lender to maintain the Applicable Rate at an Adjusted LIBOR Rate with respect to the Loan or any portion
thereof, or to fund the Loan or any portion thereof in Dollars in the London interbank market, or to give effect to its obligations regarding the accrual of interest on the Loan at the Adjusted LIBOR Rate as contemplated by the Loan Documents, then
(1) Agent shall notify Borrower that Lenders are no longer able to maintain the Applicable Rate at an Adjusted LIBOR Rate, (2) the Applicable Rate for any portion of the Loan for which the Applicable Rate is then an Adjusted LIBOR Rate
shall automatically be converted to the Adjusted Base Rate, and (3) Borrower shall pay to Agent the amount of Breakage Costs (if any) incurred in connection with such conversion. Thereafter, the Loan shall accrue interest at the Adjusted Base
Rate until such time as the situation described herein is no longer in effect or can be avoided, at which time the Loan shall again accrue interest at the Adjusted LIBOR Rate. 

(f) The Loan shall bear interest at the Default Rate upon the election of the Lenders at any time at which an Event of
Default shall exist. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 20

 ARTICLE 6 
 COSTS OF MAINTAINING LOAN 
 6.1 Increased Costs and
Capital Adequacy. 
 (a) Borrowers recognize that the cost to the Lenders of maintaining the Loan or any
portion thereof may fluctuate and, Borrowers agree to pay Agent for the pro rata benefit of the Lenders additional amounts to compensate the Lenders for any increase in its actual costs incurred in maintaining the Loan or any portion thereof
outstanding or for the reduction of any amounts received or receivable from Borrowers as a result of: 
 (i) any change after the date hereof in any applicable Law, regulation or treaty, or in the interpretation or administration thereof, or by any domestic or foreign court, (A) changing the basis of
taxation of payments under this Agreement to Agent (other than taxes imposed on all or any portion of the overall net income or receipts of any Lender), or (B) imposing, modifying or applying any reserve, special deposit or similar requirement
against assets of, deposits with or for the account of, credit extended by, or any other acquisition of funds for loans by the Lenders (which includes the Loan or any applicable portion thereof), or (C) imposing on any Lender, or the London
interbank market generally, any other condition affecting the Loan, provided that the result of the foregoing is to increase the cost to Lender of maintaining the Loan or any portion thereof or to reduce the amount of any sum received or receivable
from Borrowers by Lenders under the Loan Documents; or 
 (ii) the maintenance by any Lender of
reserves in accordance with reserve requirements promulgated by the Board of Governors of the Federal Reserve System of the United States with respect to “Eurocurrency Liabilities” of a similar term to that of the applicable portion of the
Loan (without duplication for reserves already accounted for in the calculation of a LIBOR Rate pursuant to the terms hereof). 
 (b) If the application of any Law, rule, regulation or guideline adopted or arising out of the July, 1988 report of the Basel Committee on Banking Regulations and Supervisory Practices entitled
“International Convergence of Capital Measurement and Capital Standards”, or the adoption after the date hereof of any other Law, rule, regulation or guideline regarding capital adequacy, or any change after the date hereof in any of the
foregoing, or in the interpretation or administration thereof by any domestic or foreign Governmental Authority, central bank or comparable agency charged with the interpretation or administration thereof, or compliance by Lender, with any request
or directive regarding capital adequacy (whether or not having the force of law) of any such authority, central bank or comparable agency, has the effect of reducing the rate of return on Lender’s capital to a level below that which Lender
would have achieved but for such application, adoption, change or compliance (taking into consideration the policies of Lender with respect to capital adequacy), then, from time to time Borrowers shall pay to Lender such additional amounts as will
compensate Lender for such reduction with respect to any portion of the Loan outstanding. 
 (c) Any amount
payable by Borrowers under subsection (a) or subsection (b) of this Section 6.1 shall be paid within five (5) days of receipt by Borrowers of a certificate signed by an authorized officer of Agent setting
forth the amount due and the basis for the determination of such amount, which statement shall be conclusive and binding upon Borrowers, absent manifest error. Failure on the part of Agent to demand payment from Borrowers for any such amount
attributable to any particular period shall not constitute a waiver of each Lender’s right to demand payment of such amount for any subsequent or prior period. Agent shall use reasonable efforts to deliver to Borrowers prompt notice of any
event described in subsection (a) or (b) above, of the amount of the reserve and capital adequacy payments resulting therefrom and the reasons therefor and of the basis of calculation of such amount; provided,
however, that any failure by Agent to so notify Borrowers shall not affect Borrowers’ obligation to pay the reserve and capital adequacy payment resulting therefrom. 

6.2 Borrower Withholding. 

If by reason of a change in any applicable Laws occurring after the date hereof, any Borrower is required by Law to make
any deduction or withholding in respect of any taxes (other than taxes imposed on or measured by the net income of any Lender or any franchise tax imposed on any Lender), duties or other charges

  

			
	 SECURED LOAN AGREEMENT
	  	Page 21

 
from any payment due under the Notes, the sums due from such Borrower in respect of such payment shall be increased to the extent necessary to ensure that, after the making of such deduction or
withholding, Lender receives and retains a net sum equal to the sum which it would have received had no such deduction or withholding been required to be made. 
 ARTICLE 7 
 LOAN EXPENSE AND ADVANCES 

7.1 Loan and Administration Expenses. 

Each Borrower unconditionally agrees to pay all reasonable expenses of the Loan, including all amounts payable pursuant to
Sections 7.2 and 7.3 and any and all other fees owing to Agent or any Lender pursuant to the Loan Documents, and also including, without limiting the generality of the foregoing, all recording, filing and registration fees and charges,
mortgage or documentary taxes, all insurance premiums, title insurance premiums and other charges of each Title Insurer, printing and photocopying expenses, survey fees and charges, cost of certified copies of instruments, cost of premiums on surety
company bonds and the Title Policies, at the promulgated rates, if applicable, charges of a Title Insurer or other escrowee for administering disbursements, all fees and costs of Agent’s Environmental Report, all appraisal fees, insurance
consultant’s fees, travel related expenses and all costs and expenses incurred by Agent in connection with the determination of whether or not Borrowers have performed the obligations undertaken by Borrowers hereunder or have satisfied any
conditions precedent to the obligations of each Lender hereunder and, if any default or Event of Default occurs hereunder or under any of the Loan Documents or if the Loan or the Notes or any portion thereof is not paid in full when and as due, all
costs and expenses of Lenders (including, without limitation, court costs and counsel’s fees and disbursements) incurred in attempting to enforce payment of the Loan and expenses of Agent and each Lender incurred (including court costs and
counsel’s fees and disbursements) in attempting to realize, while a default or Event of Default exists, on any security or incurred in connection with the sale or disposition (or preparation for sale or disposition) of any security for the
Loan. Each Borrower agrees to pay all brokerage, finder or similar fees or commissions payable in connection with the transactions contemplated hereby and shall indemnify and hold Agent and the Lenders harmless against all claims, liabilities, costs
and expenses (including reasonable attorneys’ fees and expenses) arising in relation to any claim by broker, finder or similar person. 
 7.2 Lender’s Attorneys’ Fees and Disbursements. 
 Borrowers agree to pay the reasonable attorneys’ fees of the Lenders and disbursements incurred in connection with the Loan, including (i) the preparation of this Agreement, any intercreditor
agreements and the other Loan Documents and the preparation of the closing binders, (ii) the disbursement, syndication, amendment and administration of the Loan and (iii) the enforcement of the terms of this Agreement and the other Loan
Documents. 
 7.3 Time of Payment of Fees and Expenses. 

Borrowers shall pay all expenses and fees incurred as of the Loan Opening on the Loan Opening Date (unless sooner required
herein). At the time of the Opening of the Loan, Agent may pay from the proceeds of the initial disbursement of the Loan all Loan expenses. Agent is hereby authorized, without any specific request or direction by Borrowers, to make disbursements
from time to time in payment of or to reimburse Agent for all reasonable Loan expenses and fees. 
 7.4
Expenses and Advances Secured by Loan Documents. 
 Any and all advances or payments made by any
Lender under this Article 7 from time to time, and any amounts expended by Agent pursuant to this Agreement, shall, as and when advanced or incurred, constitute additional indebtedness evidenced by the Notes and secured by the Mortgage and
the other Loan Documents. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 22

 7.5 Right of Lender to Make Advances to Cure Borrowers’
Defaults. 
 In the event that any Borrower fails to perform any of such Borrower’s covenants,
agreements or obligations contained in this Agreement or any of the other Loan Documents (after the expiration of applicable grace periods, except in the event of an emergency or other exigent circumstances), Agent may (but shall not be required to)
perform any of such covenants, agreements and obligations, and any amounts expended by Agent in so doing and shall constitute additional indebtedness evidenced by the Notes and secured by the Mortgages and the other Loan Documents and shall bear
interest at the Default Rate. 
 ARTICLE 8 
 REQUIREMENTS PRECEDENT 
 TO THE OPENING OF THE LOAN AND ANY SUBSEQUENT
DISBURSEMENT 
 8.1 Conditions Precedent to Closing and Opening of the Loan. 

Borrowers agree that the obligation of the Lenders’ to open the Loan is conditioned upon Borrowers’ performance
and satisfaction of the following conditions precedent in form and substance satisfactory to Agent in its reasonable discretion: 
 (a) Borrowers shall have furnished to Agent ALTA Mortgagee Title Insurance Policies, issued by the Title Insurer in the maximum amount of the Loan, insuring the lien of each Mortgage as a valid first,
prior and paramount lien upon the applicable Project and all appurtenant easements, and subject to no exceptions other than the applicable Permitted Exceptions (collectively, the “Title Policies”). The Title Policies shall satisfy
the requirements of Exhibit C attached hereto and made a part hereof; 
 (b) Borrowers shall have
furnished an ALTA plat of survey of each Project prepared and certified by a surveyor licensed in the State in which the respective Land is located and otherwise satisfactory to Agent, in triplicate, showing, through the use of course bearings and
distances, (i) all foundations of the Improvements in place; (ii) the dimensions and locations of all easements and roads or rights of way and setback lines, if any, affecting each Project, or required by subsection (i) of this
Section and that the same are unobstructed; (iii) the dimensions, boundaries and square footage of the applicable Improvements, if any; (iv) that all foundations and other structures are within the lot lines and in compliance with any
restrictions of record or ordinances relating to the location thereof; (v) the dimensions of all buildings and improvements, if any, and distance of such buildings and improvements from the lot lines; (vi) no encroachments by any
improvements located on adjoining property, except as approved by Agent; (vii) whether or not the applicable Project is located within a flood plain or flood hazard area; (viii) the location of adjoining streets and utilities and the
distance and name of the nearest intersecting streets; (ix) the dimensions and locations of all exterior parking areas, if any; and (x) such additional information which may be required by Agent. Each such survey shall be dated no earlier
than ninety (90) days prior to the Loan Opening, shall be made (and certified to have been made) as set forth in Exhibit D attached hereto and made a part hereof. Such survey shall include the legal description of the applicable Land;

 (c) Borrowers shall have furnished to Agent prior to the Loan Opening Date satisfactory evidence that
insurance coverages are in effect with respect to each Project and each Operator and Borrowers, in accordance with the Insurance Requirements attached hereto as Exhibit E, for which the premiums have been fully prepaid with endorsements
satisfactory to Agent; 
 (d) Borrowers shall have furnished evidence that no litigation or proceedings shall be
pending or, to the best of Borrowers’ knowledge, threatened which could or might cause a Material Adverse Change with respect to any Borrower, Guarantor, or any Project; 

(e) Borrowers shall have furnished to Agent an opinion from counsel for Borrowers and Guarantor covering due
authorization, execution and delivery and enforceability of the Loan Documents and also containing such other legal opinions as Agent shall require; 
 (f) Agent shall have obtained one or more Appraisals, which Appraisals must be satisfactory to Agent in all respects; 

(g) Borrowers shall have furnished to Agent a property condition report for each Project; 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 23

 (h) Borrowers shall have furnished to Agent current bankruptcy, federal tax
lien and judgment searches and searches of all Uniform Commercial Code financing statements filed in each place UCC Financing Statements are to be filed hereunder, demonstrating the absence of adverse claims; 

(i) Borrowers shall have furnished to Agent current annual financial statement of Guarantor, and such other persons or
entities connected with the Loan as Agent may request, each in form and substance and certified by Borrowers or Guarantor, as applicable, as acceptable to Agent. Guarantor shall provide such other additional financial information Agent reasonably
requires; 
 (j) Borrowers shall have furnished to Agent legible copies of all title exception documents cited
in the Title Policy and all other legal documents affecting each Project or the use thereof; 
 (k)
Intentionally Deleted; 
 (l) Agent has received evidence that no portion of the Projects is located in an area
designated by the Secretary of Housing and Urban Development as a special flood hazard area, or flood hazard insurance acceptable to Agent in its sole discretion; 

(m) If any Title Policy does not include a zoning endorsement, Borrowers shall have furnished to Agent a zoning report
for each Project in form satisfactory to Agent; 
 (n) Borrowers shall have furnished to Agent proof
satisfactory to Agent of authority, formation, organization and good standing in the state of its incorporation or formation and, if applicable, qualification as a foreign entity in good standing in the state of its incorporation or formation, of
all corporate, partnership, trust and limited liability company entities (including each Borrower and Guarantor) executing any Loan Documents, whether in their own name or on behalf of another entity. Borrower shall also provide certified
resolutions in form and content satisfactory to Agent, authorizing execution, delivery and performance of the Loan Documents, and such other documentation as Agent may reasonably require to evidence the authority of the persons executing the Loan
Documents; 
 (o) Borrowers shall have furnished an environmental report (“Environmental
Report”) for each Project prepared at Borrowers’ expense by a qualified environmental consultant approved by Agent. The environmental survey shall, at a minimum, (a) demonstrate the absence of any existing or potential Hazardous
Material contamination or violations of environmental Laws at each Project, except as acceptable to Agent in its sole and absolute discretion, (b) include the results of all sampling or monitoring to confirm the extent of existing or potential
Hazardous Material contamination at any Project, including the results of leak detection tests for each underground storage tank located at such Project, if any, (c) describe response actions appropriate to remedy any existing or potential
Hazardous Material contamination, and report the estimated cost of any such appropriate response, (d) confirm that any prior removal of Hazardous Material or underground storage tanks from any Project was completed in accordance with applicable
Laws, and (e) confirm whether or not the Land is located in a wetlands district; 
 (p) Intentionally
Deleted; 
 (q) Intentionally Deleted; 

(r) Borrowers shall have delivered to Agent a copy of the executed Operating Lease for each Project between the
applicable Borrower and the applicable Operator along with a subordination, non-disturbance and attornment agreement fully executed between the applicable parties on Agent’s form; 

(s) Intentionally Deleted; 
 (t) There shall be no uncured Default or Event of Default by any Borrower hereunder; 
 (u) Borrowers shall have delivered to Agent copies of the current renewed licenses for each Project that expire as of June 30, 2014; and 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 24

 (v) Borrowers shall have furnished to Agent such other materials, documents,
papers or requirements regarding any Project, any Borrower and Guarantor as Agent shall reasonably request. 
 The conditions
contained in this Section 8.1 are for the sole benefit of the Lenders, and Agent, on behalf of the Lenders, may, in its sole discretion, waive Borrowers’ compliance with any one (1) or more conditions; provided, that, in no
event shall the waiver of one (1) condition by Agent constitute the waiver of any other condition listed above. 

ARTICLE 9 

RESERVED 

ARTICLE 10 

BORROWERS’ AGREEMENTS 
 10.1 Borrowers further covenant and agree as follows: 

(a) Opening of Loan on the Loan Opening Date. All conditions precedent to the Opening of the Loan shall be complied
with on or prior to the Loan Opening Date. If such conditions are not complied with as of the Loan Opening Date, Agent may at its sole option terminate the obligation of the Lenders to fund the Loan by written notice to Borrowers. 

(b) Inspection by Agent. Borrowers will cooperate with Agent in arranging for inspections by representatives of
Agent from time to time provided, that unless an Event of Default exists, upon twenty-four (24) hours prior notice to Borrowers. Such inspection shall include an examination of (i) the Improvements, and (ii) all books, contracts and
records with respect to the Improvements. 
 (c) Mechanics’ Liens and Contest Thereof. Borrowers
will not suffer or permit any mechanics’ lien claims to be filed or otherwise asserted against any Project, and will promptly discharge the same in case of the filing of any claims for lien or proceedings for the enforcement thereof,
provided, however, that Borrowers shall have the right to contest in good faith and with reasonable diligence the validity of any such lien or claim upon furnishing to the Title Insurer such security or indemnity as it may require to
induce said Title Insurer to issue an endorsement to the Title Policy insuring against all such claims or liens; and provided further, that the aggregate amount of liens so insured against at any time shall not exceed $25,000.00 for any one Project
or $150,000.00 in the aggregate without Agent’s prior written consent. 
 (d) Settlement of
Mechanics’ Lien Claims. If Borrowers shall fail promptly either (i) to discharge any such lien, or (ii) to contest claims asserted and give security or indemnity in the manner provided in subsection (c) of this
Section, or having commenced to contest the same, and having given such security or indemnity, shall fail to prosecute such contest with diligence, or to maintain such indemnity or security so required by the Title Insurer for its full amount, or
upon adverse conclusion of any such contest, to cause any judgment or decree to be satisfied and lien to be released, then and in any such event Agent may, at its election (but shall not be required to), procure the release and discharge of any such
claim and any judgment or decree thereon and, further, may in its sole discretion effect any settlement or compromise of the same, or may furnish such security or indemnity to the Title Insurer, and any amounts so expended by Agent or any Lender,
including premiums paid or security furnished in connection with the issuance of any surety company bonds, shall be deemed to constitute disbursement of the proceeds of the Loan hereunder. In settling, compromising or discharging any claims for
lien, Agent shall not be required to inquire into the validity or amount of any such claim. 
 (e) Renewal of
Insurance. Borrowers shall maintain, or cause the Operators to maintain, insurance policies to be maintained in compliance with Exhibit E at all times. Borrowers shall timely pay, or cause the Operators to pay, all premiums on all
insurance policies required hereunder, and as and when additional insurance is required by Agent, from time to time, and as and when any policies of insurance may expire, furnish to Agent, premiums prepaid, additional and renewal insurance policies
with companies, coverage and in amounts satisfactory to Agent in accordance with Section 8.1(c). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 25

 (f) Payment of Taxes. Borrowers shall pay, or cause to be paid, all
real estate taxes and assessments and charges of every kind upon the Projects before the same become delinquent, provided, however, that Borrowers shall have the right to pay such tax under protest or to otherwise contest any such tax or assessment,
but only if (i) such contest has the effect of preventing the collection of such taxes so contested and also of preventing the sale or forfeiture of the Project or any part thereof or any interest therein, (ii) Borrowers have notified
Agent of their intent to contest such taxes, and (iii) Borrowers have deposited security in form and amount satisfactory to Agent, in its sole discretion. If Borrowers fail to commence such contest or, having commenced to contest the same, and
having deposited such security required by Agent for its full amount, shall thereafter fail to prosecute such contest in good faith or with due diligence, or, upon adverse conclusion of any such contest, shall fail to pay such tax, assessment or
charge, Agent, on behalf of the Lenders, may, at its election (but shall not be required to), pay and discharge any such tax, assessment or charge, and any interest or penalty thereon, and any amounts so expended by Agent shall be deemed to
constitute disbursements of the Loan proceeds hereunder (even if the total amount of disbursements would exceed the face amount of the Notes). Borrowers shall furnish to Agent evidence that taxes are paid at least five (5) days prior to the
last date for payment of such taxes and before imposition of any penalty or accrual of interest. 
 (g)
Escrow Accounts. During the continuance of an Event of Default, Borrowers shall, following the written request of Agent and for so long as such Event of Default is continuing, make insurance and tax escrow deposits, in amounts reasonably
determined by Agent from time to time as being needed to pay taxes and insurance premiums when due, in an interest bearing escrow account held by Agent in Agent’s name and under its sole dominion and control. All payments deposited in the
escrow account, and all interest accruing thereon, are pledged as additional collateral for the Loan. Notwithstanding Agent’s holding of the escrow account, nothing herein shall obligate Agent or any Lender to pay any insurance premiums or real
property taxes with respect to any portion of the Projects, provided that, so long as no Event of Default exists, Agent shall make available to Borrowers such funds as may be deposited in the escrow account from time to time for Borrowers’
payment of insurance premiums or real property taxes due with respect to the Projects. 
 (h) Personal
Property. All of Borrowers’ personal property, fixtures, attachments and equipment delivered upon, attached to or used in connection with the operation of the Projects shall always be located at the applicable Project and shall be kept free
and clear of all liens, encumbrances and security interests. 
 (i) Operating Leases. Each Borrower shall
maintain its Operating Lease in full force and effect and timely perform all of its obligations thereunder and not permit the termination or any material amendment of any Operating Lease unless the prior written consent of Lenders is first obtained.
Upon the occurrence of default by an Operator under an Operating Lease that is not cured within applicable notice and cure periods, upon Lenders’ request, Borrowers shall promptly engage oversight management services from a management company
reasonably acceptable to the Lenders. In the event that bankruptcy or insolvency proceedings are instituted by or against any Operator, each Borrower shall (to the extent permitted by the applicable bankruptcy court having jurisdiction over such
proceedings), upon written instruction received from Agent, terminate the Operating Lease. 
 (j) Defaults
Under Leases. Borrowers will not suffer or permit any breach or material default to occur in any of Borrowers’ obligations under any of the Leases nor suffer or permit the same to terminate by reason of any failure of Borrowers to meet any
requirement of any Lease, which default or failure results in a Material Adverse Change, including, without limitation, under any Operating Lease between any of the Borrowers and any Operator. 

(k) Agent’s Attorneys’ Fees for Enforcement of Agreement. In case of any default or Event of Default
hereunder, Borrowers (in addition to Agent’s reasonable attorneys’ fees, if any, to be paid pursuant to Section 7.3) will pay Agent’s reasonable attorneys’ and paralegal fees (including, without limitation, any
attorney and paralegal fees and costs incurred in connection with any litigation or bankruptcy or administrative hearing and any appeals therefrom) in connection with the enforcement of this Agreement; without limiting the generality of the
foregoing, if at any time or times hereafter Agent or any Lender employs counsel (whether or not any suit has been or shall be filed and whether or not other legal proceedings have been or shall be instituted) for advice or other representation with
respect to the Projects, this Agreement, or any of the other Loan Documents, or to protect, collect, lease, sell, take possession of, or liquidate the Project, or to attempt to enforce any security interest or lien in any portion of the Project, or
to enforce any rights of Agent and each Lender or any of Borrowers’ obligations 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 26

 
hereunder, then in any of such events all of the reasonable attorneys’ fees arising from such services, and any expenses, costs and charges relating thereto, shall constitute an additional
liability owing by Borrowers to Agent and/or the applicable Lender, on a joint and several basis, payable on demand. 
 (l) Appraisals. Agent shall have the right to obtain a new or updated Appraisal of any Project from time to time. Borrowers shall cooperate with Agent in this regard. If the Appraisal is obtained
to comply with any applicable law or regulatory requirement, or bank policy promulgated to comply therewith, or an Event of Default exists, Borrowers shall pay for any such Appraisal upon Agent’s request. 

(m) Furnishing Information. Borrowers shall provide Lender or shall cause Guarantor or Operator to provide to
Agent the following financial statements and information on a continuing basis during the term of the Loan: 
 (i) Within ninety (90) days after the end of each Fiscal Year of each Project, Borrowers unaudited financial statements prepared in accordance with GAAP, and certified by an officer of Borrower,
which statements shall be prepared in accordance with GAAP, and shall include a balance sheet and a statement of income and expenses for the year then ended, and shall be certified as true and correct by a financial officer of Borrowers. 

(ii) Within ninety (90) days after the end of each calendar year, audited financial statements of the
Guarantor on a GAAP basis (which include balance sheet, income statement, cash flow statement and all supporting notes); 
 (iii) Within forty-five (45) days after the end of each quarter, unaudited interim financial statements of the operations of the Projects, certified as true and correct by a financial officer of the
Borrowers or Operators, prepared in accordance with GAAP, which statements shall include a balance sheet and statement of income and expenses for the quarter then ended and for the fiscal year to date, which such statements shall be accompanied by a
covenant compliance certificate in the form attached hereto as Exhibit G;  
 (iv) Within
forty-five (45) days after the end of each quarter, quarterly census information by payor-class of the Projects as of the end of such quarter on an average basis for such year through the end of such quarter, certified by the chief financial
officer of Borrowers or Operator to be true and correct. 
 (v) Within sixty (60) days after
the end of each quarter, unaudited interim financial statements of the operations of the Guarantor, certified as true and correct by a financial officer of the Guarantor, prepared in accordance with GAAP, which statements shall include a balance
sheet and statement of income and expenses for the quarter then ended and for the Fiscal Year to date. 
 (vi) If and to the extent applicable, within ten (10) days after filing or receipt, all Medicaid cost reports and any amendments thereto filed with respect to the Projects and all responses, audit
reports, or other inquiries with respect to such cost reports (based on availability and applicability). 
 (vii) Within ten (10) days after receipt, copies of all licensure survey reports and statements of deficiencies (with plans of correction attached thereto) (based on availability and applicability).

 (viii) Within three (3) days after receipt, any and all notices (regardless of form) from
any and all licensing agency, that any Project’s license or certification is being downgraded to a substandard category, revoked or suspended, or that action is pending or being considered to downgrade to a substandard category, revoke or
suspend a Project’s license or certification. 
 (ix) If requested by Lender, within one
hundred twenty (120) days after the end of the Projects’ Fiscal Year, and more frequently, if reasonably requested by Lender (but in no event more often than twice during any calendar year), an aged accounts receivable report for any
Project by the account age classifications of 30 days, 60 days, 90 days, 120 days, and over 120 days. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 27

 Lender reserves the right to require that the annual and/or quarterly
financial statements of Borrowers, or Guarantor be audited and prepared by a nationally recognized accounting firm or independent certified public accounting firm acceptable to Lender, at their respective sole cost and expense, if (i) an Event
of Default exists, or (ii) if Lender has reasonable grounds to believe that the unaudited financial statements do not accurately represent the financial condition of Borrowers or Guarantor as the case may be. Lender further reserves the right
to require such other financial information of Borrowers, Guarantor, and/or the Projects, at such other times (including monthly or more frequently) as it shall deem necessary. All financial statements must be in the form and detail as Lender shall
from time to time reasonably request. Borrowers shall during regular business hours permit Agent or any of its agents or representatives (after twenty-four hours prior notice to Borrowers unless an Event of Default exists) to have access to and
examine all of its books and records regarding the development and operation of each Project. 
 (n) Lost
Note. Upon any Lender’s furnishing to Borrowers an affidavit to such effect, Borrowers shall, if the applicable Note is mutilated, destroyed, lost or stolen, deliver to such Lender, in substitution therefor, a new note containing the same
terms and conditions as the such Note. 
 (o) INDEMNIFICATION. BORROWERS SHALL INDEMNIFY
AGENT, EACH LENDER AND EACH AFFILIATE THEREOF AND THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES AND CONSULTANTS (EACH, AN “INDEMNIFIED PARTY”) AND DEFEND AND HOLD EACH INDEMNIFIED PARTY HARMLESS FROM AND AGAINST ALL CLAIMS, INJURY,
DAMAGE, LOSS AND LIABILITY, COST AND EXPENSE (INCLUDING REASONABLE ATTORNEYS’ FEES, COSTS AND EXPENSES) OF ANY AND EVERY KIND TO ANY PERSONS OR PROPERTY BY REASON OF (I) THE OPERATION OR MAINTENANCE OF THE PROJECT; (II) ANY
BREACH OF REPRESENTATION OR WARRANTY, DEFAULT OR EVENT OF DEFAULT; OR (III) ANY OTHER MATTER ARISING IN CONNECTION WITH THE LOAN, ANY BORROWER OR PROJECT (EXPRESSLY INCLUDING, WITHOUT LIMITATION, TO THE EXTENT CAUSED BY THE NEGLIGENCE OF THE
INDEMNIFIED PARTY). NO INDEMNIFIED PARTY SHALL, HOWEVER, BE ENTITLED TO BE INDEMNIFIED AGAINST ITS OWN GROSS NEGLIGENCE OR WILLFUL MISCONDUCT. 
 (p) No Additional Debt. Except for the Loan, no Borrower shall incur any indebtedness (whether personal or nonrecourse, secured or unsecured) other than customary trade payables paid within sixty
(60) days after they are incurred and equipment lease financing in the ordinary course of business; provided, however, Borrowers shall be permitted to enter into recourse debt with the consent of Agent, which consent shall not be unreasonably
withheld by Agent. 
 (q) Compliance With Laws. Each Borrower shall comply with all applicable
requirements (including applicable Laws) of any Governmental Authority having jurisdiction over such Borrower or any applicable Project. 
 (r) Organizational Documents. No Borrower shall, without the prior written consent of Agent, permit or suffer (i) a material amendment or modification of its organizational documents,
(ii) the admission of any new member, partner or shareholder, or (iii) any dissolution or termination of its existence. 
 (s) Furnishing Reports. Within thirty (30) days from receipt thereof, Borrowers shall provide Agent with copies of all inspections, reports, test results and other information received by any
Borrower, which relate to any Project or any part thereof in any material respect. 
 (t)
Management Contracts. Borrowers shall not and shall not permit its Operators to, enter into, modify in any material respect, amend in any material respect, terminate or cancel any management agreement (or any other contract related to the
management or operation of any Project) for any Project (except that the Interim Agreements (as defined below) may terminate by their express terms) or agreements with agents or brokers, without the prior written approval of Agent, which approval
shall not be unreasonably withheld by Agent. Pursuant to applicable law, the licenses and permits required for Operator to operate the Projects as a skilled nursing facility (the “Operator Permits”) may not be transferred or new
Operator Permits issued prior to August 1st of any
calendar year and application of such transfer or issuance cannot be made more than thirty (30) days prior to August 1, 2013. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 28

 
Accordingly, as of the date hereof, the Operators have not been issued Operator Permits. Borrower agrees to cause Operator to apply for the issuance of new Operator Permits (the “New
Operator Permits”) in a timely manner. Furthermore, as is customary practice in the State of Arkansas, in order for the Operators to operate the Projects during the period prior to the issuance of the New Operator Permits, (i) each
Operator, as a sublessor, and each of the existing holders of the Operating Permits (the “Existing Permit Holders”), as a sublessee, have entered a Sublease Agreement of even date herewith with respect to each Project (individually,
a “Sublease” and collectively, the “Subleases”) and (ii) each Existing Permit Holder and an affiliate of Operator, as a manager, have entered into a Management Agreement of even date herewith with respect to
each Project (individually, a “Management Agreement” and collectively, the “Management Agreements”) (the Subleases and Management Agreements being collectively referred to as the “Interim
Agreements”), which Interim Agreements shall terminate upon issuance of the New Operator Permits. Lender and Borrower acknowledge the foregoing arrangement with respect to the Operator Permits and issuance of New Operator Permits.

 (u) Furnishing Notices. Borrowers shall provide Agent with copies of all material notices pertaining
to any Project received by any Borrower from any Operator, any Governmental Authority or insurance company within seven (7) days after such notice is received. 

(v) Alterations. Without the prior written consent of Agent, which consent will be not be unreasonably withheld,
Borrowers shall not make, or permit to be made, any material alterations to any Project, other than alterations and improvements in the ordinary course of business and the Immediate Repairs. 

(w) Distributions. At all times while any indebtedness under the Loan remains outstanding, Borrowers shall not
make any distributions to partners, members or shareholders; provided, however, so long as no Event of Default exists as of the date of any such distribution and after giving effect thereto, Borrowers shall have access to and may use any or all
Monthly Excess Cash Flow for any cash distribution. If an Event of Default occurs, Agent, for the pro rata benefit of the Lenders, may take all Monthly Excess Cash Flow and apply the same to the aggregate outstanding balance under the Loan
Documents. Notwithstanding the foregoing, Borrowers shall be permitted to make equity distributions as, and in an amount, necessary to maintain REIT status whether or not an Event of Default exists. 

(x) Minimum Occupancy. Borrowers shall not permit the aggregate Occupancy level for the Projects to be less than
seventy-five percent (75%) of the number Available Beds based upon the average trailing twelve (12) months. Such covenant shall be tested on a quarterly basis commencing on September 30, 2013, and continuing on the last day of each
quarter thereafter until the Final Maturity Date. The initial calculation shall be based upon a trailing three months with each successive test aggregating the prior period or periods until a trailing twelve months is achieved. If the foregoing
covenant is not achieved for any quarter during the term of the Loan for which it is tested, Borrowers shall submit to Agent within thirty (30) days following such failure, a written plan of correction reasonably satisfactory to the Agent,
detailing the Borrowers’ plan to bring the Projects into compliance with such covenant. If the Projects fail to achieve the required level for a second consecutive quarter, upon request by Agent, Borrowers shall (1) promptly retain a
marketing consultant satisfactory to the Agent to advise the Borrowers regarding the Projects, (2) obtain and submit the recommendations or reports of such marketing consultant to Agent within thirty (30) days following the engagement of
the marketing consultant, and (3) promptly implement the recommendations of the foregoing marketing consultant. Notwithstanding any provision herein to the contrary, Agent agrees that failure of the Projects to achieve the occupancy covenant
shall not, in and of itself, constitute an Event of Default so long as Borrowers provide Agent with evidence satisfactory to Agent that a marketing plan submitted to and approved by Lender is being timely implemented to correct the non-compliance.

 (y) Minimum Debt Service Coverage. Borrowers shall not permit the Debt Service Coverage to be less
than 1.45 to 1.0 at all times. Such covenant shall be tested on a quarterly basis commencing on September 30, 2013, and continuing on the last day of each quarter thereafter until the Final Maturity Date. The initial calculation shall be based
upon a trailing three months with each successive test aggregating the prior period or periods until a trailing twelve months is achieved. 
 (z) Minimum Rent Coverage. Borrowers shall not permit the Rent Coverage to be less than that set forth in Schedule II attached hereto. Such covenant shall be tested on a quarterly basis in
accordance with such Schedule and for the periods therein set forth. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 29

 (aa) Lien Searches. Without limiting the obligations of the Borrowers
hereunder, Borrowers agree, within ten (10) days of Lender’s written demand, to reimburse Agent for all expenses not to exceed $2,000 in any twelve (12) month period incurred by Agent in periodically (up to two (2) times per
year) verifying the performance of each Borrower of its obligations under the Loan Documents and the security and priority of the Mortgages, including without limitation expenses incurred by Agent for title searches, title updates and endorsements,
tax and judgment lien searches, litigation searches, and UCC searches. 
 (bb) REIT Status. Guarantor
shall maintain its status as a real estate investment trust at all times that any portion of the Loan is outstanding. 
 (cc) Immediate Repairs. Borrowers shall promptly commence the Immediate Repairs and shall complete the same prior to September 1, 2013. 

(dd) Conduct of Operations. Borrowers shall conduct, or cause Operator to conduct, the operation of each Project
at all times in a manner consistent with the level of operation of other similar skilled nursing facilities, including without limitation, the following: 

(i) to maintain the standard of care for the residents of the Project at all times at a level necessary to
ensure quality care for the residents of the Project in accordance with customary and prudent industry standards; 
 (ii) to operate the Project in a prudent manner and in substantial compliance with applicable laws and regulations relating thereto and cause all permits, Reimbursement Contracts, and any other agreements
necessary for the use and operation of the Project or, if applicable, as may be necessary for participation in reimbursement programs (if any) to remain in effect without reduction in the number of licensed units authorized for applicable
reimbursement programs; 
 (iii) to maintain sufficient inventory and equipment of types and
quantities at the Project to enable each Borrower and Operator to perform operations of the Projects adequately; 
 (iv) to keep all improvements and equipment located on or used or useful in connection with each Project in good repair, working order and condition, reasonable wear and tear excepted, and from time to
time make all needed and proper repairs, renewals, replacements, additions, and improvements thereto to keep the same in good operating condition; 

(v) to maintain sufficient cash in the operating accounts of the Projects in order to satisfy the working
capital needs of the Projects; 
 (vi) to keep all required permits current and in full force and
effect; and 
 (vii) to cause all current Operator Permits to be transferred to Operator by the
applicable Governmental Authorities on or before August 31, 2013, with copies of such licenses delivered promptly to Agent. 
 (ee) Periodic Surveys. Borrowers shall furnish or cause each Operator to furnish to Agent, within twenty (20) days of receipt, a copy of any licensing agency survey or report and any statement
of deficiencies and/or any other report indicating that any action is pending or being considered to downgrade any Project to a substandard category, and within the time period required by the particular agency for furnishing a plan of correction
also furnish or cause to be furnished to Agent a copy of the plan of correction generated from such survey or report for any Project, and correct or cause to be corrected any deficiency, the curing of which is a condition of continued licensure or
for full participation in a reimbursement program pursuant to any Reimbursement Contract for existing residents or for new residents to be admitted with coverage, by the date required for cure by such agency (plus extensions granted by such agency).

  

			
	 SECURED LOAN AGREEMENT
	  	Page 30

 (ff) Fraud and Abuse. 

(i) Anti-Kickback Law. After consultation with counsel concerning the federal anti-kickback law (42
U.S.C.A. SEC. 1320a-7b(b)), neither Borrowers nor their agents shall offer or give any remuneration or thing of value to any person to encourage referral to the Projects nor will Borrowers or their agents solicit or receive any remuneration or thing
of value in exchange for Borrowers’ agreement to make referrals or to purchase goods or services for the Projects. 
 (ii) Relationships. Except for indirect ownership interests in any Borrower as a result of ownership of publicly traded shares of stock of Guarantor, Borrowers will not allow a physician or other
healthcare practitioner to have an ownership interest in, or financial relationship with, a Borrower or any Project. 

ARTICLE 11 

CASUALTIES AND CONDEMNATION 
 11.1 Agent’s Election to Apply Proceeds on Indebtedness. 
 (a) Subject to the provisions of Section 11.1(b) below, the Lenders may elect to collect, retain and apply upon the indebtedness of Borrowers under this Agreement or any of the other Loan
Documents all proceeds of insurance or condemnation (individually and collectively referred to as “Proceeds”) after deduction of all expenses of collection and settlement, including reasonable attorneys’ and adjusters’
fees and charges. Any proceeds remaining after repayment of the indebtedness under the Loan Documents shall be paid by Agent to Borrowers. 
 (b) Notwithstanding anything in Section 11.1(a) to the contrary, in the event of any casualty to any Improvements or any condemnation of part of any Project, Agent and the Lenders agree to
make available the Proceeds to restoration of such Improvements if (i) no Event of Default exists, (ii) all Proceeds are deposited with Agent, (iii) in Agent’s reasonable judgment, the amount of Proceeds available for
restoration of the applicable Improvements is sufficient to pay the full and complete costs of such restoration, (iv) if the cost of restoration exceeds ten percent (10%) of the Loan Amount, in Agent’s sole determination after
completion of restoration the Loan Amount will not exceed (A) 60% of the aggregate “leased fee” value of the Projects, and (B) 75% of the “leased fee” value of the applicable Project, (v) in Agent’s reasonable
determination, the applicable Project can be restored to an architecturally and economically viable project in compliance with applicable Laws, (vi) each Guarantor reaffirms its Guaranty in writing, and (vii) in Agent’s reasonable
determination, such restoration is likely to be completed no later than three months prior to the Final Maturity Date.  
 11.2 Borrowers’ Obligation to Rebuild and Use of Proceeds Therefor. 
 In case the Lenders do not elect to apply or does not have the right to apply the Proceeds to the indebtedness, as provided in Section 11.1 above, Borrower shall: 

(a) Proceed with diligence to make settlement with insurers or the appropriate governmental authorities and cause the
Proceeds to be deposited with Agent; 
 (b) In the event of any delay in making settlement with insurers or the
appropriate governmental authorities or effecting collection of the Proceeds, deposit with Agent the full amount required to complete construction as aforesaid; 

(c) In the event the Proceeds are insufficient to assure the Lenders that the Loan will be in balance, promptly deposit
with Agent any amount necessary to place the Loan in balance; and 
 (d) Promptly proceed with the assumption of
construction of such Improvements, including the repair of all damage resulting from such fire, condemnation or other cause and restoration to its former condition. 
 Any request by Borrowers for a disbursement by Agent of Proceeds and funds deposited by Borrowers shall be treated by Agent as if such request were for an advance of the Loan hereunder, and the
disbursement thereof shall be conditioned upon Borrower’s compliance with and satisfaction of the same conditions precedent as would be applicable under this Agreement for an advance of the Loan. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 31

 ARTICLE 12 
 ASSIGNMENTS BY BORROWERS 
 12.1 Prohibition of
Assignments and Transfers by Borrowers; Partial Releases. 
 (a) Borrowers shall not assign or attempt to
assign its rights under this Agreement and any purported assignment shall be void. Without the prior written consent of Agent, in Agent’s sole discretion, Borrowers shall not suffer or permit the sale, transfer, lease (other than the Operating
Leases and in the ordinary course of business pursuant to residency agreements and without material deviation from the pro forma rents previously provided by Borrowers to Agent), conveyance, alienation, pledge, assignment, encumbrance, hypothecation
or other disposition (a “Transfer”) of (i) all or any portion of any Project or any portion of any other security for the Loan, (ii) all or any portion of any Borrower’s right, title and interest in and to any Project
or any portion of any other security for the Loan, or (iii) any interest in Guarantor or any Borrower or any interest in any entity which holds an interest in, or directly or indirectly controls, any Borrower. Notwithstanding the provisions
hereof to the contrary, Agent and the Lenders acknowledge that CHP Holding owns one hundred percent (100%) of the direct ownership interests in each Borrower. Further, any third party or combination of third parties which is not under common
Control with, or an Affiliate of, CHP Holding shall be permitted to acquire direct or indirect ownership interests in Guarantor or any Borrower so long as no Change of Control occurs. 

(b) Notwithstanding the foregoing, Borrowers shall have the right at any time to obtain release of any Buyback Project
from the liens securing the Notes upon making the respective payments set out hereunder and upon compliance with the following terms and conditions: 

(i) No Event of Default or event which with the passing of time and/or giving of notice will constitute an
Event of Default exists or will exist after giving effect to the proposed release; 
 (ii)
Borrowers deliver to Agent for the benefit of the Lenders the Release Price for the applicable Project to be applied to the aggregate outstanding principal balance under the Notes; 

(iii) Agent shall have received evidence satisfactory to Agent that (a) the aggregate
“as-is” value of the remaining Projects (based upon the Appraisals delivered to Agent in connection with the closing of the Loan) on a fee simple basis exceeds the aggregate Loan Amount, after giving effect to any pay down of the Loan in
connection with the applicable release, such that the Loan Amount shall be less than or equal to sixty percent (60%) of the aggregate “as is” value for the remaining Projects on a fee simple basis, and (b) the Rent Coverage for
the remaining Projects is in excess of 1.40 to 1.00 for the six month period immediately preceding the applicable date of determination; 
 (iv) All partial release documents shall be prepared at the expense of Borrowers and shall be in form and substance satisfactory to Agent. Borrowers shall present to Agent a written request for a partial
release, specifically identifying the Project to be released, together with an appropriate partial release document required to be paid in order to entitle Borrowers to such partial release, or escrow arrangements satisfactory to Agent for delivery
of any partial release. Agent will execute, acknowledge and return the partial release documents to Borrowers within five (5) business days after Agent’s receipt of the above specified items. In connection with and at the time of the
partial release of a Project, Agent shall further release the applicable Borrower from any and all liabilities and obligations under the Loan Documents which accrue from and after the date of such release, subject to any indemnity obligations that
expressly survive payment in full; and 
 (v) Borrowers shall reimburse Agent for all
out-of-pocket fees and costs, including, without limitation, reasonable legal fees in connection with the granting of such partial releases and shall provide Agent with any and all information reasonably requested by Agent with respect to the
Project to be released. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 32

 12.2 Prohibition of Transfers in Violation of ERISA.

 In addition to the prohibitions set forth in Section 12.2 above, no Borrower shall assign,
sell, pledge, encumber, transfer, hypothecate or otherwise dispose of its interest or rights in this Agreement or in the Project, or attempt to do any of the foregoing or suffer any of the foregoing, nor shall any party owning a direct or indirect
interest in Borrower assign, sell, pledge, encumber, transfer, hypothecate or otherwise dispose of any of its rights or interest (direct or indirect) in Borrower, attempt to do any of the foregoing or suffer any of the foregoing, if such action
would cause the Loan, or the exercise of any of the Lenders’ rights in connection therewith, to constitute a prohibited transaction under ERISA or the Internal Revenue Code or otherwise result in any Lender being deemed in violation of any
applicable provision of ERISA. Borrower agrees to indemnify and hold Agent and each Lender free and harmless from and against all losses, costs (including reasonable attorneys’ fees and expenses), taxes, damages (including consequential
damages) and expenses Agent or any Lender may suffer by reason of the investigation, defense and settlement of claims and in obtaining any prohibited transaction exemption under ERISA necessary or desirable in Lender’s sole judgment or by
reason of a breach of the foregoing prohibitions. The foregoing indemnification shall be a recourse obligation of Borrower and shall survive repayment of the Notes, notwithstanding any limitations on recourse contained herein or in any of the Loan
Documents. 
 12.3 Successors and Assigns. 

Subject to the foregoing restrictions on transfer and assignment contained in this Article 12, this Agreement
shall inure to the benefit of and shall be binding on the parties hereto and their respective successors and permitted assigns. 

ARTICLE 13 

TIME OF THE ESSENCE 
 13.1 Time is of the Essence. 
 Borrowers agree that
time is of the essence under this Agreement. 
 ARTICLE 14 

EVENTS OF DEFAULT 
 14.1 Events of Default. 
 The occurrence of any one
or more of the following shall constitute an “Event of Default” as said term is used herein: 
 (a)
Failure of Borrowers (i) (x) to pay the aggregate outstanding balance under the Notes on the Final Maturity Date, (y) to make any scheduled payment of principal (other than that required on the Final Maturity Date) or interest within
ten (10) days after the date when due or (z) to observe or perform any of the other covenants or conditions by any Borrower to be performed under the terms of this Agreement or any other Loan Document concerning the payment of money, for a
period of ten (10) days after written notice from Lender that the same is due and payable; or (ii) for a period of thirty (30) days after written notice from Lender, to observe or perform any non-monetary covenant or condition
contained in this Agreement or any other Loan Documents; provided that if any such failure concerning a non-monetary covenant or condition is susceptible to cure and cannot reasonably be cured within said thirty (30) day period, then Borrowers
shall have an additional sixty (60) days, so long as Borrowers have commenced and is diligently pursuing a cure of the applicable default, and provided further that if a different notice or grace period is specified under any other paragraph of
this Article 14 with respect to a particular breach, the specific provision shall control. No cure period shall be afforded to Borrowers’ failure to observe or perform any covenants or conditions contained in
Section 10.1(m), (p), (r), (w), (x), (z) or (bb). 

(b) Any Transfer or other disposition in violation of Sections 12.2 or 12.3. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 33

 (c) If any warranty, representation, statement, report or certificate made
now or hereafter by any Borrower or Guarantor is materially untrue or materially incorrect at the time made or delivered, provided that if such breach is reasonably susceptible of cure, then no Event of Default shall exist so long as Borrowers cure
said breach (i) within the notice and cure period provided in (a)(i) above for a breach that can be cured by the payment of money or (ii) within the notice and cure period provided in (a)(ii) above for any other breach. 

(d) Any Borrower or Guarantor shall commence a voluntary case concerning any Borrower or Guarantor under Title 11 of
the United States Code entitled “Bankruptcy” as now or hereafter in effect, or any successor thereto or any other present or future bankruptcy or insolvency statute (the “Bankruptcy Code”); or an involuntary proceeding is
commenced against any Borrower or Guarantor under the Bankruptcy Code and relief is ordered against any Borrower or Guarantor, or the petition is controverted but not dismissed or stayed within sixty (60) days after the commencement of the
case, or a custodian (as defined in the Bankruptcy Code) is appointed for or takes charge of all or substantially all of the property of any Borrower or Guarantor; or any Borrower or Guarantor commences any other proceedings under any
reorganization, arrangement, readjustment of debt, relief of debtors, dissolution, insolvency or liquidation or similar Law of any jurisdiction whether now or hereafter in effect relating to any Borrower or Guarantor; or there is commenced against
any Borrower or Guarantor any such proceeding which remains undismissed or unstayed for a period of ninety (90) days; or any Borrower or Guarantor fails to controvert in a timely manner any such case under the Bankruptcy Code or any such
proceeding, or any order of relief or other order approving any such case or proceeding is entered; or any Borrower or Guarantor by any act or failure to act indicates its consent to, approval of, or acquiescence in any such case or proceeding or
the appointment of any custodian or the like of or for it for any substantial part of its property or suffers any such appointment to continue undischarged or unstayed for a period of ninety (90) days. 

(e) Any Borrower or Guarantor shall make an assignment for the benefit of creditors, or shall admit in writing its
inability to pay its debts generally as they become due, or shall consent to the appointment of a receiver or trustee or liquidator of all of its property or the major part thereof or if all or a substantial part of the assets of any Borrower or
Guarantor are attached, seized, subjected to a writ or distress warrant, or are levied upon, or come into the possession of any receiver, trustee, custodian or assignee for the benefit of creditors. 

(f) If any Borrower is enjoined, restrained or in any way prevented by any court order from operating any Project.

 (g) One or more final, unappealable judgments are entered against any Borrower in amounts aggregating in
excess of $50,000, and said judgments are not paid, stayed or bonded over within thirty (30) days after entry. 
 (h) If any Borrower shall fail to pay any debt owed by it or is in default under any agreement with Lender or any other party which failure to pay or default would have a Material Adverse Change to
Borrowers, the Projects or Borrowers’ ability to perform their obligations under this Agreement, and such failure or default continues after any applicable grace or cure period specified in the instrument or agreement relating thereto.

 (i) If a Material Adverse Change occurs with respect to any Borrower, any Project or Guarantor. 

(j) The occurrence of an event of default by any Borrower under any Lease with the Operator beyond any applicable notice
and/or cure period. 
 (k) The occurrence of a payment or other material event of default by any Operator under
any Lease with the Operator beyond any applicable notice and/or cure period, and the continuation of the same for a period of thirty (30) days. Prior to the expiration of such thirty (30) day period, Borrowers shall present to Lender a
course of action to remedy such default (such as waiver, modification or termination of the lease and replacement of the tenant) and obtain Lender’s approval thereto. So long as Borrowers follow the approved course of action and meet any
deadlines in connection therewith, such default shall be deemed cured. 
 (l) The occurrence of any other event
or circumstance denominated as an Event of Default herein or under any of the other Loan Documents and the expiration of any applicable grace or cure periods, if any, specified for such Event of Default herein or therein, as the case may be.

  

			
	 SECURED LOAN AGREEMENT
	  	Page 34

 (m) The failure of Borrowers to correct or to cause its Operator to correct,
within the time deadlines set by any applicable Medicare, Medicaid or licensing agency, any deficiency which would result in the following actions by such agency with respect to any Project: 

(i) a termination of any Reimbursement Contract or any permit; or 

(ii) a ban on new admissions generally or, if applicable, on admission of patients otherwise qualifying
for Medicare or Medicaid coverage; 
 (n) The assessment against any Borrower, Operator, or any Project of any
fines or penalties by any state or any Medicare, Medicaid, health or licensing agency having jurisdiction over such Persons or the Project in excess of $25,000, which are not paid or discharged within thirty (30) days following such assessment;
provided, however, Borrower shall not be in default if Borrower or Operator is in good faith disputing such assessment. 

ARTICLE 15 

LENDERS’ REMEDIES IN EVENT OF DEFAULT 
 15.1 Remedies Conferred Upon Lenders. 
 Upon the
occurrence of any Event of Default that is continuing, Agent may, and at the request of Required Lenders shall, pursue any one or more of the following remedies concurrently or successively, it being the intent hereof that none of such remedies
shall be to the exclusion of any other: 
 (a) Take possession of the Projects and do anything which is necessary
or appropriate in its sole judgment to fulfill the obligations of Borrowers under this Agreement and the other Loan Documents, including either the right to avail itself of and procure performance of existing contracts or let any contracts with the
same contractors or others. Without restricting the generality of the foregoing and for the purposes aforesaid, each Borrower hereby appoints and constitutes Agent its lawful attorney-in-fact with full power of substitution in the Projects to pay,
settle or compromise all existing bills and claims, which may be liens or security interests, or to avoid such bills and claims becoming liens against the Projects; to execute all applications and certificates in the name of each Borrower prosecute
and defend all actions or proceedings in connection with the Improvements or the Projects; to take action and require such performance as it deems necessary under any of the bonds to be furnished hereunder and to make settlements and compromises
with the surety or sureties thereunder, and in connection therewith, to execute instruments of release and satisfaction; and to do any and every act which any Borrower might do in its own behalf; it being understood and agreed that this power of
attorney shall be a power coupled with an interest and cannot be revoked; 
 (b) Declare the Notes to be
immediately due and payable; 
 (c) Use and apply any monies or letters of credit deposited by any Borrower with
Agent, regardless of the purposes for which the same was deposited, to cure any such default or to apply on account of any indebtedness under this Agreement which is due and owing to Lenders; 

(d) Exercise or pursue any other remedy or cause of action permitted under this Agreement or any other Loan Documents, or
conferred upon Lenders by operation of Law. 
 Notwithstanding the foregoing, upon the occurrence of any Event of Default under
Section 14(d), all amounts evidenced by the Notes shall automatically become due and payable, without any presentment, demand, protest or notice of any kind to Borrowers. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 35

 ARTICLE 16 
 GENERAL PROVISIONS 
 16.1 Captions.

 The captions and headings of various Articles, Sections and subsections of this Agreement and Exhibits
pertaining hereto are for convenience only and are not to be considered as defining or limiting in any way the scope or intent of the provisions hereof. 
 16.2 Modification; Waiver. 
 No modification, waiver,
amendment or discharge of this Agreement or any other Loan Document shall be valid unless the same is in writing and signed by the party against which the enforcement of such modification, waiver, amendment or discharge is sought. 

16.3 GOVERNING LAW. 

EXCEPT AS SET FORTH IN THE MORTGAGE, ALL OF THE LOAN DOCUMENTS SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF OHIO WITHOUT GIVING EFFECT TO ANY PRINCIPLES OF CONFLICTS OF LAWS. 
 16.4 Acquiescence Not to Constitute Waiver of Lenders’ Requirements. 
 Each and every covenant and condition for the benefit of the Lenders contained in this Agreement may be waived by the Lenders, provided, however, that to the extent that the Lenders may have acquiesced in
any noncompliance with any construction or nonconstruction conditions precedent to the Opening of the Loan or to any subsequent disbursement of Loan proceeds, such acquiescence shall not be deemed to constitute a waiver by the Lenders of such
requirements with respect to any future disbursements of Loan proceeds. 
 16.5 Disclaimer by Lenders.

 This Agreement is made for the sole benefit of Borrowers and the Lenders, and no other person or persons
shall have any benefits, rights or remedies under or by reason of this Agreement, or by reason of any actions taken by Agent or the Lenders pursuant to this Agreement. Neither Agent nor any Lender shall be liable for any debts or claims accruing in
favor of any such parties against any Borrower or others or against the Project. The Lenders, by making the Loan or taking any action pursuant to any of the Loan Documents, shall not be deemed a partner or a joint venturer with any Borrower or any
fiduciary of Borrower. 
 16.6 Partial Invalidity; Severability. 

If any of the provisions of this Agreement, or the application thereof to any person, party or circumstances, shall, to
any extent, be invalid or unenforceable, the remainder of this Agreement, or the application of such provision or provisions to persons, parties or circumstances other than those as to whom or which it is held invalid or unenforceable, shall not be
affected thereby, and every provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. 
 16.7 Definitions Include Amendments. 
 Definitions
contained in this Agreement which identify documents, including, but not limited to, the Loan Documents, shall be deemed to include all amendments and supplements to such documents from the date hereof, and all future amendments and supplements
thereto entered into from time to time to satisfy the requirements of this Agreement or otherwise with the consent of Agent (and, to the extent applicable, the Required Lenders). Reference to this Agreement contained in any of the foregoing
documents shall be deemed to include all amendments and supplements to this Agreement. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 36

 16.8 Execution in Counterparts. 

This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts,
each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
 16.9 Entire Agreement. 
 This Agreement, taken
together with all of the other Loan Documents and all certificates and other documents delivered by Borrowers to the Lenders, embody the entire agreement and supersede all prior agreements, written or oral, relating to the subject matter hereof.

 16.10 Waiver of Damages. 

In no event shall Agent or any Lender be liable to any Borrower for punitive, exemplary or consequential damages,
including, without limitation, lost profits, whatever the nature of a breach by Agent or any Lender of its obligations under this Agreement or any of the Loan Documents, and each Borrower for itself and Guarantor waive all claims for punitive,
exemplary or consequential damages. 
 16.11 Claims Against Lenders. 

Neither Agent nor any Lender shall not be in default under this Agreement, or under any other Loan Documents, unless a
written notice specifically setting forth the claim of any Borrower shall have been given to Agent within three (3) months after such Borrower first had knowledge of the occurrence of the event which such Borrower alleges gave rise to such
claim and such person does not remedy or cure the default, if any there be, promptly thereafter. Each Borrower waives any claim, set-off or defense against Agent or any Lender arising by reason of any alleged default by Agent or any Lender as to
which such Borrower does not give such notice timely as aforesaid. Each Borrower acknowledges that such waiver is or may be essential to the Lenders’ ability to enforce its remedies without delay and that such waiver therefore constitutes a
substantial part of the bargain between the Lenders and Borrowers with regard to the Loan. 
 16.12
Jurisdiction. 
 TO THE GREATEST EXTENT PERMITTED BY LAW, EACH BORROWER HEREBY WAIVES ANY AND ALL
RIGHTS TO REQUIRE MARSHALLING OF ASSETS BY THE LENDERS. WITH RESPECT TO ANY SUIT, ACTION OR PROCEEDINGS RELATING TO THIS AGREEMENT (EACH, A “PROCEEDING”), EACH BORROWER IRREVOCABLY (A) SUBMITS TO THE NON-EXCLUSIVE JURISDICTION
OF THE STATE AND FEDERAL COURTS HAVING JURISDICTION IN THE CITY OF CLEVELAND, COUNTY OF CUYAHOGA, STATE OF OHIO, AND (B) WAIVES ANY OBJECTION WHICH IT MAY HAVE AT ANY TIME TO THE LAYING OF VENUE OF ANY PROCEEDING BROUGHT IN ANY SUCH COURT,
WAIVES ANY CLAIM THAT ANY PROCEEDING HAS BEEN BROUGHT IN AN INCONVENIENT FORUM AND FURTHER WAIVES THE RIGHT TO OBJECT, WITH RESPECT TO SUCH PROCEEDING, THAT SUCH COURT DOES NOT HAVE JURISDICTION OVER SUCH PARTY. NOTHING IN THIS AGREEMENT SHALL
PRECLUDE AGENT ON BEHALF OF THE LENDERS FROM BRINGING A PROCEEDING IN ANY OTHER JURISDICTION NOR WILL THE BRINGING OF A PROCEEDING IN ANY ONE OR MORE JURISDICTIONS PRECLUDE THE BRINGING OF A PROCEEDING IN ANY OTHER JURISDICTION. EACH BORROWER
FURTHER AGREES AND CONSENTS THAT, IN ADDITION TO ANY METHODS OF SERVICE OF PROCESS PROVIDED FOR UNDER APPLICABLE LAW, ALL SERVICE OF PROCESS IN ANY PROCEEDING IN ANY STATE OF OHIO OR UNITED STATES COURT SITTING IN THE CITY OF CLEVELAND, COUNTY OF
CUYAHOGA, STATE OF OHIO MAY BE MADE BY CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO SUCH BORROWER AT THE ADDRESS INDICATED BELOW, AND SERVICE SO MADE SHALL BE COMPLETE UPON RECEIPT; EXCEPT THAT IF A BORROWER SHALL
REFUSE TO ACCEPT DELIVERY, SERVICE SHALL BE DEEMED COMPLETE FIVE (5) DAYS AFTER THE SAME SHALL HAVE BEEN SO MAILED. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 37

 16.13 Set-Offs. 

After the occurrence and during the continuance of an Event of Default, each Borrower hereby irrevocably authorizes and
directs each Lender from time to time to charge such Borrower’s accounts and deposits with such Lender (or its Affiliates), and to pay over to such Lender an amount equal to any amounts from time to time due and payable to such Lender
hereunder, under the Notes or under any other Loan Document. Each Borrower hereby grants to Agent for the benefit of the Lenders a security interest in and to all such accounts and deposits maintained by such Borrower with each Lender (or its
Affiliates). 
 16.14 Authorized Representative. 

Borrowers hereby appoint Steven M. Wortman, Senior Vice President of Borrowers, as their “Authorized
Representative” for purposes of dealing with Agent on behalf of Borrowers in respect of any and all matters in connection with this Agreement, the other Loan Documents, and the Loan. The Authorized Representative shall have the power, in his
discretion, to give and receive all notices, monies, approvals, and other documents and instruments, and to take any other action on behalf of Borrowers. All actions by the Authorized Representative shall be final and binding on Borrowers. The
Lenders may rely on the authority given to the Authorized Representative until actual receipt by Agent on behalf the Lenders of a duly authorized resolution substituting a different person as the Authorized Representative. No more than one person
shall serve as Authorized Representative at any given time. 
 ARTICLE 17 

NOTICES 
 Any notice, demand, request or other communication which any party hereto may be required or may desire to give hereunder shall be in writing and shall be deemed to have been properly given (a) if
hand delivered, when delivered; (b) if mailed by United States Certified Mail (postage prepaid, return receipt requested), three Business Days after mailing (c) if by Federal Express or other reliable overnight courier service, on the next
Business Day after delivered to such courier service or (d) if by telecopier on the day of transmission so long as copy is sent on the same day by overnight courier as set forth below: 

 

					
		 	If to Borrowers:
			
		 		  	 c/o CNL Healthcare Properties, Inc.
 450 South Orange Avenue
 Orlando, Florida 32801

Attention: Joseph T. Johnson, Senior Vice President and Chief Financial Officer
 Attention: Holly J. Greer, Esq., Senior Vice President and General Counsel

Telephone:  (407) 540-7500

Facsimile:   (407) 540-2544

		
		 	 With a courtesy copy to:

			
		 		  	 Lowndes, Drosdick, Doster, Kantor & Reed, P.A.
 215 North Eola Drive
 Orlando, Florida 32801

Attention: Peter L. Lopez, Esq.

Telephone:  (407) 843-4600

Facsimile:   (407) 843-4444

  

			
	 SECURED LOAN AGREEMENT
	  	Page 38

					
		 	 If to Agent:

			
		 		  	 KeyBank National Association
 Real Estate Capital-Healthcare
 Mailcode: OH-01-51-0311

4910 Tiedeman Road, 3rd Floor
 Brooklyn, Ohio 44144
 Attention: Amy MacLearie, Closer

Telephone:  (216) 813-6935
 Facsimile:   (216) 357-6383

		
		 	 With copies to:

			
		 		  	 Synovus Bank
 800 Shades Creek Parkway, Suite 325
 Birmingham, Alabama 35209

Telephone:  (205) 868-4752
 Facsimile:   (205) 868-                    

			
		 		  	 Gail Livingston Mills, Esq.
 Burr & Forman LLP
 420 North 20th Street, Suite 3400

Birmingham, Alabama 35203
 Telephone:  (205) 458-5300
 Facsimile:   (205)
244-5681

			
		 		  	 Alfred G. Kyle, Esq.
 Bracewell & Giuliani LLP
 1445 Ross Avenue, Suite 3800

Dallas, Texas 75202
 Telephone:  (214) 758-1660
 Facsimile:   (214)
758-8360
  
 And, if required under any
applicable intercreditor agreement:
  
 Capital
Finance, LLC
 1422 Clarkview Road
 Baltimore, MD 21209
 Attention: Account Manager for Perennial
Transaction

 or at such other address as the party to be served with notice may have furnished in writing to the party
seeking or desiring to serve notice as a place for the service of notice. 
 ARTICLE 18 

RESERVED 

ARTICLE 19 

ASSIGNMENTS AND PARTICIPATIONS 
 19.1 Assignments and Participations. 
 (a)
Each Lender shall have the right to assign, transfer, sell, negotiate, pledge or otherwise hypothecate this Agreement and any of its rights and security hereunder and under the other Loan Documents to any other Eligible Assignee with the prior
written consent of the Agent and with the prior written consent of Borrower, which consents by the Agent and the Borrowers shall not be unreasonably withheld, conditioned or delayed (provided that no consent of Borrower shall be required if the
Eligible Assignee is also a Lender as of the date 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 39

 
hereof or if an Event of Default then exists) and no consent of the Agent shall be required if the Eligible Assignee is also a Lender; provided, however, that (i) the parties to each such
assignment shall execute and deliver to Agent, for its approval and acceptance, an Assignment and Assumption Agreement substantially in the form of Exhibit H attached hereto (the “Assignment and Assumption”), (ii) each such assignment
shall be of a constant, and not a varying, percentage of the assigning Lender’s rights and obligations under this Agreement, (iii) if the potential assignee is not already a Lender hereunder, at least ten (10) days prior to the date
of the assignment, the potential assignee shall deliver to Agent all information reasonably necessary for Agent to successfully complete the Agent’s Patriot Act Customer Identification Process and OFAC Review Process, (iv) unless the Agent
and, so long as no Event of Default exists, Borrowers otherwise consent, the aggregate amount of the Commitment of the assigning Lender being assigned pursuant to each such assignment shall in no event be less than Five Million Dollars ($5,000,000),
(v) the Agent shall receive from the assigning Lender a processing fee of Three Thousand Five Hundred Dollars ($3,500), and (vi) if the assignment is less than the assigning Lender’s entire interest in the Loan, the assigning Lender
must retain at least a Ten Million Dollar ($10,000,000.00) interest in the Loan. The Agent may designate any Eligible Assignee accepting an assignment of a specified portion of the Loan to be a Co-Agent, an “Arranger” or similar title, but
such designation shall not confer on such Assignee the rights or duties of the Agent. Upon such execution, delivery, approval and acceptance, and upon the effective date specified in the applicable Assignment and Assumption, (a) the Eligible
Assignee thereunder shall be a party hereto and, to the extent that rights and obligations hereunder have been assigned to it pursuant to such Assignment and Assumption, have the rights and obligations of a Lender hereunder and under the other Loan
Documents, and Borrowers hereby agree that all of the rights and remedies of Lenders in connection with the interest so assigned shall be enforceable against Borrowers by an Eligible Assignee with the same force and effect and to the same extent as
the same would have been enforceable but for such assignment, and (b) the assigning Lender thereunder shall, to the extent that rights and obligations hereunder and under the other Loan Documents have been assigned by it pursuant to such
Assignment and Assumption, relinquish its rights and be released from its obligations hereunder and thereunder. 

(b) By executing and delivering an Assignment and Assumption, the assigning Lender thereunder and the Eligible Assignee
thereunder confirm to and agree with each other and the other parties hereto as follows: (i) except as provided in such Assignment and Assumption, such assigning Lender makes no representation or warranty and assumes no responsibility with
respect to any statements, warranties or representations made in or in connection with this Agreement or any other Loan Document or the execution, legality, validity, enforceability, genuineness, sufficiency or value of this Agreement or any other
Loan Document or any other instrument or document furnished in connection therewith; (ii) such assigning Lender makes no representation or warranty and assumes no responsibility with respect to the financial condition of Borrowers or the
performance or observance by each Borrower of any of its obligations under any Loan Document or any other instrument or document furnished in connection therewith; (iii) such Eligible Assignee confirms that it has received a copy of this
Agreement together with such financial statements, Loan Documents and other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into the Assignment and Assumption and to become a Lender
hereunder; (iv) such Eligible Assignee will, independently and without reliance upon Agent, the assigning Lender or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own
credit decisions in taking or not taking action under this Agreement; (v) such Eligible Assignee appoints and authorizes the Agent to take such action as the Agent on its behalf and to exercise such powers under this Agreement and the other
Loan Documents as are delegated to Agent by the terms hereof and thereof, together with such powers as are reasonably incidental thereto; and (vi) such Eligible Assignee agrees that it will perform in accordance with their terms all of the
obligations which by the terms of this Agreement are required to be performed by it as a Lender. 
 (c) Agent
shall maintain a copy of each Assignment and Assumption delivered to and accepted by it and shall record in its records the names and address of each Lender and the Commitment of, and Percentage of the Loan owing to, such Lender from time to time.
Borrowers, the Agent and Lenders may treat each entity whose name is so recorded as a Lender hereunder for all purposes of this Agreement. 
 (d) Upon receipt of an Assignment and Assumption executed by an assigning Lender and an Eligible Assignee, Agent shall, if such Assignment and Assumption has been properly completed and consented to if
required herein, accept such Assignment and Assumption, and record the information contained therein in its records, and the Agent shall use its best efforts to give prompt notice thereof to Borrowers (provided that neither the Agent nor the Lenders
shall be liable for any failure to give such notice). 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 40

 (e) Borrowers shall, at no cost or expense to Borrowers, use reasonable
efforts to cooperate with Agent and each Lender in connection with the assignment of interests under this Agreement or the sale of participations herein. 
 (f) Anything in this Agreement to the contrary notwithstanding, and without the need to comply with any of the formal or procedural requirements of this Agreement, including this Section, any Lender may
at any time and from time to time pledge and assign all or any portion of its rights under all or any of the Loan Documents to a Federal Reserve Bank; provided that no such pledge or assignment shall release such Lender from its obligations
hereunder. To facilitate any such pledge or assignment, the Agent shall, at the request of such Lender, enter into a letter agreement with the Federal Reserve Bank in, or substantially in, the form of the exhibit to Appendix C to the Federal Reserve
Bank of New York Operating Circular No. 12. 
 (g) Anything in this Agreement to the contrary
notwithstanding, any Lender may assign all or any portion of its rights and obligations under this Agreement to another branch or Affiliate of such Lender without first obtaining the approval of any Agent or the Borrowers, provided that
(i) such Lender remains liable hereunder unless the Borrowers and Agent shall otherwise agree, (ii) at the time of such assignment such Lender is not a Defaulting Lender, (iii) such Lender gives the Agent and Borrower at least fifteen
(15) days prior written notice of any such assignment; (iv) the parties to each such assignment execute and deliver to Agent an Assignment and Assumption, and (v) the Agent receives from the assigning Lender a processing fee of One
Thousand Five Hundred Dollars ($1,500). 
 (h) Each Lender shall have the right, without the consent of the
Borrowers, to sell participations to one or more Eligible Assignees in or to all or a portion of its rights and obligations under the Loan and the Loan Documents; provided, however, that (i) such Lender’s obligations under this Agreement
(including without limitation its Commitment to Borrower hereunder) shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations (iii) the Borrowers, the Agent
and the other Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement and with regard to any and all payments to be made under this Agreement and
(iv) the holder of any such participation shall not be entitled to voting rights under this Agreement or the other Loan Documents (but such holder may contract with the Lender selling such Eligible Assignee its interest in such Lender’s
share of the Loan as to voting of such Lender’s interest under Section 20.6(b) [but not under any other section of this Agreement], provided that any such agreement by a Lender shall bind only such Lender alone and not Borrowers,
the other Lenders or the Agent). 
 (i) No Eligible Assignee of any rights and obligations under this Agreement
shall be permitted to subassign such rights and obligations. No participant in any rights and obligations under this Agreement shall be permitted to sell subparticipations of such rights and obligations. 

(j) Borrowers acknowledge and agree that Lenders may provide to any Eligible Assignee or participant originals or copies
of this Agreement, any other Loan Document and any other documents, instruments, certificates, opinions, insurance policies, letters of credit, reports, requisitions and other materials and information of every nature or description, and may
communicate all oral information, at any time submitted by or on behalf of Borrowers or received by any Lender in connection with the Loan or with respect to Borrowers, provided that prior to any such delivery or communication, such Eligible
Assignees or participants shall agree to preserve the confidentiality of any of the foregoing to the same extent that such Lender agreed to preserve such confidentiality. In order to facilitate assignments to Eligible Assignees and sales to Eligible
Assignees, Borrowers shall execute such further documents, instruments or agreements as Lenders may reasonably require; provided, that no Borrower shall be required (i) to execute any document or agreement which would materially decrease its
rights, or materially increase its obligations, relative to those set forth in this Agreement or any of the other Loan Documents (including financial obligations, personal recourse, representations and warranties and reporting requirements), or
(ii) to expend more than incidental sums of money or incidental administrative time for which it does not receive reasonable reimbursement in order to comply with any requests or requirements of any Lender in connection with such assignment or
sale arrangement. In addition, Borrowers agrees to cooperate fully with Lenders in the exercise of Lenders’ rights pursuant to this Section, including providing such information and documentation regarding Borrower as any Lender or any
potential Eligible Assignee or participant may reasonably request and to meet with potential Eligible Assignees. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 41

 19.2 Several Liability. 

Anything in this Agreement contained to the contrary notwithstanding, the obligations of each Lender to Borrowers under
this Agreement are several and not joint and several; each Lender shall only be obligated to fund its Percentage of each disbursement to be made hereunder up to the amount of its Commitment. During any time, and only during such time, as Agent is
the sole Lender and has not assigned any portion or portions of its interest in the Loan to another Lender pursuant to an Assignment and Assumption Agreement, Agent in its individual capacity shall be liable for all of the obligations of the Lender
under this Agreement and the other Loan Documents. From and after the date that Agent as the sole Lender assigns any portion or portions of its interest in the Loan to another Lender pursuant to an Assignment and Assumption Agreement, then Agent
shall act as the administrative agent on behalf of itself as a Lender and the other Lenders. 
 ARTICLE 20 

AGENT 
 20.1 Appointment. 
 KeyBank National Association is
hereby appointed as Agent hereunder and under each other Loan Document, and each Lender hereby irrevocably authorizes the Agent to act as agent for such Lender and to take such actions as such Lender is obligated or entitled to take under the
provisions of this Agreement and the other Loan Documents. Agent agrees to act as such upon the express conditions contained in this Article in substantially the same manner that it would act in dealing with a loan held for its own account. Agent
shall not have a fiduciary relationship with respect to any Lender by reason of this Agreement. 
 The
provisions of this Article are solely for the benefit of the Agent and the Lenders, and Borrowers shall not have any rights to rely on or enforce any of the provisions hereof except as provided in Section 20.2 below. In performing its
functions and duties under this Agreement, the Agent shall act solely as agent of Lender and does not assume, and shall not be deemed to have assumed, any obligations toward or relationship of agency or trust with or for the Borrowers. 

20.2 Reliance on Agent. 

All acts of and communications by the Agent, as agent for the Lenders, shall be deemed legally conclusive and binding; and
Borrower or any third party (including any court) shall rely on any and all communications or acts of the Agent with respect to the exercise of any rights or the granting of any consent, waiver or approval on behalf of a Lender in all circumstances
where an action by such Lender is required or permitted pursuant to this Agreement or the provisions of any other Loan Document or by applicable law without the right or necessity of making any inquiry of any individual Lender as to the authority of
Agent with respect to such matter. In no event shall any of the foregoing limit the rights or obligations of any Lender with respect to any other Lender pursuant to this Article 20. 

20.3 Powers. 
 The Agent shall have and may exercise such powers under the Loan Documents as are specifically delegated to the Agent by the terms of each thereof, together with such powers as are reasonably incidental
thereto or are otherwise necessary or desirable in connection with the administration of the Loan, and may exercise all other powers of Lenders as are not made subject to the consent of the Required Lenders pursuant to Section 20.6(a) or
to the consent of all Lenders pursuant to Section 20.6(b). Without limiting the foregoing, the Agent may consent to or execute easements, plats, dedications, release of minor portions of the collateral and similar documents. The Agent
shall not be considered, or be deemed, a separate agent of the Lenders hereunder, but is, and shall be deemed, acting in its contractual capacity as Agent, exercising such rights and powers under the Loan Documents as are specifically delegated to
the Agent or Agent is otherwise entitled to take hereunder. Agent shall have no implied duties to the Lenders, or any obligation to the Lenders to take any action except any action specifically provided by the Loan Documents to be taken by the
Agent. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 42

 20.4 Disbursements. 

(a) At least one (1) Business Day (by 11:00 a.m. Cleveland time) prior to the date the Loan is to be disbursed
hereunder pursuant to this Agreement (or at least two (2) LIBOR Business Days [by 11:00 a.m. Cleveland time] for such disbursement to be made at the Adjusted LIBOR Rate), the Agent shall notify each Lender of the proposed disbursement. Each
Lender shall make available to Agent (or the funding Lender or entity designated by the Agent), the amount of such Lender’s Percentage of such disbursement (with respect to such Lender, such amount being referred to herein as an
“Advance”) in immediately available funds not later than 11:00 a.m. (Cleveland time) on the date such disbursement is to be made (such date being referred to herein as a “Funding Date”). Unless the Agent shall have
been notified by any Lender prior to such time for funding in respect of any Advance that such Lender does not intend to make available to the Agent such Lender’s Advance, the Agent may assume that such Lender has made such amount available to
the Agent and the Agent, in its sole discretion, may, but shall not be obligated to, make available to Borrowers a corresponding amount. If such corresponding amount is not in fact made available to the Agent by such Lender on or prior to the
respective Funding Date, such Lender agrees to pay and Borrowers agree to repay to Agent forthwith on demand such corresponding amount together with interest thereon, for each day from the date such amount is made available to Borrowers until the
date such amount is paid or repaid to Agent, at (A) in the case of such Lender, the Federal Funds Effective Rate, and (B) in the case of Borrowers, the interest rate applicable at the time to a disbursement made on such Funding Date. If
such Lender shall pay to Agent such corresponding amount, such amount so paid shall constitute such Lender’s Advance, and if both such Lender and Borrowers shall have paid and repaid, respectively, such corresponding amount, Agent shall
promptly return to Borrowers such corresponding amount in same day funds. 
 (b) Requests by the Agent for
funding by the Lenders of disbursements of the Loan will be made by facsimile. Each Lender shall make its Advance available to the Agent in dollars and in immediately available funds to such Lender and account as the Agent may designate, not later
than Noon (Cleveland time) on the Funding Date. Nothing in this Section 20.4 shall be deemed to relieve any Lender of its obligation hereunder to make any Advance on any Funding Date, nor shall any Lender be responsible for the failure
of any other Lender to perform its obligations to make any Advance hereunder, and the Commitment of any Lender shall not be increased or decreased as a result of the failure by any other Lender to perform its obligation to make any Advances
hereunder. 
 20.5 Distribution and Apportionment of Payments. 

(a) Subject to Section 20.5(b), payments actually received by Agent for the account of the Lenders shall be
paid to them promptly after receipt thereof by Agent, but in any event within one (1) Business Day, provided that, if any such payments are not distributed to the Lenders within one (1) Business Day after Agent’s receipt thereof,
Agent shall pay to such Lenders interest thereon, at the lesser of (i) the Federal Funds Effective Rate and (ii) if the applicable payment represents repayment of a portion of the principal of the Loan, the rate of interest applicable to
such portion of the Loan, from the date of receipt of such funds by Agent until such funds are paid in immediately available funds to such Lenders provided such funds are received by Agent not later than 11:00 A.M. (Cleveland time) on the date of
receipt. All payments of principal and interest in respect of the Loan, all payments of the fees described in this Agreement (but not in any separate fee letter except to the extent expressly set forth therein), and all payments in respect of any
other obligations of Borrower under the Loan Documents shall be allocated among such of Lenders as are entitled thereto, in proportion of their respective Percentages or otherwise as provided herein in the other Loan Documents, as the case may be.
The Agent shall distribute to each Lender at its primary address set forth herein or in its Assignment and Assumption, or at such other address as a Lender may request in writing, such funds as it may be entitled to receive, provided that the Agent
shall in any event not be bound to inquire into or determine the validity, scope or priority of any interest or entitlement of any Lender and may suspend all payments and seek appropriate relief (including without limitation instructions from the
Required Lenders, or all Lenders, as applicable, or an action in the nature of interpleader) in the event of any doubt or dispute as to any apportionment or distribution contemplated hereby. The order of priority herein is set forth solely to
determine the rights and priorities of the Lenders as among themselves and may at any time or from time to time be changed by the Lenders as they may elect, in writing, without necessity of notice to or consent of or approval by Borrowers.

  

			
	 SECURED LOAN AGREEMENT
	  	Page 43

 (b) If a Lender (a “Defaulting Lender”) defaults in making
any Advance or paying any other sum payable by it hereunder, such sum together with interest thereon at the Default Rate from the date such amount was due until repaid (such sum and interest thereon as aforesaid referred to, collectively, as the
“Lender Default Obligation”) shall be payable by the Defaulting Lender (i) to any Lender(s) which elect, at their sole option (and with no obligation to do so), to fund the amount which the Defaulting Lender failed to fund or
(ii) to Agent or any other Lender which under the terms of this Agreement is entitled to reimbursement from the Defaulting Lender for the amounts advanced or expended. Notwithstanding any provision hereof to the contrary, until such time as a
Defaulting Lender has repaid the Lender Default Obligation in full, all amounts which would otherwise be distributed to the Defaulting Lender shall instead be applied first to repay the Lender Default Obligation (to be applied first to interest at
the Default Rate and then to principal) until the Lender Default Obligation has been repaid in full (whether by such application or by cure by the Defaulting Lender), whereupon such Lender shall no longer be a Defaulting Lender. Any interest
collected from Borrowers on account of principal advanced by any Lender(s) on behalf of a Defaulting Lender shall be paid to the Lender(s) who made such advance and shall be credited against the Defaulting Lender’s obligation to pay interest on
the amount advanced at the Default Rate. If no other Lender makes an advance a Defaulting Lender failed to fund, a portion of the indebtedness of Borrowers to the Defaulting Lender equal to the Lender Default Obligation shall be subordinated to the
indebtedness of Borrowers to all other Lenders and shall be paid only after the indebtedness of Borrowers to all other Lenders is paid. The provisions of this Section shall apply and be effective regardless of whether an Event of Default occurs and
is then continuing, and notwithstanding (i) any other provision of this Agreement to the contrary or (ii) any instruction of Borrowers as to their desired application of payments. No Defaulting Lender shall have the right to vote on
matters which are subject to the consent or approval of Required Lenders or all Lenders and while any Lender is a Defaulting Lender the requisite percentage of Lenders which constitutes the Required Lenders shall be calculated exclusive of the
Percentage of the Defaulting Lender. The Agent shall be entitled to (i) withhold or set off, and to apply to the payment of the Lender Default Obligation any amounts to be paid to such Defaulting Lender under this Agreement, and (ii) bring
an action or suit against such Defaulting Lender in a court of competent jurisdiction to recover the Lender Default Obligation and, to the extent such recovery would not fully compensate the Lenders for the Defaulting Lender’s breach of this
Agreement, to collect damages. In addition, the Defaulting Lender shall indemnify, defend and hold Agent and each of the other Lenders harmless from and against any and all claims, actions, liabilities, damages, costs and expenses (including
attorneys’ fees and expenses), plus interest thereon at the Default Rate, for funds advanced by Agent or any other Lender on account of the Defaulting Lender or any other damages such persons may sustain or incur by reason of or as a direct
consequence of the Defaulting Lender’s failure or refusal to abide by its obligations under this Agreement. 
 (c) At least five Business Days prior to the first date on which interest or fees are payable hereunder for the account of any Lender, each Lender that is not incorporated under the laws of the United
States of America, or a state thereof, agrees that it will deliver to the Agent two duly completed copies of United States Internal Revenue Service Form W-8 BEN or W-8 ECI, certifying in either case that such Lender is entitled to receive payments
under this Agreement and the Note without deduction or withholding of any United States federal income taxes. Each Lender which so delivers a Form W-8 BEN or W-8 ECI further undertakes to deliver the Agent two additional copies of such form (or a
successor form) on or before the date that such form expires or becomes obsolete or after the occurrence of any event requiring a change in the most recent forms so delivered by it, and such amendments thereto or extensions or renewals thereof as
may be reasonably requested by the Agent, in each case certifying that such Lender is entitled to receive payments under this Agreement and the Note without deduction or withholding of any United States federal income taxes, unless an event
(including without limitation any change in treaty, law or regulation) has occurred prior to the date on which any such delivery would otherwise be required which renders all such forms inapplicable or which would prevent such Lender from duly
completing and delivering any such form with respect to it and such Lender advises the Agent that it is not capable of receiving payments without any deduction or withholding of United States federal income tax. 

20.6 Consents and Approvals. 

(a) Each of the following shall require the approval or consent of the Required Lenders: 

(i) The exercise of any rights and remedies under the Loan Documents following an Event of Default,
provided that absent any direction from the Required Lenders, Agent may exercise any right or remedy under the Loan Documents as Agent may determine in good faith to be necessary or appropriate to protect the Lenders or the collateral securing the
Loan; 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 44

 (ii) Appointment of a successor Agent; 

(iii) Approval of Post-Default Plan (defined in Section 20.7(d)); and 

(iv) Except as referred to in subsection (b) below, approval of any amendment or modification of this
Agreement or any of the other Loan Documents, or issuance of any waiver of any material provision of this Agreement or any of the other Loan Documents; 
 (b) Each of the following shall require the approval or consent of all the Lenders: 
 (i) Extension of the Maturity Date (beyond any extension permitted herein) or forgiveness of all or any portion of the principal amount of the Loan or any accrued interest thereon, or any other amendment
of this Agreement or the other Loan Documents which would reduce the interest rate options or the rate at which fees are calculated or forgive any loan fee, or extend the time of payment of any principal, interest or fees; 

(ii) Reduction of the percentage specified in the definition of Required Lenders; 

(iii) Increasing the amount of the Loan or any non-consenting Lender’s Commitment; 

(iv) Release of any lien on any material collateral (except as Borrowers are entitled to under the Loan
Documents); and 
 (v) Amendment of the provisions of this Section 20.6. 

(c) In addition to the required consents or approvals referred to in subsections (a) and
(b) above, the Agent may at any time request instructions from the Required Lenders with respect to any actions or approvals which, by the terms of this Agreement or of any of the Loan Documents, the Agent is permitted or required to
take or to grant without instructions from any Lenders, and if such instructions are promptly requested, the Agent shall be absolutely entitled to refrain from taking any action or to withhold any approval and shall not be under any liability
whatsoever for refraining from taking any action or withholding any approval under any of the Loan Documents until it shall have received such instructions from the Required Lenders. Without limiting the foregoing, no Lender shall have any right of
action whatsoever against any Agent as a result of such Agent acting or refraining from acting under this Agreement or any of the other Loan Documents in accordance with the instructions of the Required Lenders or, where applicable, all Lenders. The
Agent shall promptly notify each Lender at any time that the Required Lenders have instructed the Agent to act or refrain from acting pursuant hereto. 
 (d) Each Lender authorizes and directs the Agent to enter into the Loan Documents other than this Agreement for the benefit of the Lenders. Each Lender agrees that any action taken by the Agent at the
direction or with the consent of the Required Lenders in accordance with the provisions of this Agreement or any other Loan Document, and the exercise by the Agent at the direction or with the consent of the Required Lenders of the powers set forth
herein or therein, together with such other powers as are reasonably incidental thereto, shall be authorized and binding upon all Lenders, except for actions specifically requiring the approval of all Lenders. All communications from the Agent to
the Lenders requesting Lenders’ determination, consent, approval or disapproval (i) shall be given in the form of a written notice to each Lender, (ii) shall be accompanied by a description of the matter or item as to which such
determination, approval, consent or disapproval is requested, or shall advise each Lender where such matter or item may be inspected, or shall otherwise describe the matter or issue to be resolved, (iii) shall include, if reasonably requested
by a Lender and to the extent not previously provided to such Lender, written materials and a summary of all oral information provided to the Agent by Borrower in respect of the matter or issue to be resolved, and (iv) shall include the
Agent’s recommended course of action or determination in respect thereof. Each Lender shall reply promptly, but in any event within ten (10) Business Days after receipt of the request therefor from the Agent (the “Lender Reply
Period”). Unless a Lender shall give written notice to the Agent that it objects to the recommendation or determination of the Agent (together with a written explanation of the 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 45

 
reasons behind such objection) within the Lender Reply Period, such Lender shall be deemed to have approved of or consented to such recommendation or determination. With respect to decisions
requiring the approval of the Required Lenders or all Lenders, the Agent shall upon receiving the required approval or consent follow the course of action or determination recommended to the Lenders by the Agent or such other course of action
recommended by the Required Lenders. 
 20.7 Agency Provisions Relating to Collateral. 

(a) The Agent is hereby authorized on behalf of all Lenders, without the necessity of any notice to or further consent
from any Lender, at any time and from time to time, to take any action with respect to any collateral for the Loan or any Loan Document which may be necessary to preserve and maintain such collateral or to perfect and maintain perfected the liens
upon such collateral granted pursuant to this Agreement and the other Loan Documents. 
 (b) Except as provided
in this Agreement, the Agent shall have no obligation whatsoever to any Lender or to any other person or entity to assure that any collateral exists or is owned by any Borrower or is cared for, protected or insured or has been encumbered or that the
liens granted herein or in any of the other Loan Documents or pursuant hereto or thereto have been properly or sufficiently or lawfully created, perfected, protected or enforced or are entitled to any particular priority. 

(c) Should the Agent commence any proceeding or in any way seek to enforce the Agent’s or the Lenders’ rights
or remedies under the Loan Documents, irrespective of whether as a result thereof the Agent shall acquire title to any collateral, each Lender, upon demand therefor from time to time, shall contribute its share (based on its Percentage) of the
reasonable costs and/or expenses of any such enforcement or acquisition, including, but not limited to, fees of receivers or trustees, court costs, title company charges, filing and recording fees, appraisers’ fees and fees and expenses of
attorneys to the extent not otherwise reimbursed by Borrowers. Without limiting the generality of the foregoing, each Lender shall contribute its share (based on its Percentage) of all reasonable costs and expenses incurred by the Agent (including
reasonable attorneys’ fees and expenses) if the Agent employs counsel for advice or other representation (whether or not any suit has been or shall be filed) with respect to any collateral for the Loan or any part thereof, or any of the Loan
Documents, or the attempt to enforce any security interest or lien on any collateral, or to enforce any rights of the Agent or the Lenders or any of Borrowers’ or any other party’s obligations under any of the Loan Documents, but not with
respect to any dispute between Agent and any other Lender(s). It is understood and agreed that in the event the Agent determines it is necessary to engage counsel for Lender from and after the occurrence of a Default or Event of Default, said
counsel shall be selected by the Agent and written notice of such selection, together with a copy of such counsel’s engagement letter and fee estimate, shall be delivered to the Lenders. 

(d) In the event that all or any portion of the collateral for the Loan is acquired by the Agent as the result of the
exercise of any remedies hereunder or under any other Loan Document, or is retained in satisfaction of all or any part of Borrowers’ obligations under the Loan Documents, title to any such collateral or any portion thereof shall be held in the
name of the Agent or a nominee or subsidiary of Agent, as agent, for the ratable benefit of the Agent and the Lenders. The Agent shall prepare a recommended course of action for such collateral (the “Post-Default Plan”), which shall
be subject to the approval of the Required Lenders. The Agent shall administer the collateral in accordance with the Post-Default Plan, and upon demand therefor from time to time, each Lender will contribute its share (based on its Percentage) of
all reasonable costs and expenses incurred by the Agent pursuant to the Post-Default Plan, including without limitation, any operating losses and all necessary operating reserves. To the extent there is net operating income from such collateral, the
Agent shall, in accordance with the Post-Default Plan, determine the amount and timing of distributions to Lenders. All such distributions shall be made to Lenders in accordance with their respective Percentages. In no event shall the provisions of
this subsection or the Post-Default Plan require the Agent or any Lender to take an action which would cause such Lender to be in violation of any applicable regulatory requirements. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 46

 20.8 Lender Actions Against Borrower or the Collateral.

 Each Lender agrees that it will not take any action, nor institute any actions or proceedings, against any
Borrower or any other person hereunder or under any other Loan Documents with respect to exercising claims against such Borrower or rights in any collateral without the consent of the Required Lenders. With respect to any action by the Agent to
enforce the rights and remedies of the Agent and Lenders with respect to such Borrower and any collateral in accordance with the terms of this Agreement, each Lender hereby consents to the jurisdiction of the court in which such action is
maintained. 
 20.9 Assignment and Participation. 

No Lender shall be permitted to assign or sell all or any portion of its rights and obligations under this Agreement to
any Borrower or any Affiliate of any Borrower. 
 20.10 Ratable Sharing. 

Subject to Sections 20.4 and 20.5, Lenders agree among themselves that (i) with respect to all amounts
received by them which are applicable to the payment of the Loan, equitable adjustment will be made so that, in effect, all such amounts will be shared among them ratably in accordance with their Percentages, whether received by voluntary payment,
by the exercise of the right of set-off or bankers’ lien, by counterclaim or cross action or by the enforcement of any or all of the Loan Documents or any collateral and (ii) if any of them shall by voluntary payment or by the exercise of
any right of counterclaim, set-off, bankers’ lien or otherwise, receive payment of a proportion of the aggregate amount of the Loan held by it which is greater than its Percentage of the payments on account of the Loan, the one receiving such
excess payment shall purchase, without recourse or warranty, an undivided interest and participation (which it shall be deemed to have done simultaneously upon the receipt of such payment) in such obligations owed to the others so that all such
recoveries with respect to such obligations shall be applied ratably in accordance with their Percentages; provided, that if all or part of such excess payment received by the purchasing party is thereafter recovered from it, those purchases shall
be rescinded and the purchase prices paid for such participations shall be returned to that party to the extent necessary to adjust for such recovery, but without interest except to the extent the purchasing party is required to pay interest in
connection with such recovery. Borrowers agree that any Lender so purchasing a participation from another Lender pursuant to this Section may, to the fullest extent permitted by law, exercise all its rights of payment (including the right of
set-off) with respect to such participation as fully as if such Lender were the direct creditor of Borrowers in the amount of such participation. 
 20.11 General Immunity. 
 Neither Agent nor any of
its directors, officers, agents or employees shall be liable to Borrowers or any Lender for any action taken or omitted to be taken by it or them hereunder or under any other Loan Document or in connection herewith or therewith, except for its or
their own gross negligence or willful misconduct. In the absence of gross negligence, the Agent shall not be liable for any apportionment or distribution of payments made by it in good faith pursuant to Section 20.5, and if any such
apportionment or distribution is subsequently determined to have been made in error the sole recourse of any Lender to whom payment was due, but not made, shall be to recover from the recipients of such payments any payment in excess of the amount
to which they are determined to have been entitled. 
 20.12 No Responsibility for Loan, Recitals,
etc.. 
 Neither Agent nor any of its directors, officers, agents or employees shall be responsible for
or have any duty to ascertain, inquire into, or verify (i) any statement, warranty or representation made in connection with any Loan Document or any use of the Loan; (ii) the performance or observance of any of the covenants or agreements
of any party to any Loan Document; (iii) the satisfaction of any condition specified in this Agreement, except receipt of items purporting to be the items required to be delivered to any Agent; or (iv) the validity, effectiveness or
genuineness of any Loan Document or any other instrument or writing furnished in connection therewith, provided that the foregoing shall not release Agent from liability for its gross negligence or willful misconduct. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 47

 20.13 Action on Instructions of Lenders. 

The Agent shall in all cases be fully protected in acting, or in refraining from acting, hereunder and under any other
Loan Document in accordance with written instructions signed by all the Lenders (or the Required Lenders, if such action may be directed hereunder by the Required Lenders), and such instructions and any action taken or failure to act pursuant
thereto shall be binding on all of Lenders. Each Lender, severally to the extent of its Percentage, hereby agrees to indemnify Agent against and hold it harmless from any and all liability, cost and expense that it may incur by reason of taking or
continuing to take any such action, provided that the foregoing shall not release Agent from liability for its gross negligence or willful misconduct. 
 20.14 Employment of Agents and Counsel. 
 The Agent
may undertake any of its duties as Agent hereunder and under any other Loan Document by or through employees, agents, and attorneys-in-fact and shall not be liable to Lenders, except as to money or securities received by them or their authorized
agents, for the default or misconduct of any such agents or attorneys-in-fact selected by it with reasonable care. The Agent shall be entitled to advice of counsel concerning all matters pertaining to the agency hereby created and its duties
hereunder and under any other Loan Document. 
 20.15 Reliance on Documents; Counsel. 

The Agent shall be entitled to rely upon any notice, consent, certificate, affidavit, letter, telegram, statement, paper
or document believed by it to be genuine and correct and to have been signed or sent by the proper person or persons, and, in respect to legal matters, upon the opinion of counsel selected by the Agent, which counsel may be an employee of Agent,
provided that the foregoing shall not release the Agent from liability for its gross negligence or willful misconduct. Any such counsel shall be deemed to be acting on behalf of Lender in assisting the Agent with respect to the Loan, but shall not
be precluded from also representing Agent in any matter in which the interests of Agent and the other Lenders may differ. 
 20.16 Agent’s Reimbursement and Indemnification. 

Lenders agree to reimburse and indemnify Agent ratably (i) for any amounts (excluding principal and interest on the
Loan and loan fees) not reimbursed by Borrowers for which Agent is entitled to reimbursement under the Loan Documents, (ii) for any other expenses incurred by Agent on behalf of Lender, in connection with the preparation, execution, delivery,
administration and enforcement of the Loan Documents, if not paid by Borrowers, (iii) for any expenses incurred by Agent on behalf of Lender which may be necessary or desirable to preserve and maintain collateral or to perfect and maintain
perfected the liens upon the collateral granted pursuant to this Agreement and the other Loan Documents, if not paid by Borrowers, (iv) for any amounts and other expenses incurred by Agent on behalf of Lender in connection with any default by
any Lender hereunder or under the other Loan Documents, if not paid by such Lender, and (v) for any liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind and nature
whatsoever which may be imposed on, incurred by or asserted against Agent in any way relating to or arising out of the Loan Documents or any other document delivered in connection therewith or the transactions contemplated thereby, or the
enforcement of any of the terms thereof or of any such other documents, provided that no Lender shall be liable for any of the foregoing to the extent they arise from the gross negligence or willful misconduct of Agent. 

20.17 Rights as a Lender. 

With respect to its Commitment, if any, Agent shall have the same rights, powers and obligations hereunder and under any
other Loan Document as any Lender and may exercise such rights and powers as though it were not an Agent, and the term “Lender” or “Lenders” shall, unless the context otherwise indicates, include Agent in its individual
capacities. Borrowers and each Lender acknowledge and agree that Agent and/or its affiliates may accept deposits from, lend money to, hold other investments in, and generally engage in any kind of trust, debt, equity or other transaction or have
other relationships, in addition to those contemplated by this Agreement or any other Loan Document, with Borrowers or any of their affiliates in which Borrowers or such affiliate are not restricted hereby from engaging with any other person.

  

			
	 SECURED LOAN AGREEMENT
	  	Page 48

 20.18 Lenders’ Credit Decisions. 

Each Lender acknowledges that it has, independently and without reliance upon the Agent or any other Lender and based on
the financial statements and other information prepared by Borrowers and such other documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement and the other Loan Documents. Each
Lender also acknowledges that it will, independently and without reliance upon Agent or any other Lender and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not
taking action under this Agreement and the other Loan Documents. 
 20.19 Notice of Events of
Default. 
 Should Agent receive any written notice of the occurrence of a default or Event of Default,
or should the Agent send Borrowers a notice of Default or Event of Default, the Agent shall promptly furnish a copy thereof to each Lender. 
 20.20 Successor Agent. 
 (a) Agent may resign from
the performance of all its functions and duties hereunder at any time by giving at least thirty (30) days prior written notice to Lenders and Borrowers. Such resignation shall take effect on the date set forth in such notice or as otherwise
provided below. Such resignation by Agent as agent shall not affect its obligations hereunder, if any, as a Lender. 
 (b) Upon resignation by the Agent, or any successor Agent, the Required Lenders shall appoint a successor Agent with the written consent of Borrowers, which shall not be unreasonably withheld, conditioned
or delayed (provided that no consent of Borrowers shall be required if an Event of Default then exists). If no successor Agent shall have been so appointed by the Required Lenders (with the consent of Borrowers as set forth in the preceding
sentence), and shall have accepted such appointment within thirty (30) days after the retiring Agent’s giving notice of resignation, then the retiring Agent may appoint a successor Agent with the consent of Borrower, which shall not
unreasonably withheld, conditioned or delayed (provided that no consent of Borrower shall be required if an Event of Default then exists). Upon the acceptance of any appointment as an Agent hereunder by a successor Agent, such successor Agent shall
thereupon succeed to and become vested with all the rights, powers, privileges and duties of the Agent and the Agent, and the retiring Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents other than
its liability, if any, for duties and obligations accrued prior to its retirement. After any retiring Agent’s resignation hereunder as an Agent, the provisions of this Article 20 shall continue in effect for its benefit in respect
of any actions taken or omitted to be taken by it while it was acting as an Agent hereunder and under the other Loan Documents. In the event that Synovus Bank, in its sole discretion, elects to become successor Agent, the consent of Borrowers shall
not be required. 
 ARTICLE 21 
 WAIVER OF JURY TRIAL 
 EACH BORROWER AND LENDER EACH WAIVE
ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS OR RELATING THERETO OR ARISING FROM THE LENDING RELATIONSHIP WHICH IS THE SUBJECT OF THIS AGREEMENT AND AGREE
THAT ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. 

  

			
	 SECURED LOAN AGREEMENT
	  	Page 49

 EXECUTED as of the date first set forth above. 

 

									
	BORROWERS:	 		 	 CHP BATESVILLE HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President
				
		 		 		 	 CHP BROADWAY HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President
				
		 		 		 	 CHP JONESBORO HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President
				
		 		 		 	 CHP MAGNOLIA HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President
				
		 		 		 	 CHP MINE CREEK HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President
				
		 		 		 	 CHP SEARCY HEALTHCARE OWNER, LLC,
 a Delaware limited liability company

					
		 		 		 	By:	 	 /s/ Steven M. Wortman

		 		 		 		 	Steven M. Wortman, Senior Vice President

  

			
	 SECURED LOAN AGREEMENT
	  	Page 50

									
	AGENT:	 		 	KEYBANK NATIONAL ASSOCIATION, a national banking association, as administrative agent on behalf of itself and the other lenders
					
		 		 		 	By:	 	 /s/ Amy L. MacLearie

		 		 		 		 	Amy L. MacLearie, AVP-Closing Officer
			
	LENDERS:	 		 	KEYBANK NATIONAL ASSOCIATION, a national banking association
					
		 		 		 	By:	 	 /s/ Amy L. MacLearie

		 		 		 		 	Amy L. MacLearie, AVP-Closing Officer
			
		 		 	SYNOVUS BANK, a Georgia state banking corporation
					
		 		 		 	By:	 	 /s/ James C. Thompson

		 		 		 		 	James C. Thompson, Senior Director

  

			
	 SECURED LOAN AGREEMENT
	  	Page 51

 EXHIBIT A-1 

Legal Description of Batesville Land 
 [Intentionally Omitted] 
 .EXHIBIT A-2 

Legal Description of Broadway Land 
 [Intentionally Omitted] 
 EXHIBIT A-3 

Legal Description of Jonesboro Land 
 [Intentionally Omitted] 
 EXHIBIT A-4 

Legal Description of Magnolia Land 
 [Intentionally Omitted] 
 .EXHIBIT A-5 

Legal Description of Mine Creek Land 
 [Intentionally Omitted] 
 EXHIBIT A-6 

Legal Description of Searcy Land 
 [Intentionally Omitted] 
 EXHIBIT B-1 

Batesville Permitted Exceptions 
 [Intentionally Omitted] 

 EXHIBIT B-2 

Broadway Permitted Exceptions 
 [Intentionally Omitted] 
 EXHIBIT B-3 

Jonesboro Permitted Exceptions 
 [Intentionally Omitted] 
 EXHIBIT B-4 

Magnolia Permitted Exceptions 
 [Intentionally Omitted] 
 EXHIBIT B-5 

Mine Creek Permitted Exceptions 
 [Intentionally Omitted] 
 EXHIBIT B-6 

Searcy Permitted Exceptions 
 [Intentionally Omitted] 
 EXHIBIT C 

Title Requirements 
 [Intentionally Omitted] 
 EXHIBIT D 

SURVEY REQUIREMENTS 
 [Intentionally Omitted] 

 EXHIBIT E 

 
 

 
 INSURANCE REQUIREMENTS FOR COMMERCIAL REAL ESTATE LOANS 

TERM LOAN – Existing or Completed Building – Health Care Group 

[Intentionally Omitted] 
 EXHIBIT F 
 RESERVED 

EXHIBIT G 
 FORM OF BORROWERS’ CERTIFICATE OF COMPLIANCE 
 [Intentionally Omitted]

 EXHIBIT H 
 ASSIGNMENT AND ASSUMPTION AGREEMENT 
 [Intentionally Omitted] 

SCHEDULE I 
 Environmental Documents 
 [Intentionally Omitted] 

SCHEDULE II 
 Minimum Quarterly Rent Coverage Requirements 
 [Intentionally Omitted]

 SCHEDULE III 
 Immediate Repairs 
 [Intentionally Omitted]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]